D-Wave Quantum (QBTS) S-1 13 Feb 23 IPO registration Financial data

Cover

Cover	9 Months Ended
	Sep. 30, 2022
Document Information [Line Items]
Document Type	S-1
Entity Registrant Name	D-Wave Quantum Inc.
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Central Index Key	0001907982
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents		$ 13,764	$ 9,483
Trade accounts receivable, net		740	421
Receivable research incentives		1,052	4,774
Inventories		2,533	2,114
Prepaid expenses and other current assets		8,190	1,116
Deferred offering costs		0	1,250
Total current assets		26,279	19,158
Property and equipment, net		2,537	3,249
Operating lease right-of-use assets		8,066	8,578
Intangible assets, net		262	272
Other noncurrent assets		1,345	1,353
Total assets		38,489	32,610
Current liabilities:
Trade accounts payable		3,158	2,109
Accrued expenses and other current liabilities		5,318	3,614
Current portion of operating lease liabilities		1,461	1,687
Loans payable, current		2,232	220
Deferred revenue, current		1,989	2,665
Promissory note - related party		420	0
Total current liabilities		14,578	10,295
Warrant liabilities		5,498	0
Operating lease liabilities, net of current portion		6,211	6,990
Loans payable, noncurrent		12,912	12,233
Deferred revenue, noncurrent		0	54
Other noncurrent liabilities		0	18
Total liabilities		39,199	29,590
Commitments and contingencies (Note 10)
Stockholders' (deficit) equity:
Non-redeemable convertible preferred stock, no par value; 137,765,828 shares authorized as of June 30, 2022 and 137,765,828 shares issued and outstanding as of December 31, 2021.	[1]	0	189,881
Common stock	[1]	11	0
Additional paid-in capital		372,840	148,850
Accumulated deficit		(363,136)	(325,268)
Accumulated other comprehensive loss		(10,425)	(10,443)
Total stockholders' (deficit) equity		(710)	3,020	$ 30,237
Total liabilities and stockholders' equity		$ 38,489	32,610
DWave System [Member]
Current assets:
Cash and cash equivalents			9,483	21,335
Trade accounts receivable, net			421	590
Receivable research incentives			4,774	15,585
Inventories			2,114	2,521
Prepaid expenses and other current assets			1,116	1,253
Deferred offering costs			1,250	0
Total current assets			19,158	41,284
Property and equipment, net			3,249	2,894
Operating lease right-of-use assets			8,578	2,948
Intangible assets, net			272	148
Other noncurrent assets			1,353	187
Total assets			32,610	47,461
Current liabilities:
Trade accounts payable			2,109	2,176
Accrued expenses and other current liabilities			3,614	3,183
Current portion of operating lease liabilities			1,687	1,544
Loans payable, current			220	355
Deferred revenue, current			2,665	4,713
Total current liabilities			10,295	11,971
Operating lease liabilities, net of current portion			6,990	1,440
Loans payable, noncurrent			12,233	1,321
Deferred revenue, noncurrent			54	0
Other noncurrent liabilities			18	0
Total liabilities			29,590	14,732
Commitments and contingencies (Note 10)
Stockholders' (deficit) equity:
Non-redeemable convertible preferred stock, no par value; 137,765,828 shares authorized as of June 30, 2022 and 137,765,828 shares issued and outstanding as of December 31, 2021.			189,881	189,881
Common stock			2,610	2,492
Additional paid-in capital			146,240	144,537
Accumulated deficit			(325,268)	(293,723)
Accumulated other comprehensive loss			(10,443)	(10,458)
Total stockholders' (deficit) equity			3,021	32,729
Total liabilities and stockholders' equity			$ 32,610	$ 47,461
[1]Shares of legacy non-redeemable convertible preferred stock and legacy common stock have been retroactively restated to give effect to the Business Combination.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2022
Preferred stock, authorized (in shares)	122,564,333		0
Preferred stock, issued (in shares)	122,564,333		0
Preferred stock, outstanding (in shares)	122,564,333		0
Common stock, par value (in usd per share)	$ 0.0001		$ 0.0001
Common stock, shares authorized			675,000,000
Common stock, issued (in shares)	2,817,498		110,377,357
Common stock, outstanding (in shares)	2,817,498		110,377,357
DWave System [Member]
Preferred stock, par value (in Dollars per share)	$ 0	$ 0
Preferred stock, shares authorized, unlimited	Unlimited	Unlimited
Preferred stock, issued (in shares)	137,765,828	137,765,828
Preferred stock, outstanding (in shares)	137,765,828	137,765,828
Common stock, par value (in usd per share)	$ 0	$ 0
Common stock, shares authorized, unlimited	Unlimited	Unlimited
Common stock, issued (in shares)	3,166,949	3,061,746
Common stock, outstanding (in shares)	3,166,949	3,061,746

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands		3 Months Ended		9 Months Ended		12 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Revenue		$ 1,695	$ 1,307	$ 4,778	$ 3,853
Cost of revenue		609	307	1,778	873
Total gross profit		1,086	1,000	3,000	2,980
Operating expenses:
Research and development		7,334	6,313	20,933	19,268
General and administrative		6,921	2,801	14,527	7,831
Sales and marketing		2,099	1,679	5,438	3,975
Total operating expenses		16,354	10,793	40,898	31,074
Loss from operations		(15,268)	(9,793)	(37,898)	(28,094)
Other income (expense), net:
Interest expense		(1,336)	(205)	(3,874)	(590)
Government assistance		0	4,560	0	9,146
Gain on investment in marketable securities		0	1,164	0	1,164
Change in fair value of warrant liabilities		2,603	0	2,603	0
Other income (expense), net		948	65	1,301	669
Total other income (expense), net		2,215	5,584	30	10,389
Net income (loss)		$ (13,053)	$ (4,209)	$ (37,868)	$ (17,705)
Net loss per share, basic (in usd per share)		$ (0.11)	$ (0.03)	$ (0.31)	$ (0.14)
Net loss per share, diluted (in usd per share)		$ (0.11)	$ (0.03)	$ (0.31)	$ (0.14)
Weighted-average shares used in calculating net loss per share, basic and diluted	[1]	116,256,805	125,362,390	122,337,727	125,331,065
Weighted-average shares used in computing net loss per share, diluted (in shares)	[1]	116,256,805	125,362,390	122,337,727	125,331,065
Comprehensive loss:
Net income (loss)		$ (13,053)	$ (4,209)	$ (37,868)	$ (17,705)
Foreign currency translation adjustment, net of tax		56	29	18	40
Comprehensive loss		$ (12,997)	$ (4,180)	$ (37,850)	$ (17,665)
DWave System [Member]
Revenue						$ 6,279	$ 5,160
Cost of revenue						1,750	915
Total gross profit						4,529	4,245
Operating expenses:
Research and development						25,401	20,411
General and administrative						11,897	11,587
Sales and marketing						6,179	3,714
Total operating expenses						43,477	35,712
Loss from operations						(38,948)	(31,467)
Other income (expense), net:
Interest expense						(1,728)	(5,257)
Government assistance						7,167	12,027
Gain on debt extinguishment						0	3,873
Gain on settlement of warrant liability						0	7,836
Gain on investment in marketable securities						1,163	0
Other income (expense), net						801	2,969
Total other income (expense), net						7,403	21,448
Net income (loss)						$ (31,545)	$ (10,019)
Net loss per share, basic (in usd per share)						$ (0.28)	$ (0.08)
Net loss per share, diluted (in usd per share)						$ (0.28)	$ (0.08)
Weighted-average shares used in calculating net loss per share, basic and diluted						111,911,127	121,358,898
Weighted-average shares used in computing net loss per share, diluted (in shares)						111,911,127	121,358,989
Comprehensive loss:
Net income (loss)						$ (31,545)	$ (10,019)
Foreign currency translation adjustment, net of tax						15	(82)
Comprehensive loss						$ (31,530)	$ (10,101)
[1]Weighted-average shares have been retroactively restated to give effect to the Business Combination.

Condensed consolidated statem_2

Condensed consolidated statements of stockholders' (deficit) equity - USD ($) $ in Thousands	Total	Restatement Adjustment	Scenario Previously Reported	Private Placement [Member]	Equity Line Of Credit [Member]	D-Wave Systems Inc. [Member]	Non-redeemable convertible preferred stock	Non-redeemable convertible preferred stock Restatement Adjustment	Non-redeemable convertible preferred stock Scenario Previously Reported	Non-redeemable convertible preferred stock D-Wave Systems Inc. [Member]	Common stock	Common stock Restatement Adjustment	Common stock Scenario Previously Reported	Common stock Private Placement [Member]	Common stock Equity Line Of Credit [Member]	Common stock D-Wave Systems Inc. [Member]	Additional Paid-in capital	Additional Paid-in capital Restatement Adjustment	Additional Paid-in capital Scenario Previously Reported	Additional Paid-in capital Private Placement [Member]	Additional Paid-in capital Equity Line Of Credit [Member]	Additional Paid-in capital D-Wave Systems Inc. [Member]	Accumulated deficit	Accumulated deficit Restatement Adjustment	Accumulated deficit Scenario Previously Reported	Accumulated deficit D-Wave Systems Inc. [Member]	Accumulated other comprehensive loss	Accumulated other comprehensive loss Restatement Adjustment	Accumulated other comprehensive loss Scenario Previously Reported	Accumulated other comprehensive loss D-Wave Systems Inc. [Member]
Balance at Dec. 31, 2019						$ (103,868)				$ 152,091						$ 16,337						$ 21,784				$ (283,704)				$ (10,376)
Balance (in Shares) at Dec. 31, 2019										135,012,939						15,220,212
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)																11,250
Exercise of stock options						4										$ 10						(6)
Stock-based compensation						269																269
D-Wave issuance of preferred stock pursuant to exercise of warrants						818				$ 818
D-Wave issuance of preferred stock pursuant to exercise of warrants (in shares)										313,159
D-Wave share issuance costs						(110)				$ (110)
D-Wave stock exchanged on transaction						(169,140)				$ (152,799)						$ (16,347)
D-Wave stock exchanged on transaction (in Shares)										(135,326,098)						(15,231,462)
DWSI Common Stock issued on D-Wave common stock conversion						8,450										$ 2,491						5,966
DWSI Common Stock issued on D-Wave common stock conversion (in Shares)																3,060,746
DWSI Class A Preferred Stock issued on D-Wave preferred stock conversion						160,690				$ 47,336												113,354
DWSI Class A Preferred Stock issued on D-Wave preferred stock conversion (in Shares)										27,065,220
DWSI Class B Preferred Stock issued for cash						43,679				$ 43,679
DWSI Class B Preferred Stock issued for cash (in Shares)										53,958,748
DWSI Class B Preferred Stock issued on D-Wave convertible debt transfer						99,298				$ 99,298
DWSI Class B Preferred Stock issued on D-Wave convertible debt transfer (in Shares)										56,741,860
DWSI share issuance costs						(432)				$ (432)
DWSI fair value of warrants issued for services						450																450
DWSI exercise of stock options						1										$ 1
DWSI exercise of stock options (in Shares)																1,000
DWSI stock-based compensation						2,720																2,720
Net income (loss)						(10,019)																				(10,019)
Foreign currency translation adjustment, net of tax						$ (82)																								(82)
Preferred stock, balance (in shares) at Dec. 31, 2020						137,765,828	122,564,333	(15,201,495)	137,765,828
Common stock, balance (in shares) at Dec. 31, 2020						3,061,746					2,723,903	(337,843)	3,061,746
Balance (in Shares) at Dec. 31, 2020										137,765,828						3,061,746
Balance at Dec. 31, 2020	$ 30,237	$ (2,492)	$ 32,729			$ 32,729	$ 189,881	$ 0	$ 189,881	$ 189,881	$ 0	$ (2,492)	$ 2,492			$ 2,492	$ 144,537	$ 0	$ 144,537			144,537	$ (293,723)	$ 0	$ (293,723)	(293,723)	$ (10,458)	$ 0	$ (10,458)	(10,458)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)											74,770
Exercise of stock options	(30)																(30)
Stock-based compensation	555																555
Net income (loss)	(17,705)																						(17,705)
Foreign currency translation adjustment, net of tax	40																										40
Preferred stock, balance (in shares) at Sep. 30, 2021							122,564,333
Common stock, balance (in shares) at Sep. 30, 2021											2,798,673
Balance at Sep. 30, 2021	13,097						$ 189,881				$ 0						145,062						(311,428)				(10,418)
Balance at Dec. 31, 2020	$ 30,237	(2,492)	32,729			$ 32,729	$ 189,881	$ 0	$ 189,881	$ 189,881	$ 0	$ (2,492)	$ 2,492			$ 2,492	144,537	0	144,537			144,537	(293,723)	0	(293,723)	(293,723)	(10,458)	0	(10,458)	(10,458)
Balance (in Shares) at Dec. 31, 2020										137,765,828						3,061,746
Preferred stock, balance (in shares) at Dec. 31, 2020						137,765,828	122,564,333	(15,201,495)	137,765,828
Common stock, balance (in shares) at Dec. 31, 2020						3,061,746					2,723,903	(337,843)	3,061,746
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)						105,203										105,203
Exercise of stock options						$ 82										$ 118						(36)
Stock-based compensation						1,739																1,739
Net income (loss)						(31,545)																				(31,545)
Foreign currency translation adjustment, net of tax						$ 15																								15
Preferred stock, balance (in shares) at Dec. 31, 2021	122,564,333					137,765,828	122,564,333	(15,201,495)	137,765,828
Common stock, balance (in shares) at Dec. 31, 2021	2,817,498					3,166,949					2,817,498	(349,451)	3,166,949
Balance (in Shares) at Dec. 31, 2021										137,765,828						3,166,949
Balance at Dec. 31, 2021	$ 3,020	0	3,020			$ 3,021	$ 189,881	$ 0	$ 189,881	$ 189,881	$ 0	$ (2,610)	$ 2,610			$ 2,610	148,850	2,610	146,240			146,240	(325,268)	0	(325,268)	(325,268)	(10,443)	0	(10,443)	(10,443)
Balance at Jun. 30, 2021	17,053	(2,586)	19,639				$ 189,881	$ 0	$ 189,881		$ 0	$ (2,586)	$ 2,586				144,838	0	144,838				(307,219)	0	(307,219)		(10,447)	0	(10,447)
Preferred stock, balance (in shares) at Jun. 30, 2021							122,564,333	(15,201,495)	137,765,828
Common stock, balance (in shares) at Jun. 30, 2021											2,796,004	(346,785)	3,142,789
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)											2,669
Exercise of stock options	(1)																(1)
Stock-based compensation	225																225
Net income (loss)	(4,209)																						(4,209)
Foreign currency translation adjustment, net of tax	29																										29
Preferred stock, balance (in shares) at Sep. 30, 2021							122,564,333
Common stock, balance (in shares) at Sep. 30, 2021											2,798,673
Balance at Sep. 30, 2021	13,097						$ 189,881				$ 0						145,062						(311,428)				(10,418)
Balance at Dec. 31, 2021	$ 3,020	0	3,020			$ 3,021	$ 189,881	$ 0	$ 189,881	$ 189,881	$ 0	$ (2,610)	$ 2,610			$ 2,610	148,850	2,610	146,240			$ 146,240	(325,268)	0	(325,268)	$ (325,268)	(10,443)	0	(10,443)	$ (10,443)
Preferred stock, balance (in shares) at Dec. 31, 2021	122,564,333					137,765,828	122,564,333	(15,201,495)	137,765,828
Common stock, balance (in shares) at Dec. 31, 2021	2,817,498					3,166,949					2,817,498	(349,451)	3,166,949
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	174,378										155,137
Exercise of stock options	$ 72																72
Stock-based compensation	$ 3,695																3,695
Issuance of common stock				$ 40,000	$ 3,271									$ 1						$ 39,999	$ 3,271
Issuance of common stock (in shares)					381,540									5,816,528	381,540
Stock Issued During Period Shares Exercise Of Warrants	115,025										115,025
Stock Issued During Period Value Exercise Of Warrants	$ 910																910
Net income (loss)	(37,868)																						(37,868)
Issuance of common stock upon conversion of D-Wave Systems preferred stock in connection with the Business Combination (Note 3) (in shares)							(122,564,333)				96,764,117
Issuance of common stock upon conversion of D-Wave Systems preferred stock in connection with the Business Combination (Note 3)	0						$ (189,881)				$ 10						189,871
Exchange of common stock (in shares)											4,327,512
Business Combination, net of redemptions and transaction costs (Note 3)	(13,828)																(13,828)
Foreign currency translation adjustment, net of tax	$ 18																										18
Preferred stock, balance (in shares) at Sep. 30, 2022	0						0
Common stock, balance (in shares) at Sep. 30, 2022	110,377,357										110,377,357
Balance at Sep. 30, 2022	$ (710)						$ 0				$ 11						372,840						(363,136)				(10,425)
Balance at Jun. 30, 2022	(20,093)	$ 0	$ (20,093)				$ 189,881	$ 0	$ 189,881		$ 0	$ (2,811)	$ 2,811				150,590	$ 2,811	$ 147,779				(350,083)	$ 0	$ (350,083)		(10,481)	$ 0	$ (10,481)
Preferred stock, balance (in shares) at Jun. 30, 2022							122,564,333	(15,201,495)	137,765,828
Common stock, balance (in shares) at Jun. 30, 2022											2,972,635	(368,692)	3,341,327
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,027																2,027
Issuance of common stock				$ 40,000	$ 3,271									$ 1						$ 39,999	$ 3,271
Issuance of common stock (in shares)														5,816,528	381,540
Stock Issued During Period Shares Exercise Of Warrants											115,025
Stock Issued During Period Value Exercise Of Warrants	910																910
Net income (loss)	(13,053)																						(13,053)
Issuance of common stock upon conversion of D-Wave Systems preferred stock in connection with the Business Combination (Note 3) (in shares)							(122,564,333)				96,764,117
Issuance of common stock upon conversion of D-Wave Systems preferred stock in connection with the Business Combination (Note 3)	0						$ (189,881)				$ 10						189,871
Exchange of common stock (in shares)											4,327,512
Business Combination, net of redemptions and transaction costs (Note 3)	(13,828)																(13,828)
Foreign currency translation adjustment, net of tax	$ 56																										56
Preferred stock, balance (in shares) at Sep. 30, 2022	0						0
Common stock, balance (in shares) at Sep. 30, 2022	110,377,357										110,377,357
Balance at Sep. 30, 2022	$ (710)						$ 0				$ 11						$ 372,840						$ (363,136)				$ (10,425)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)				5,816,528	127,180
Common stock, balance (in shares) at Aug. 05, 2022	110,007,972

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income (loss)	$ (37,868)	$ (17,705)
Adjustments to reconcile net loss to cash used in by operating activities:
Depreciation and amortization	1,038	1,135
Allowance for doubtful accounts	1	0
Stock-based compensation	3,695	555
Amortization of operating right of use assets	590	764
Provision for excess and obsolete inventory	265	215
Non-cash interest expense on government payable	1,902	601
Venture loan interest and final payment fee	1,808	0
Grant income	0	(9,135)
Fair Value Adjustment of Warrants	(2,603)	0
Gain on investments in marketable securities	0	(1,164)
Non-cash lease expense	0	(756)
(Gain) loss on marketable securities	0	(1,164)
Unrealized foreign exchange loss (gain)	(1,226)	15
Change in operating assets and liabilities:
Trade accounts receivable	(320)	(334)
Research incentives receivable	579	(10,374)
Inventories	(684)	(29)
Deferred offering costs	1,250	0
Prepaid expenses and other current assets	(7,074)	(929)
Trade accounts payable	1,049	(1,081)
Right-of-use assets	(97)	0
Accrued expenses and other current liabilities	1,704	(313)
Deferred revenue, current	(730)	(148)
Loan program payable	0	11,068
Current portion of long-term debt	2,893	0
Operating lease liability	(442)	0
Net cash used in operating activities	(34,270)	(27,615)
Cash flows from investing activities:
Purchase of property and equipment	(249)	(1,493)
Purchase of software	(67)	(214)
Net cash used in investing activities	(316)	(1,707)
Cash flows from financing activities:
Proceeds from issuance of common stock from the PIPE investment (Note 3)	40,000	0
Business Combination, net of redemption and transaction costs (Note 3)	4,100	0
Transaction costs paid directly by D-Wave Systems	(6,528)	0
Proceeds from exercise of public warrants	910	0
Proceeds from promissory note - related party	420	0
Proceeds from government assistance	3,124	16,346
Proceeds from issuance of common stock upon exercise of stock options	72	66
Proceeds from debt financing	19,870	0
Payment for directors and officers insurance	(864)	0
Debt payments	(20,000)	(23)
Venture loan interest and final payment fee	(1,808)	0
Government loan payment	(398)	(399)
Net cash provided by financing activities	38,898	15,990
Effect of exchange rate changes on cash and cash equivalents	(31)	42
Net (decrease) increase in cash and cash equivalents	4,281	(13,290)
Cash and cash equivalents at beginning of period	9,483	21,335	$ 21,335
Cash and cash equivalents at end of period	13,764	8,045	9,483	$ 21,335
Supplemental disclosure of noncash investing and financial activities:
Initial warrant liabilities recognized in connection with closing of Business Combination	8,101	0
Non-cash Business Combination financing	(11,400)	0
Stock Issued	3,271	0
Conversion of convertible preferred stock to common stock	189,871	0
Public Warrants [Member]
Adjustments to reconcile net loss to cash used in by operating activities:
Fair Value Adjustment of Warrants	(1,483)	0
Private Warrants [Member]
Adjustments to reconcile net loss to cash used in by operating activities:
Fair Value Adjustment of Warrants	(1,120)	0
DWave System [Member]
Cash flows from operating activities:
Net income (loss)			(31,545)	(10,019)
Adjustments to reconcile net loss to cash used in by operating activities:
Depreciation and amortization			1,534	1,886
Stock-based compensation			1,739	2,989
Amortization of operating right of use assets			1,068	840
Provision for excess and obsolete inventory			269	246
Non-cash interest expense on government assistance			1,722	137
Non-cash interest expense on convertible debt				5,095
Gain on settlement of warrant liability			0	(7,836)
Gain on investments in marketable securities			(1,163)	0
Gain on debt extinguishment			0	(3,873)
Interest benefit on debt			(19)
Government assistance			(7,140)	(12,027)
Fair value of warrants issued for services				451
Non-cash lease expense				201
Unrealized foreign exchange loss (gain)			(100)	(287)
Change in operating assets and liabilities:
Trade accounts receivable			163	8,002
Research incentives receivable			2,236	(9,053)
Inventories			182	(652)
Prepaid expenses and other current assets			(1,012)	(16)
Trade accounts payable			(379)	1,279
Accrued expenses and other current liabilities			578	(5,579)
Deferred revenue, current			(1,902)	(335)
Operating lease liability			(1,031)	(736)
Net cash used in operating activities			(34,800)	(29,287)
Cash flows from investing activities:
Purchase of property and equipment			(1,774)	(736)
Purchase of software			(225)	(53)
Net cash used in investing activities			(1,999)	(789)
Cash flows from financing activities:
Proceeds from issuance of preferred stock for cash			43,600	43,679
Share issuance costs				(542)
Proceeds from government assistance			25,147
Proceeds from issuance of common stock upon exercise of stock options			85	5
Proceeds from debt financing			111
Debt payments			(31)
Government loan payment			(399)
Proceeds from exercise of warrants				2
Net cash provided by financing activities			24,913	43,144
Effect of exchange rate changes on cash and cash equivalents			34	(13)
Net (decrease) increase in cash and cash equivalents			(11,852)	13,055
Cash and cash equivalents at beginning of period	$ 9,483	$ 21,335	21,335	8,280
Cash and cash equivalents at end of period			9,483	21,335
Supplemental disclosure of noncash investing and financial activities:
Operating lease right-of-use assets recognized in exchange for new operating lease obligations			11,870	4,932
Acquisition of property and equipment included in accounts payable			14	(79)
Cash payments included in the measurement of operating lease liabilities			1,573	$ 1,474
Unpaid deferred costs			$ 1,142

Description of business

Description of business	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Description of Business	1. Description of business D-Wave (“D-Wave” D-Wave (“D-Wave D-Wave D-Wave For the three and nine month periods ended September 30, 2022 and 2021, the Company’s revenue was derived primarily from customers located in the United States, Japan, and Germany.
DWave System [Member]
Description of Business		1. Description of business D-Wave (“D-Wave” web-based TM D-Wave TM References to the “Company” herein for the periods before April 14, 2020, shall be to D-Wave D-Wave”) D-Wave D-Wave On February 7, 2022, DPCM Capital Inc., a Delaware corporation (the “SPAC” or “DPCM”), and D-Wave D-Wave, D-Wave D-Wave b) D-Wave For the years ended December 31, 2021 and 2020, the Company’s revenue was derived primarily from customers located in the United States, Japan, and Germany.

Basis of presentation and Summa

Basis of presentation and Summary of Significant Accounting Policies	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Basis of presentation and Summary of Significant Accounting Policies	2. Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The Company has prepared the accompanying condensed consolidated financial statements in accordance with the accounting principles generally accepted in the United States of America (“U.S. GAAP”). Any reference in these notes to applicable guidance is meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Updates (“ASUs”) of the Financial Accounting Standards Board (“FASB”) and pursuant to the regulations of the U.S. Securities and Exchange Commission (“SEC”). The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, DPCM, as a direct wholly-owned subsidiary of D-Wave, D-Wave (i) D-Wave D-Wave (iii) D-Wave (iv) D-Wave D-Wave D-Wave As a result, the condensed consolidated financial statements included herein reflect (i) the historical operating results of D-Wave D-Wave D-Wave In accordance with ASC 805 guidance applicable to these circumstances, the equity structure has been restated in all comparative periods up to the closing date of the Business Combination, to reflect the number of the Company’s shares of common stock, par value $0.0001 (“Common Shares”) issued to D-Wave D-Wave Unaudited Interim Financial Information The accompanying interim condensed consolidated financial statements included in this quarterly report have been prepared by the Company and are unaudited, pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures contained within these interim condensed consolidated financial statements comply with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) for interim condensed consolidated financial statements and are adequate to make the information presented not misleading. The interim condensed consolidated financial statements included herein have been prepared on the same basis as the audited annual consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2021 included in the registration statement on Form S-1 No. 333-267124) D-Wave, Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in the condensed consolidated financial statements upon consolidation. Liquidity and going concern The Company has prepared its condensed consolidated financial statements assuming that it will continue as a going concern. Since its inception, the Company has incurred net losses and negative cash flows from operations. As of September 30, 2022, the Company had an accumulated deficit of $363.1 million and a working capital deficiency of $11.7 million. For the three months ended September 30, 2022 and 2021, the Company incurred a net loss of $13.1 million and $4.2 million respectively. For the nine months ended September 30, 2022 and 2021, the Company incurred a net loss of $37.9 million and $17.7 million respectively. The Company had net cash outflows from operations of $34.3 million and $27.6 million, respectively. As of September 30, 2022, the Company had $13.8 million of cash. The Company expects to incur additional operating losses and negative cash flows from operations as it continues to expand its commercial operations and research and development programs. On August 5, 2022, the Company completed a Business Combination with DPCM. The Company received gross proceeds of $49.0 million from the PIPE Investment (as defined below) and the DPCM trust account. In conjunction with the Business Combination, the Company and D-Wave D-Wave D-Wave D-Wave D-wave D-Wave To the extent that sufficient capital is not obtained through the cash received in connection with the sale D-Wave D-Wave’s D-Wave D-Wave These condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. Such adjustments could be material. COVID-19 The Company is subject to risks and uncertainties relating to the ongoing outbreak of the novel strain of coronavirus (“COVID-19”), The COVID-19 quarantines, shelter-in-place the COVID-19 COVID-19. Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s condensed consolidated financial statements and accompanying notes as of the date of the condensed consolidated financial statements. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience. The Company’s accounting estimates and assumptions may change over time in response to COVID-19 Public Warrants and Private Warrants The Company evaluated its outstanding warrants which were issued in exchange for (i) the warrants initially included in the DPCM units (the “Units”) issued in DPCM’s initial public offering (the “Public Warrants”), and (ii) the warrants of DPCM held by CDPM Sponsor Group, LLC (the “Sponsor”) that were issued to the Sponsor at the closing of DPCM’s initial public offering (the “Private Warrants,” and together with the Public Warrants, the “Warrants”), which are discussed in Note 8— Warrants 815-40, “Derivatives and Hedging—Contracts in Entity’s Own Equity The Private Warrants do not meet the derivative scope exception and are accounted for as derivative liabilities. Specifically, the Private Warrants contain provisions that cause the settlement amounts to be dependent upon the characteristics of the holder of the warrant which is not an input into the pricing of a fixed-for-fixed The Public Warrants also do not meet the indexation guidance in ASC 815-40 Operating segment Operating segments are defined as components of an enterprise for which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s Chief Executive Officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating and evaluating financial performance. As such, the Company views its operations and manages its business in one Geographic areas Foreign currency translation and transactions The Company’s reporting currency is the U.S. dollar. Generally, the functional and reporting currency of its international subsidiaries is the currency of their primary economic environment. Accordingly, all foreign balance sheet accounts have been translated into the U.S. dollars using the rate of exchange at the respective balance sheet date. Components of the condensed consolidated statements of operation and comprehensive loss have been translated at the average exchange rate for the year or the corresponding period. Translation gains and losses are recorded in accumulated other comprehensive loss as a component of stockholders’ equity. Gains or losses arising from currency exchange rate fluctuations on transactions denominated in a currency other than the local functional currency are included in the condensed consolidated statements of operations and comprehensive loss. For the three months ended September 30, 2022, the Company recorded $956,000 of foreign currency transaction gain in other income in its condensed consolidated statement of operations. For the three months ended September 30, 2021, the Company recorded $29,000 of foreign currency transaction loss in other income in its condensed consolidated statement of operations and comprehensive loss. For the nine months ended September 30, 2022 and 2021, the Company recorded $1,322,000 and $538,000 in foreign currency transaction gain, respectively, in other income in its condensed consolidated statements of operations and comprehensive loss. Cash and cash equivalents The Company’s cash and cash equivalents consists of money held in demand depository accounts. The carrying amount of cash was $13.8 million and $9.5 million as of September 30, 2022 and December 31, 2021, respectively, which approximates fair value and was determined based upon Level 1 inputs. The Company did not hold short-term investments as of September 30, 2022 and December 31, 2021. Fair value of financial instruments Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: • Level 1—Quoted prices in active markets for identical assets or liabilities. • Level 2—Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. • Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company recognizes transfers between levels of the fair value hierarchy on the date of the event or change in circumstances that caused the transfer. The carrying amounts reflected in the condensed consolidated balance sheets for cash , trade accounts receivable, net, trade accounts payable and accrued expenses approximate their fair values (Level 1). The Company carries its marketable investments at cost, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments by the same issuer, as they represent investments in privately held companies for which there are no quoted market prices. As of September 30, 2022 and December 31, 2021, the Company estimated the fair value of its securities denominated in Canadian dollars to be C$10.2 million for both periods presented, and its securities denominated in United States dollars to be $1.2 million and $279,000, respectively. The carrying value of its securities as of September 30, 2022 and December 31, 2021 was $1.2 million and $5,000, respectively and is included in other assets on the consolidated balance sheet. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis as of September 30, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value (in thousands): Description Level September 30, Liabilities: Warrant Liabilities – Public Warrants 1 $ 3,018 Warrant Liabilities – Private Placement Warrants 2 $ 2,480 The Warrants are accounted for as liabilities in accordance with ASC 815-40 The Warrants were initially valued using a binomial lattice model, which is considered to be a Level 3 fair value measurement. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the Warrants is the expected volatility of the Common Shares. The expected volatility as of the initial public offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own Public Warrant pricing. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrants was used as the fair value of the Warrants as of each relevant date. The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units are classified as Level 1 fair value measurements due to the use of an observable market quote in an active market. The subsequent measurements of the Private Warrants after the detachment of the Public Warrants from the Units are classified as Level 2 fair value measurements due to the use of an observable market quote for the Public Warrants, which are considered to be a similar asset in an active market. As of September 30, 2022, the liabilities for the Warrants were calculated by multiplying the quoted market price per DPCM Public Warrant of $0.31 by the 17,920,898 Warrants outstanding (see Note 8). Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. Net income (loss) per share Basic net loss per common share is computed by dividing the net loss available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Diluted net loss per common share is computed by dividing the net loss available to common stockholders adjusted by any preferred stock dividends declared during the period by the weighted average number of common shares and potential common shares outstanding when the impact is not antidilutive. Contingently issuable shares are included in basic EPS only when there is no circumstance under which those shares would not be issued. Shares issuable for little or no cash consideration shall be considered outstanding common shares and included in the computation of basic EPS. Concentration risk Agreements which potentially subject the Company to concentration risk consist principally of two to three customer agreements. During the three month period ended September 30, 2022, the Company earned 15%, 11% and 10% of its total revenue from three customers. During the three month period ended September 30, 2021, the Company earned 15% and 11% of its total revenue earned from two customers. During the nine month period ended September 30, 2022, the Company earned 13% of its total revenue from two separate customers. During the nine months ended September 30, 2021, the Company earned 13% and 12% of its total revenue from two customers. Government assistance The Company receives various forms of government assistance including (i) government grants (ii) investment credits, and (iii) government loans, for research and development initiatives from Canadian government agencies. The Company recognizes grants and investment tax credits relating to qualifying scientific research and development expenditures as a reduction of the related eligible expenses (research and development expenses) in its condensed consolidated statement of operations and comprehensive loss. Grants and investment tax credits are recognized in the period during which the related qualifying expenses are incurred, provided that the conditions under which the grants and investment tax credits have been met. The Company recognizes grants and investment tax credits in an amount equal to the estimated qualifying expenses incurred in each period multiplied by the applicable reimbursement percentage. Grants and investment tax credits that are recognized upon incurring qualifying expenses in advance of receipt of grant funding or proceeds from research and development incentives are recorded in the condensed consolidated balance sheets as research incentives receivable. In circumstances where the grants received relate to prior period eligible expenses, the Company recognizes them as government assistance in its condensed consolidated statement of operations and comprehensive loss in the current period. During the three months ended September 30, 2022 and 2021, the Company recorded a Scientific Research and Experimental Development (“SR&ED”) investment tax credit of $0.1 million and $$0.5 million in 2022 and 2021, respectively, as an offset to its research and development expenses in its condensed consolidated statements of operations and comprehensive loss. During the nine months ended September 30, 2022 and 2021, the Company recorded a SR&ED investment tax credit of $1.0 million and $1.2 million, respectively, as an offset to its research and development expenses in its condensed consolidated statements of operations and comprehensive loss. The Company has received government loans under funding agreements that bear interest at rates that are below market rates of interest or are interest-free. The Company accounts for the imputed benefit arising from the difference between a market rate of interest and the rate of interest charged as additional grant funding, and records interest expense for the loans at a market rate of interest. On the date that loan proceeds are earned, the Company recognizes the portion of the loan proceeds allocated to grant funding as a discount to the carrying value of the loan and as other liability, which is subsequently recognized as additional government assistance upon draw down of the qualified loan amounts. Revenue recognition The Company recognizes revenue in accordance with Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) 340-40, The standard was adopted on a full retrospective method on January 1, 2018. The adoption of ASC 606 had no impact on the Company and as such there was no recorded transition adjustment. The core principle of ASC 606 is that an entity shall recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To support this core principle, the Company applies the following five step approach: • Identify the contract with the customer • Identify the performance obligations • Determine the transaction price • Allocate the transaction price to the performance obligations • Recognize revenue when (or as) the entity satisfies a performance obligation The Company generates revenue through subscription sales to access its Quantum Computing as a Service (“QCaaS”) cloud platform and from professional services related to the practical applications of quantum computing technology to solve its customers’ business challenges, to develop quantum proofs-of-concepts, re-sellers re-seller re-sellers’ re-seller mark-up Revenue from QCaaS is recognized evenly over the contractual period, on a straight-line basis over the subscription term, beginning on the date that the service is made available to the customer. Professional services are recognized as they are earned based on the terms of the contract or based on the cost-to-cost cost-to-cost Recently adopted accounting standards and amendments D-Wave D-Wave Recent accounting pronouncements not yet adopted In November 2021, the FASB issued ASU No.2021-10, Disclosures by Business Entities about Government Assistance 2021-10 2021-10 2021-10 2021-10 initial application or (2) retrospectively to those transactions. The Company plans to adopt the ASU 2021-10
DWave System [Member]
Basis of presentation and Summary of Significant Accounting Policies		2. Basis of presentation and summary of significant accounting policies The Company has prepared the accompanying financial statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Any reference in these notes to applicable guidance is meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Updates (“ASUs”) of the Financial Accounting Standards Board (“FASB”). Liquidity and going concern The Company has prepared its consolidated financial statements assuming that it will continue as a going concern. Since its inception, the Company has incurred net losses and negative cash flows from operations. As of December 31, 2021, and 2020, the Company had an accumulated deficit of $325.3 million and $293.7 million, respectively. For the years ended December 31, 2021, and 2020, the Company incurred a net loss of $31.5 million and $10.0 million, respectively and had net cash outflows from operations of $34.8 million and $29.3 million, respectively. The Company expects to incur additional operating losses and negative cash flows from operations as it continues to expand its commercial operations and research and development programs. Duri n the year ended December 31, 2021, the Company secured $25.1 million in additional financing through an arrangement with the Strategic Innovation Fund (“SIF”) to receive up to C$40 million in contributions. As of December 31, 2021, the Company had received $25.1 million (C$32 million) from SIF. As of December 31, 2021, the Company had $9.5 million of cash and cash equivalents and $8.9 million of working capital. As further discussed in Note 1 – Description of the business As further discussed in Note 17 – Subsequent events, To the extent additional capital is not obtained through the Merger and PIPE offering, or through the cash received in connection with the Merger, management will be required to obtain additional capital through the sale of debt or equity, or other arrangements. However, there can be no assurance that the Company will be able to raise additional capital when needed or under acceptable terms. The sale of additional equity may dilute existing stockholders and newly issued shares may contain senior rights and preferences compared to currently outstanding shares. Any future debt may contain covenants and limit the Company’s ability to pay dividends or make other distributions to stockholders. If the Company is unable to obtain additional financing, operations may be scaled back or discontinued. These conditions give rise to material uncertainties that may cast substantial doubt on the ability of the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. Such adjustments could be material. Principles of consolidation The consolidated financial statements include the accounts of the Company. All intercompany accounts and transactions have been eliminated on consolidation. Transaction between entities under common control In April 2020, DWSI was formed with the primary objective of facilitating additional financing from existing shareholders and additional investors. Old D-Wave, D-Wave D-Wave The Class B Preferred Stock for $ million of proceeds. The DWSI newly non-redeemable convertible preferred stock issue price was $ per share for Class B1 and Class B2 Preferred Stock and $ for Class B Preferred Stock. The Transaction was recorded as a transaction between entities under common control that led to a change in the reporting entity. In the accompanying consolidated financial statements, the assets and the liabilities and relating operations of the transferring entity (Old D-Wave) D-Wave paid-in Amalgamation of Old D-Wave In order to simplify the corporate structure of DWSI Holdings Inc. and to reduce administrative costs, effective January 1, 2021, the Company completed a vertical short-form amalgamation pursuant to the British Columbia Business Corporations Act D-Wave. D-Wave D-Wave D-Wave The amalgamation did not have a significant effect on the business and operations of D-Wave. COVID-19 The Company is subject to risks and uncertainties relating to the ongoing outbreak of the novel strain of coronavirus (“COVID-19”), The COVID-19 quarantines, shelter-in-place the COVID-19 COVID-19. Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s consolidated financial statements and accompanying notes as of the date of the consolidated financial statements. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience. The Company’s accounting estimates and assumptions may change over time in response to COVID-19 Deferred Offering Costs Deferred offering costs consist of legal, accounting and consulting fees incurred through the balance sheet date that are directly related to the Merger mentioned in Note 1 – Description of the business Operating segment Operating segments are defined as components of an enterprise for which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s Chief Executive Officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating and evaluating financial performance. As such, the Company views its operations and manages its business in one operating and reportable segment (See Note 16 - Geographic areas Foreign currency translation and transactions The Company’s reporting currency is the US dollar. Generally, the functional and reporting currency of its international subsidiaries is the currency of their primary economic environment. Accordingly, all foreign balance sheet accounts have been translated into the U.S. dollars using the rate of exchange at the respective balance sheet date. Components of the consolidated statements of operation and comprehensive loss have been translated at the average exchange rate for the year or the corresponding period. Translation gains and losses are recorded in accumulated other comprehensive loss as a component of stockholders’ equity. Gains or losses arising from currency exchange rate fluctuations on transactions denominated in a currency other than the local functional currency are included in the consolidated statements of operations and comprehensive loss. For the years ended December 31, 2021, and 2020, the Company recorded $608,000 and $623,000 in foreign currency transaction gains, respectively, in other income in its consolidated statements of operations and comprehensive loss. Comprehensive loss Comprehensive loss consists of two components, net loss and other comprehensive loss. The Company’s other comprehensive loss consists of foreign currency translation adjustments that result from consolidation of its foreign entities. Cash and cash equivalents The Company’s cash and cash equivalents consists of money held in demand depositary accounts and highly liquid investments, including commercial papers with original maturities of three months or less at the date of the purchase. The carrying amount of cash and cash equivalents was $9.5 million and $21.3 million as of December 31, 2021, and 2020, respectively, which approximates fair value and was determined based upon December 31, 2021 2020 Cash $ 9,483 $ 10,272 Cash equivalents - commercial papers — 11,063 Total cash and cash equivalents on the consolidated statements of cash flows $ 9,483 $ 21,335 Trade accounts receivable, net Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company periodically reviews the need for an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and the Company’s customers’ respective financial conditions, the amounts of receivables in dispute and the current receivables aging and current payment patterns. To the extent identified, account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. To date, the Company’s customers have proven to be credit worthy. As of December 31, 2021, and 2020, the Company did not recognize any material write-offs and has not Inventories Inventories are stated at the lower of cost, using the weighted average cost method, or net realizable value. Inventory that is obsolete or in excess of forecasted usage is written down to its estimated net realizable value based on the assumptions about future demand and market conditions. Inventory write-downs are charged to cost of revenue and establish a new cost basis for the inventory. Inventories include raw materials, which consist of parts and supplies used in the Company’s manufacturing process and research and development activities as well as service parts for the Company’s quantum computer systems, work-in-process goods. Property and equipment, net Property and equipment are stated at cost less accumulated depreciation and impairment. Depreciation is recognized using the straight-line method over the estimated useful lives of the depreciable property, or for leasehold improvements, the remaining term of the lease, whichever is shorter. Costs for capital assets not yet placed into service are capitalized as construction-in-progress and depreciated once placed into service. Estimated Useful Lives Quantum computer systems 5 years Lab equipment 5 years Computer equipment 3 years Furniture and fixtures 5 years Leasehold improvements Shorter of expected lease term or estimated useful life Upon sale or retirement of the assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the statement of operations and comprehensive loss. Expenditures for general maintenance and repairs are expensed as incurred. Intangible assets, net The Company’s intangible assets consist of acquired computer software, including off-the-shelf Off-the-shelf off-the-shelf Internally developed software Costs related to the formulation and design of internally developed software are expensed as incurred to research and development. Impairment of Long-Lived Assets Long-lived assets, such as property and equipment and other long-term assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group to be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent the carrying amount of the underlying asset exceeds its fair value. The Company did not record any impairment loss on long-lived assets during the years ended December 31, 2021 and 2020. Fair value of financial instruments Certain assets and liabilities are carried at fair value under US GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: • Level 1—Quoted prices in active markets for identical assets or liabilities. • Level 2—Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. • Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company recognizes transfers between levels of the fair value hierarchy on the date of the event or change in circumstances that caused the transfer. The carrying amounts reflected in the consolidated balance sheets for cash and cash equivalents, trade accounts receivable, net, trade accounts payable and accrued expenses approximate their fair values (Level 1). The Co Concentration of credit risk and other risks and uncertainties Credit risk Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company maintains cash and cash equivalents with major and reputable financial institutions. Deposits held with the financial institutions may exceed the amount of insurance provided by the Canadian Deposit Insurance Corporation on such deposits but may be redeemed upon demand. The Company performs periodic evaluations of the relative credit standing of the financial institutions. With respect to accounts receivable, the Company monitors the credit quality of its customers as well as maintain an allowance for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. Concentration risk Agreements which potentially subject the Company to concentration risk consist principally of three customer agreements. For the year ended December 31, 2021, 15% of the Company’s total revenue was earned from a single customer, 13% was earned from a second customer and 12% was earned from a third customer. For the year ended December 31, 2020, 22% of the Company’s total revenue was earned from a single customer, 17% was earned from a second customer and 10% was earned from a third customer. Foreign currency risk The Company’s customers are located in the United States, Japan, Europe, Canada and other locations; therefore, foreign exchange risk exposures arise from transactions denominated in currencies other than the functional and reporting currency (United States dollars). To date, a majority of the Company’s sales have been denominated in United States dollars and a significant portion of the Company’s operating expenses are denominated in Canadian dollars. The Company also purchases certain of its key manufacturing inputs in Euros. As the Company expands its presence in international markets, the Company’s results of operations and cash flows may increasingly be subject to fluctuations due to changes in foreign currency exchange rates and may be adversely affected in the future due to changes in foreign exchange rates. To date, the Company has not entered into any hedging arrangements to minimize the impact of these fluctuations in the exchange rates. The Company will reassess its approach to manage our risk relating to fluctuations in currency rates. The Company does not believe that foreign currency risk had a material effect on its business, financial condition, or result of operations during the periods presented. Inflation Risk We do not believe that inflation had a significant impact on our results of operations for any periods presented in our consolidated financial statements. Nonetheless, if our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs, and our inability or failure to do so could harm our business, financial condition, and results of operations. Leases The Company adopted ASC 842, Leases (“ASC 842”) as of January 1, 2018. ASC 842 was adopted using the modified retrospective transition approach, with no restatement of prior periods or cumulative adjustments to the use-of-hindsight to and non-lease components The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from a lease. ROU assets and operating lease liabilities are recognized at the commencement date based on the present value of the future minimum lease payments over the lease term. Operating lease ROU assets also include the impact of any lease incentives. Amendments to a lease are assessed to determine if it represents a lease modification or a separate contract. Lease modifications are reassessed as of the effective date of the modification using an incremental borrowing rate based on the information available at the commencement date. For modified leases, the Company also reassesses the lease classification as of the effective date of the modification. The interest rate used to determine the present value of the future lease payments is the Company’s incremental borrowing rate, because the interest rate implicit in the Company’s leases is not readily determinable. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in economic environments where the leased asset is located. The Company’s lease terms include periods under options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option in the measurement of its ROU assets and liabilities. The Company considers contractual-based factors such as the nature and terms of the renewal or termination, asset-based factors such as physical location of the asset and entity-based factors such as the importance of the leased asset to the Company’s operations to determine the lease term. The Company generally uses the base, non-cancelable, lease right-of-use Government assistance US GAAP for profit-oriented entities does not define government assistance; nor is there specific guidance applicable to government assistance. During the years ended 2021 and 2020, the Company received various forms of government assistance including (i) government grants (ii) investment credits, and (iii) government loans, for research and development initiatives from Canadian government agencies. The Company recognizes grants and investment tax credits relating to qualifying scientific research and development expenditures as a reduction of the related eligible expenses (research and development expenses) in its consolidated statement of operations and comprehensive loss. Grants and investment tax credits are recognized in the period during which the related qualifying expenses are incurred, provided that the conditions under which the grants and investment tax credits have been met. The Company recognizes grants and investment tax credits in an amount equal to the estimated qualifying expenses incurred in each period multiplied by the applicable reimbursement percentage. Grants and investment tax credits that are recognized upon incurring qualifying expenses in advance of receipt of grant funding or proceeds from research and development incentives are recorded in the consolidated balance sheets as research incentives receivable. In circumstances where the grants received relates to prior period eligible expenses, the Company recognizes them as government assistance in its consolidated statement of operations and comprehensive loss in the current period. During the year ended December 31, 2020, the Company recorded Sustainable Development Technology Canada and BC Innovative Clean Energy (“SDTC”) grants of $7.6 million, as an offset to its research and development expenses in its consolidated statements of operations and comprehensive loss. The Company did not record any SDTC grants during the year ended December 31, 2021. During the years ended December 31, 2021, and 2020, the Company recorded a Scientific Research and Experimental Development (“SR&ED”) investment tax credit of $1.5 million and $2.1 million, respectively, as an offset to its research and development expenses in its consolidated statements of operations and comprehensive loss. The Company has received government loans under funding agreements that bear interest at rates that are below market rates of interest or interest-free. The Company accounts for the imputed benefit arising from the difference between a market rate of interest and the rate of interest charged as additional grant funding, and records interest expense for the loans at a market rate of interest. On the date that loan proceeds are earned, the Company recognizes the portion of the loan proceeds allocated to grant funding as a discount to the carrying value of the loan and as other liability, which is subsequently recognized as additional government assistance upon draw down of the qualified loan amounts. During the year ended December 31, 2021, the Company recorded the interest benefit on Strategic Innovation Fund (“SIF”) government loans for $7.2 million, as government assistance in its consolidated statements of operations and comprehensive loss. During the year ended December 31, 2020, the Company recorded the interest benefit on SIF and Technology Partnership of Canada (“TPC”) government loans for $ million, as government assistance in its consolidated statements of operations and comprehensive loss. See Note 8 – Loans payable for further details on government loans. Revenue recognition The Company recognizes revenue in accordance with Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) 340-40, The standard was adopted on a full retrospective method on January 1, 2018. The adoption of ASC 606 had no impact on the Company and as such there was no recorded transition adjustment. The core principle of ASC 606 is that an entity shall recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To support this core principle, the Company applies the following five step approach: • Identify the contract with the customer • Identify the performance obligations • Determine the transaction price • Allocate the transaction price to the performance obligations • Recognize revenue when (or as) the entity satisfies a performance obligation The Company generates revenue through subscription sales to access its Quantum Computing as a Service (“QCaaS”) cloud platform and from professional services related to the practical applications of quantum computing technology to solve its customers’ business challenges, to develop quantum proofs-of-concepts, re-sellers re-seller re-sellers’ re-seller mark-up When the Company determines that its contracts with customers contain multiple performance obligations, for these arrangements, the Company allocates the transaction price based on the relative standalone selling price (“SSP”) method by comparing the SSP of each distinct performance obligation to the total value of the contract. The Company uses a range of amounts to estimate SSP for products and services sold together in a contract to determine whether there is a discount to be allocated based on the relative SSP of the various products and services. In instances where SSP is not directly observable, such as when the Company does not sell the product or service separately, the Company determines the SSP using information that may include market conditions and other observable inputs. Standalone selling price is typically established as a range. In situations in which the stated contract price for a performance obligation is outside of the applicable standalone selling price range and has a different pattern of transfer to the customer than the other performance obligations in the contract, the Company will reallocate the total transaction price to each performance obligation based on the relative standalone selling price of each. At times, the Company may sell bundled services that include professional services, QCaaS and training. For these bundled arrangements, the Company’s selling prices associated with QCaaS and training are observable, predictable and consistent. Accordingly, the Company uses the residual method under which the total transaction price and observable SSP of the QCaaS and training performance obligations are used to arrive at the estimated SSP of the professional services performance obligation. The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring goods and services to the customer. Revenue is recorded based on the transaction price. The Company’s contracts with customers may include renewals or other options at fixed prices. Determining whether such options are considered distinct performance obligations that provide the customer with a material right and therefore should be accounted for separately requires significant judgment. Judgment is required to determine the standalone selling price for each renewal option to determine whether the renewal pricing is reflective of the standalone selling price or is reflective of a discount that would provide the customer with a material right. Based on the Company’s assessment of standalone selling prices, the Company determined that there were no significant material rights provided to its customers requiring separate recognition. The timing of revenue recognition may not align with the right to invoice the customer. The Company records accounts receivable when it has the unconditional right to issue an invoice and receive payment, regardless of whether revenue has been recognized. Deferred revenue is primarily composed of fees related to QCaaS, which are generally billed in advance and recognized as revenue over the related subscription term. Unbilled receivables relate to revenue recognized for milestones completed under professional services contracts for which the related milestone billing has not yet occurred. In instances where the timing of revenue recognition differs from the timing of the right to invoice, the Company has determined that a significant financing component generally does not exist. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable way of purchasing the products and services and not to receive financing from or provide financing to the customer. Additionally, the Company has elected the practical expedient terms that permit an entity not to recognize a significant financing component if the time between the transfer of a good or service and payment is one year or less. Payment terms on invoiced amounts are typically net 30 days. The Company does not offer rights of return for its services in the normal course of business and contracts generally do not include service-type warranties that provide any incremental service to the customer beyond providing assurance that the services conform to applicable specifications or customer-specific or subjective acceptance provisions. The Company also excludes from revenue government-assessed and imposed taxes on revenue-generating activities that are invoiced to customers. The Company has identified up to two performance obligations regularly included in arrangements involving the Leap Quantum Cloud (QCaaS) subscriptions and the D-Wave Launch professional services. The Company’s professional services are typically not coterminous with the QCaaS subscriptions. Revenue from QCaaS is recognized evenly over the contractual period, on a straight-line basis over the subscription term, beginning on the date that the service is made available to the customer. Professional services are recognized as they are earned based on the cost-to-cost cost-to-cost Contract assets and contract liabilities The timing of revenue recognition, billings and cash collections may result in accounts receivable, contract assets, and contract liabilities (deferred revenue) on the Company’s consolidated balance sheets. A receivable is recorded in the period in which we provide services when we have an unconditional right to payment. Contract assets primarily relate to the value of services transferred to the customer for which the right to payment is not just dependent on the passage of time. Contract assets are transferred to accounts receivable when rights to payment become unconditional. A contract liability is recognized when the Company receives payment or has an unconditional right to payment in advance of the satisfaction of performance. The contract liabilities represent deferred service revenue, which is recorded when we receive consideration, or such consideration is unconditionally due, from a customer prior to transferring services to the customer under the terms of a contract. Deferred service revenue typically results from fees related to the Company’s QCaaS platform. Cost to obtain and fulfilling contracts The Company has elected to apply the practical expedient to expense contract acquisition costs as incurred when the expected amortization period is one year or less. The Company capitalizes incremental costs incurred to fulfill its contracts that (i) relate directly to the contract, (ii) are expected to generate resources that will be used to satisfy the Company’s performance obligation(s) under the contract, and (iii) are expected to be recovered through revenue generated under the contract. The Company has not identified any costs that are incremental to the acquisition of customer contracts that would be capitalized as deferred costs on the balance sheet in accordance with ASC 340-40. 340-40 Cost of revenue Cost of revenue primarily consists of expenses related to delivering the Company’s services, including direct labor costs, direct services costs and depreciation and amortization related to the Company’s quantum computing systems and related software. Research and development costs Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred in performing research and development activities, including personnel costs, stock-based compensation, employee benefits, facility costs, depreciation, manufacturing expenses and all other costs for the Company’s hardware, software and engineering personnel who design and develop the Company’s quantum computing systems and research new quantum computing technologies. Unlike a standard computer, design and development efforts continue throughout the useful life of the Company’s quantum computing systems to ensure proper calibration and optimal functionality. Research and development expenses also include purchased hardware and software costs related to quantum computing systems constructed for research purposes that are not probable of providing future economic benefit and have no alternate future use. Advertising Costs Advertising costs are expensed as incurred and are primarily included in sales and marketing expenses in the consolidated statements of operations and comprehensive loss. During the years ended December 31, 2021, and 2020, these costs were $887,000 and $1.0 million, respectively. Stock-based

Business Combination

Business Combination	9 Months Ended
	Sep. 30, 2022
Business Combination	3. Business Combination As discussed in Note 2—Basis of Presentation and Summary of Significant Accounting Policies, on August 5, 2022, the Company completed the Business Combination. Upon the closing of the Business Combination, the following occurred: • Each non-redeeming • All outstanding warrants of DPCM were converted into the right to receive Warrants. Each such Warrant is exercisable for 1.4541326 Common Shares, at any time commencing on September 4, 2022, the date that is 30 days after the completion of the Business Combination. The number of Common Shares received upon the exercise of Warrants will be rounded down to the nearest whole number of Common Shares; • 3,015,575 shares of DPCM Class B common stock held by Sponsor and DPCM’s officers, directors and other special advisors were converted into Common Shares on a one-for-one • Pursuant to an arrangement effected under Part 9, Division 5 of the Business Corporations Act (British Columbia) (the “Arrangement”) all holders of outstanding non-redeemable D-Wave D-Wave D-Wave D-Wave D-Wave D-Wave “Exchangeable Shares” refer to shares in the capital of D-Wave D-Wave. one-for-one In connection with the Business Combination and concurrently with the execution of the Transaction Agreement, on February 7, 2022, DPCM and the Company entered into separate subscription agreements with a number of investors (each a “PIPE Investor”), pursuant to which the PIPE Investors agreed to purchase, and the Company agreed to sell to the PIPE Investors, a number of Common Shares (the “PIPE Shares”) equal to the aggregate purchase price for all Common Shares subscribed for by each PIPE Investor, divided by $10.00 and multiplied by the Exchange Ratio for an aggregate purchase price of $40.0 million (the “PIPE Investment”), such that the PIPE Investors purchased 5,816,528 PIPE Shares in the aggregate. The PIPE Investment closed simultaneously with the consummation of the Business Combination. The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, DPCM was treated as the “acquired” company for financial reporting purposes. See Note 2 for further details. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of the Company issuing shares for the net assets of DPCM, accompanied by a recapitalization. The net assets of DPCM were stated at historical cost, with no goodwill or other intangible assets recorded. In accounting for the Business Combination and after redemptions, net proceeds received by the Company totaled $21.4 million. The following table presents the net proceeds from the Business Combination and PIPE Investment for the nine months ended September 30, 2022 (in thousands): Recapitalization Cash - DPCM trust and cash, net of redemptions $ 9,130 Cash - PIPE Investment 40,000 Less: Non-cash (13,728 ) Less: Transaction costs (14,017 ) Net Business Combination and PIPE Investment 21,385 Add back: Non-cash 13,728 Add back: Accrued transaction costs 2,459 Net cash contribution from Business Combination and PIPE Investment $ 37,572 The following table presents the number of shares of Common Shares issued immediately following the consummation of the Business Combination, PIPE Investment, and closing of the ELOC: Number of Exchange of DPCM Class A common stock for D-Wave 1,311,937 Exchange of DPCM Class B common stock for D-Wave 3,015,575 D-Wave 5,816,528 Business Combination and PIPE shares 10,144,040 Exchange of D-Wave D-Wave 99,736,752 D-Wave 127,180 Total D-Wave 110,007,972 (1) Prior to the Business Combination, there were 30,000,000 shares of DPCM Class A common stock subject to possible redemption outstanding. Also prior to the Business Combination, 29,097,787 shares of DPCM Class A common stock subject to possible redemption were redeemed, resulting in 902,213 shares of DPCM Class A common stock outstanding immediately prior to the Business Combination. The number of Common Shares that former stockholders of DPCM Class A common stock received upon exchanging their shares in connection with the Business Combination was calculated by multiplying the 902,213 shares of DPCM Class A common stock outstanding immediately prior to the Business Combination by the Exchange Ratio. All fractional shares were rounded down. (2) Prior to the Business Combination, there were 7,500,000 shares of DPCM Class B common stock outstanding. Also prior to the Business Combination, 4,484,425 shares of DPCM Class B common stock were forfeited, resulting in 3,015,575 shares of DPCM Class B common stock outstanding immediately prior to the Business Combination. In connection with the Business Combination, the former stockholders of DPCM Class B common stock exchanged their shares for Common Shares on a one-for-one (3) In conjunction with the Business Combination, all of D-Wave non-redeemable D-Wave D-Wave D-Wave D-Wave

Revenue from contracts with cus

Revenue from contracts with customers	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Revenue from contracts with customers	4. Revenue from contracts with customers Disaggregation of revenue The following table depicts the disaggregation of revenue by type of products or services and timing of transfer of products or services (in thousands): Three months ended 2022 2021 Type of products or services QCaaS $ 1,346 $ 980 Professional services 347 306 Other revenue 2 21 Total revenue, net $ 1,695 $ 1,307 Timing of revenue recognition Revenue recognized over the time $ 1,660 $ 1,247 Revenue recognized at a point in time 35 60 Total revenue, net $ 1,695 $ 1,307 Nine months ended 2022 2021 Type of products or services QCaaS $ 3,905 $ 3,063 Professional services 812 736 Other revenue 61 54 Total revenue, net $ 4,778 $ 3,853 Timing of revenue recognition Revenue recognized over the time $ 4,618 $ 3,773 Revenue recognized at a point in time 160 80 Total revenue, net $ 4,778 $ 3,853 Other revenue includes printed circuit board sales. Revenue by geographical markets is presented in Note 13 - Geographic areas. Contract balances The following table provides information about account receivable, contract assets and liabilities as of September 30, 2022 and December 31, 2021 (in thousands): September 30, December 31, 2022 2021 Contract assets: Trade account receivable $ 740 $ 421 Unbilled receivables, which are included in ‘Prepaid expenses and other current assets’ 252 17 Total contract assets 992 438 Contract liabilities: Deferred revenue, current 1,989 2,665 Deferred revenue, noncurrent — 54 Customer deposit, which are included in ‘Accrued expenses and other current liabilities’ 21 21 Total contract liabilities $ 2,010 $ 2,740 Changes in deferred revenue from contracts with customers were as follows (in thousands): September 30, December 31, 2022 2021 Balance at beginning of period $ 2,719 $ 4,713 Deferral of revenue 3,554 4,092 Recognition of deferred revenue (4,284 ) (6,086 ) Balance at end of period $ 1,989 $ 2,719 Remaining performance obligations A significant number of the Company’s product and service sales are short-term in nature with a contract term of one year or less. For those contracts, the Company has utilized the practical expedient in ASC 606-10-50-14 exempting As of September 30, 2022, the aggregate amount of remaining performance obligations that were unsatisfied or partially unsatisfied related to customer contracts was $2.0 million. This amount included deferred revenue on the Company’s condensed consolidated balance sheets, of which approximately 99% is expected to be recognized to revenue in the next 12 months. As of December 31, 2021, the aggregate amount of remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied was $2.7 million which included deferred revenue on the Company’s condensed consolidated balance sheets, of which approximately 98% was expected to be recognized to revenue in the next 12 months.
DWave System [Member]
Revenue from contracts with customers		3. Revenue from contracts with customers Disaggregation of revenue The following table depicts the disaggregation of revenue by type of products or services and timing of transfer of products or services (in thousands): Years ended 2021 2020 Type of products or services QCaaS $ 4,424 $ 4,313 Professional services 1,786 426 Other revenue 69 421 Total revenue, net $ 6,279 $ 5,160 Timing of revenue recognition Revenue recognized over time $ 6,090 $ 4,688 Revenue recognized at a point in time 189 472 Total revenue, net $ 6,279 $ 5,160 Other revenue includes printed circuit board sales. Revenue by geographical markets is presented in Note 16 - Geographic areas. Contract balances The following table provides information about account receivable, contract assets and liabilities as of December 31, 2021, and 2020 (in thousands): December 31, 2021 2020 Contract assets: Trade account receivable, net $ 421 $ 590 Unbilled receivables, which are included in ‘Prepaid expenses and other current assets’ 17 10 Total contract assets 438 600 Contract liabilities: Deferred revenue, current 2,665 4,713 Deferred revenue, noncurrent 54 — Customer deposit, which are included in ‘Accrued expenses and other current liabilities’ 21 — Total contract liabilities 2,740 4,713 Changes in deferred revenue from contracts with customers were as follows (in thousands): Years ended 2021 2020 Balance at beginning of period $ 4,713 $ 4,921 Deferral of revenue 4,092 4,513 Recognition of deferred revenue (6,086 ) (4,721 ) Balance at the end of period $ 2,719 $ 4,713 Remaining performance obligations A significant number of the Company’s product and service sales are short-term in nature with a contract term of one year or less. For those contracts, the Company has utilized the practical expedient in ASC 606-10-50-14 exempting As of December 31, 2021, the aggregate amount of remaining performance obligations that were unsatisfied or partially unsatisfied related to customer contracts was $2.7 million. This amount included deferred revenue on the Company’s consolidated balance sheets, of which approximately 98% is expected to be recognized to revenue in the next 12 months. As of December 31, 2020, the aggregate amount of remaining performance obligations that are unsatisfied or partially unsatisfied related to customer contracts was $4.7 million which included deferred revenue on the Company’s consolidated balance sheets, of which approximately 100% was expected to be recognized to revenue in the next 12 months.

Fair value of financial instrum

Fair value of financial instruments	12 Months Ended
	Dec. 31, 2021
DWave System [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of financial instruments	4. Fair value of financial instruments As of December 31, 2021, there were no assets or liabilities measured at fair value. The following tables present information about the Company’s financial assets measured at fair value on a recurring basis and indicating the level of the fair value hierarchy utilized to determine such fair values as of December 31, 2020 (in thousands): Fair value measurement as of Level 1 Level 2 Level 3 Assets Cash equivalents: Commercial paper $ — $ 11,063 $ — Total assets $ — $ 11,063 $ — Liabilities Other liabilities: Warrant liabilities — — — Total liabilities $ — $ — $ — During the years ended December 31, 2020, there were no transfers between Level 1, Level 2, and Level 3.

Balance sheet details

Balance sheet details	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Balance sheet details	5. Balance sheet details Accrued expenses and other current liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): September 30, December 31, 2022 2021 Accrued expenses: Accrued transaction costs $ 2,459 $ — Accrued professional services 1,010 1,953 Accrued compensation and related benefits 1,438 1,108 Other accruals 113 318 Other current liabilities: Other payroll expenses $ 247 $ 175 Customer deposit 21 21 Current portion of long term debt, net 30 39 Total accrued expenses and other current liabilities $ 5,318 $ 3,614 Prepaid expenses and other current assets consisted of the following (in thousands): September 30, December 31, 2022 2021 Prepaid expenses: Prepaid Lincoln Park commitment fee $ 3,279 $ — Prepaid services 1,319 125 Prepaid software 1,027 531 Prepaid rent 121 151 Prepaid commissions 117 84 Other 11 156 Other current assets: Directors and Officers insurance $ 2,028 $ — Unbilled receivables 252 17 Security deposits 36 52 Total prepaid expenses and other current assets $ 8,190 $ 1,116
DWave System [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Balance sheet details		5. Balance sheet details Inventories Inventories consisted of the following (in thousands): December 31, 2021 2020 Raw materials $ 2,103 $ 2,516 Work-in-process 11 5 Total inventories $ 2,114 $ 2,521 Prepaid expenses and other current assets Prepaid expenses and other current assets consisted of the following (in thousands): December 31, 2021 2020 Prepaid expenses: Prepaid software $ 531 $ 469 Prepaid rent 151 187 Prepaid commissions 84 102 Prepaid services 125 179 Other 156 133 Other current assets: Security deposits 52 173 Unbilled receivables 17 10 Total prepaid expenses and other current assets $ 1,116 $ 1,253 Other noncurrent assets Other noncurrent assets consisted of the following (in thousands): December 31, 2021 2020 Investment in securities $ 1,169 $ 5 Long-term deposits 184 182 Total other noncurrent assets $ 1,353 $ 187 Accrued expenses and other current liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): December 31, 2021 2020 Accrued expenses: Accrued professional services $ 1,953 $ 1,534 Accrued compensation and related benefits 1,108 1,211 Other accruals 318 147 Other current liabilities: Other payroll expenses 175 291 Customer deposits 21 — Current portion of long-term debt, net 39 — Total accrued expenses and other current liabilities $ 3,614 $ 3,183

Property and equipment, net

Property and equipment, net	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment, net	6. Property and equipment, net Property and equipment, net consisted of the following (in thousands): September 30, December 31, 2022 2021 Quantum computer systems $ 13,425 $ 13,425 Lab equipment 6,664 6,645 Computer equipment 3,439 3,305 Leasehold improvements 1,074 1,074 Furniture and fixtures 318 316 Construction-in-progress 379 285 Total property and equipment 25,299 25,050 Less: Accumulated depreciation (22,762 ) (21,801 ) Property and equipment, net $ 2,537 $ 3,249 Depreciation expense for the three month period ended September 30, 2022 and 2021 was $338,000 and $393,000 respectively. Depreciation expense for the nine month period ended September 30, 2022 and 2021 was $1.0 million and $1.1 million respectively. The Company has not acquired any property and equipment under capital leases.
DWave System [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, net		6. Property and equipment, net Property and equipment, net consisted of the following (in thousands): December 31, 2021 2020 Quantum computer systems $ 13,425 $ 12,103 Lab equipment 6,645 6,315 Computer equipment 3,305 2,954 Leasehold improvements 1,074 1,072 Furniture and fixtures 316 316 Construction-in-progress 285 502 Total property and equipment 25,050 23,262 Less: Accumulated depreciation (21,801 ) (20,368 ) Property and equipment, net $ 3,249 $ 2,894 Depreciation expense for the years ended December 31, 2021, and 2020 was $1.4 million and $1.9 million, respectively. The Company has not acquired any property and equipment under capital leases.

Intangible assets, net

Intangible assets, net	12 Months Ended
	Dec. 31, 2021
DWave System [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, net	7. Intangible assets, net Intangible assets, net consisted of the following (in thousands): December 31, 2021 2020 Capitalized software $ 1,087 $ 862 Other intangible assets 35 35 Total intangible assets 1,122 897 Less: Accumulated amortization (850 ) (749 ) Intangible assets, net $ 272 $ 148 Amortization expense for the years ended December 31, 2021 and 2020 was $101,000 and $64,000, respectively.

Loans payable

Loans payable	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Short-term Debt [Line Items]
Loans payable	7. Loans payable As of September 30, 2022 and December 31, 2021 loans payable consisted of the refundable government loans. The following table shows the component of loans payable (in thousands): September 30, December 31, 2022 2021 Loan payable, beginning of period $ 29,844 $ 13,624 SIF contribution — 16,786 Financing of Directors and Officers Insurance 2,893 — Venture Loan 20,000 — Payments (1,262 ) (399 ) Interest and final fee on Venture Loan 1,808 — Repayment of the Venture Loan (21,808 ) — Foreign exchange (gain) loss (1,948 ) (167 ) Loan payable, end of period $ 29,527 $ 29,844 Discount, beginning of period $ (17,391 ) $ (11,948 ) SIF discount on additional contribution — (7,167 ) TPC discount on additional contribution — — Venture Loan discount (130 ) — Interest expense 1,902 1,728 Foreign exchange (gain) loss 1,236 (4 ) Total discount, end of period $ (14,383 ) $ (17,391 ) Total loans payable, end of period $ 15,144 $ 12,453 Short-term portion 2,232 220 Long-term portion 12,912 12,233 Total loans payable $ 15,144 $ 12,453 SIF liability On November 20, 2020, the Company entered into an agreement with the Strategic Innovation Fund (“SIF”), whereby SIF agreed to make a repayable contribution to the Company of up to C$40.0 million (“the Contribution”). Funds from the loan are to be used for projects involving the adaption of research findings for commercial applications that have the potential for market disruption; development of current product and services through the implementation of new or incremental technology that will enhance the Company’s competitive capability; and development of process improvements which reduce the environmental footprint of current production through the use of new or improved technologies. The annual repayment of the Contribution is calculated based upon a formula using the Company’s fiscal year revenue multiplied by a repayment rate. The contractual repayment period is 15 years and commences in the first year in which the Company reports annual revenue of $70.0 million (the “Benchmark Year”). In each of those years, an annual repayment amount is due. Each annual repayment must be paid by April 30 of the year following the year for which the annual repayment due will be calculated. If the Benchmark Year is not achieved within 14 years following the fiscal year in which the project is completed, the SIF loan is forgiven. The SIF loan is initially recorded at fair value, and subsequently at amortized cost. As the SIF contribution is interest free, the difference between the carrying value and initial fair value is recorded as government assistance on the consolidated statement of operations and comprehensive loss. The initial fair value of the SIF loan is determined by using a discounted cash flow analysis for the loan, which requires a number of assumptions. The significant assumptions used in determining the discounted cash flows include estimating the amount and timing of future revenue for the Company and the appropriate discount rate. In determining the appropriate discount rates, the Company considered the weighted average cost of capital for the Company, risk adjusted based on the development risks of the Company’s product. Management used a discount rate of 26% to discount the SIF loan. Should projected revenue not be achieved as predicted, the adjustment to the fair value of the SIF loan could be material. At September 30, 2022, the carrying value of the loan approximates its fair value. Repayments of the SIF contributions could also be triggered upon default of the agreement, or termination of the agreement, or upon a change of control that has not been approved by the Canadian government. The Canadian government approved the transaction with DPCM conditionally on May 9, 2022, with all conditions being satisfied on the closing date of the Business Combination. Venture Loan On March 3, 2022, the Company entered into a Venture Loan and Security Agreement (the “Venture Loan”) with PSPIB Unitas Investments II Inc. (“PSPIB”). Under the Venture Loan, the Company may borrow up to an aggregate principal amount of $25.0 million in three tranches, subject to certain terms and conditions. The loan was subject to a per annum interest rate as published in the Wall Street Journal or any successor publication as the “prime rate” plus 7.25% provided that the Wall Street Journal prime rate is not less than 3.25% and if found to be less than 3.25%, such rate will be deemed to be 3.25%. The maturity date of the loan was defined as the earliest of December 31, 2022, or the closing of the Business Combination, or the date of acceleration of such loan following an event of default. As of September 30, 2022, the Company received $20.0 million recorded in loan proceeds that were recorded in current loans payable in its condensed consolidated balance sheet, $15.0 million of which was received on March 3, 2022 and $5.0 million of which was received on June 30, 2022. All obligations under The Venture Loan, related accrued interest, and the final payment fee totaling $21.8 million was repaid upon the completion of the Business Combination on August 5, 2022.
DWave System [Member]
Short-term Debt [Line Items]
Loans payable		8. Loans payable, net As of December 31, 2021 2020 Loans payable, beginning of year $ 13,624 $ 5,555 SIF contribution 16,786 11,661 Payments (399 ) — TPC debt forgiveness — (3,873 ) Foreign exchange (gain) loss (167 ) 281 Loans payable, end of year $ 29,844 $ 13,624 Discount, beginning of year $ (11,948 ) $ — SIF discount on additional contribution (7,167 ) (11,199 ) TPC discount on additional contribution — (748 ) Government interest expense 1,728 232 Foreign exchange (gain) loss (4 ) (233 ) Discount, end of year $ (17,391 ) $ (11,948 ) Total Loans payable, net $ 12,453 $ 1,676 Short-term portion 220 355 Long-term portion 12,233 1,321 Total loans payable, net 12,453 1,676 TPC liability During the period from 2010 through 2021, the Company received funding totalling C$12.5 million from TPC. The obligation associated with that funding was required to be repaid on a fixed schedule due in May of each year. On November 23, 2020, the Company entered into an amendment which forgave C$5.0 million of unpaid accrued debt principal and interest owed from 2019 through 2020. During the year ended December 31, 2020, the Company recorded the debt forgiveness of $3.9 million in gain on debt extinguishment in the consolidated statement of operations and comprehensive loss. The amendment also waived the interest charge on the remaining C$ million of principal and revised the repayment schedule to C$ due annually on April 30, 2021, to April 30, 2025. This repayable contribution is repayable over years. The initial fair value of the TPC loan is determined by using a discounted cash flow analysis. The only significant assumption used in determining the discounted cash flow is the discount rate used by Management of %. Loans received under government funding agreements are recorded in the consolidated balance sheets as loans payable. SIF liability On November 20, 2020, the Company entered into an agreement with SIF, whereby SIF agreed to make a repayable contribution to the Company of up to C$40.0 million (“the Contribution”). Funds from the loan are to be used for projects involving the adaption of research findings for commercial applications that have the potential for market disruption; development of current product and services through the implementation of new or incremental technology that will enhance the Company’s competitive capability; and development of process improvements which reduce the environmental footprint of current production through the use of new or improved technologies. The annual repayment of the Contribution is calculated based upon a formula using the Company’s fiscal year revenue multiplied by a repayment rate. The contractual repayment period is 15 years and commences in the first year in which the Company reports annual revenue of $70.0 million (the “Benchmark Year”). In each of those years, an annual repayment amount is due. Each annual repayment must be paid by April 30 of the year following the year for which the annual repayment due will be calculated. If the Benchmark Year is not achieved within 14 years following the fiscal year in which the project is completed, the SIF loan is forgiven. The SIF loan is initially recorded at fair value, and subsequently at amortized cost. As the SIF contribution is interest free, the difference between the carrying value and initial fair value is recorded as government assistance on the consolidated statement of operations and comprehensive loss. The initial fair value of the SIF loan is determined by using a discounted cash flow analysis for the loan, which requires a number of assumptions. The significant assumptions used in determining the discounted cash flows include estimating the amount and timing of future revenue for the Company and the discount rate. The Company’s estimates of future revenues are derived from several significant assumptions including expected success of Leap TM Repayments of the SIF contributions could also be triggered upon default of the agreement, or termination of the agreement, or upon a change of control that has not been approved by the Canadian government. As of the date of these financial statements, the Company has applied for approval from the Canadian government for the transaction with DPCM and is awaiting final confirmation of approval. In the event approval is not granted, the drawn amount of the SIF loan becomes repayable. During the years ended December 31, 2021, and 2020, the Company recognized $3.1 million and $11.7 million, respectively, in research incentives receivable related to approved eligible expenditure claims from SIF. For the years ended December 31, 2021, and 2020 the difference (“discount”) between the book value and initial fair value totalling $7.2 million and $12.0 million was recorded as government assistance. During the year ended December 31, 2021, the carrying value of the loan increased by $3.8 million due to additional SIF contributions and a change in management’s forecast of future revenue .

Leases

Leases	12 Months Ended
	Dec. 31, 2021
D-Wave Systems Inc. [Member]
Leases	9. Leases The Company leases real estate, including offices and manufacturing facilities and has entered into various other agreements with respect to assets used in conducting its business. The Company’s leases have remaining lease terms ranging from less than 1 year to 10 years. Some of the lease agreements contain rent holidays and rent escalation clauses that were included in the calculation of the right of use of assets and lease liabilities. The Company’s building leases are subject to annual operating cost charges that may change from time to time during the lease term. The Company’s lease liabilities are not remeasured as a result of changes to the operating costs; rather, these changes are treated as variable lease payments and recognized in the period in which the obligation for the payments was incurred. The annual operating costs are a non-lease In determining the initial values of the lease obligations, the Company made a number of assumptions, including using a weighted average discount rate of 18% or 20% and using the foreign exchange rate at the date of calculation in order to translate any foreign currency balances. For the year ended December 31, 2021, and 2020, the Company recorded operating lease costs of $1.3 and $1.4 million, respectively. The lease costs are reflected in the statement of operations and comprehensive loss as follow (in thousands): December 31, 2021 2020 Research and development $ 268 $ 268 General and administrative 1,057 1,158 Total lease costs $ 1,324 $ 1,426 The weighted-average remaining lease terms and discount rates for operating leases were as follows: December 31, 2021 2020 Weighted average remaining lease term in years 2.89 2.39 Weighted average discount rate (1) 18 % 20 % (1) For the lease contracts denominated in Canadian dollars, the discount rate was determined on a currency-equivalent basis. Future minimum operating lease payment under non-cancelable Year ending December 31, Operating 2022 $ 1,687 2023 1,384 2024 1,179 2025 1,212 2026 1,245 Thereafter 9,648 Total future minimum lease payments $ 16,355

Promissory note - related party

Promissory note - related party	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Promissory note - related party	9. Promissory note - related party On February 28, 2022, an affiliate of DPCM entered into an unsecured promissory note of up to $1,000,000 with the Sponsor (the “Affiliate Note”). The purpose of the Affiliate Note was to provide DPCM with additional working capital. All amounts drawn on the Affiliate Note were provided directly to DPCM. The Affiliate Note is not convertible and bears no interest. The principal balance of the Affiliate Note was originally due and payable upon the earlier of the date on which DPCM consummates its initial business combination, or the date that the winding up of DPCM is effective. As of September 30, 2022, a total of $200,000 has been drawn on the Affiliate Note. In connection with the Business Combination, the Affiliate Note was assumed by the Company and was amended and restated effective September 30, 2022. The amended and restated note has identical terms as the Affiliate Note except that the Company must pay the principal balance in three equal installments on December 31, 2022, March 31, 2023, and June 30, 2023. On April 13, 2022, DPCM entered into an unsecured promissory note of up to $1,000,000 with the Sponsor (the “DPCM Note”). The purpose of the DPCM Note was to provide DPCM with additional working capital. All amounts drawn on the DPCM Note were provided directly to DPCM. The DPCM Note is not convertible and bears no interest. The principal balance of the DPCM Note was originally due and payable upon the earlier of the date on which DPCM consummates its initial business combination, or the date that the winding up of DPCM is effective. As of September 30, 2022, a total of $220,000 has been drawn on the DPCM Note. In connection with the Business Combination, the DPCM Note was assumed by the Company and was amended and restated effective September 30, 2022. The amended and restated note has identical terms as the Affiliate Note except that the Company must pay the principal balance in three equal installments on December 31, 2022, March 31, 2023, and June 30, 2023. The executions of the amended and restated Affiliate Note and the amended and restated DPCM Note are related party transactions as these notes are payable to affiliates of the Company.
DWave System [Member]
Promissory note - related party		13. Related party transactions In 2019, the Company entered into an agreement with a third-party consulting firm who also held options for common stock in the Company. Such agreement was not outstanding as of December 31, 2020. During the year ended December 31, 2020, the Company paid the third-party consulting firm $380,000 for advisory services, and the agreement expired on December 31, 2020. During the year ended December 31, 2021, the Company did not pay the third-party consulting firm for advisory services. As of December 31, 2021 and 2020, there were no open balances to the third-party consulting firm. In March 2022, the Company entered into a Venture Loan Agreement with PSPIB, in an aggregate principal amount of $25.0 million. PSPIB is an affiliate of Public Sector Pension Investment Board which holds 46.8%, on a fully diluted basis, of D-Wave Subsequent events.

Warrant liabilities

Warrant liabilities	9 Months Ended
	Sep. 30, 2022
Warrant liabilities	8. Warrant liabilities In conjunction with the Business Combination, the Company assumed 10,000,000 DPCM public warrants and 8,000,000 DPCM private warrants. During the nine months ended September 30, 2022, 79,102 DPCM public warrants were exercised resulting in the Company receiving proceeds of $0.9 million for the issuance of 115,025 D-Wave As of September 30, 2022, the Company has 17,920,898 Warrants outstanding. As part of the Business Combination, as described in Note 3 - Business Combination D-Wave Each such Warrant will be exercisable at an exercise price of $11.50 for 1.4541326 Common Shares, or an approximate exercise price per Common Share of $7.91, subject to adjustments. The Warrants may be exercised for a whole number of shares of the Company. No fractional shares will be issued upon exercise of the Warrants. The Warrants will expire on August 5, 2027, or earlier upon redemption or liquidation. The Private Warrants are identical to the Public Warrants except that the Private Warrants are exercisable on a cashless basis and are non-redeemable The Company may redeem the Public Warrants: • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Common Share; • if, and only if, the last reported sales price of the shares of the Common Shares for any twenty (20) trading days within the thirty (30) trading-day • if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalization and the like), the Private Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above; and • if, and only if, there is an effective registration statement covering the issuance of the Common Shares issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of the Common Shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of the Common Shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. For details of the D-Wave Commitments and contingencies.

Income Tax

Income Tax	12 Months Ended
	Dec. 31, 2021
D-Wave Systems Inc. [Member]
Income Tax	10. Income taxes Income tax expense The following table presents domestic and foreign components of loss before income taxes for the years ended December 31, 2021, and 2020 (in thousands): Years ended 2021 2020 Domestic $ (27,205 ) $ (7,784 ) International (4,340 ) (2,235 ) Net loss before income taxes $ (31,545 ) $ (10,019 ) Significant components of the Company’s deferred income tax assets and liabilities as of December 31, 2021, and 2020 are as follows: Years ended 2021 2020 Deferred tax assets: Net operating loss carryforwards $ 59,916 $ 54,018 Research and development credit carryforwards 13,675 12,003 Scientific research and experimental development deductions 23,071 20,137 Depreciation and amortization 5,634 5,256 Convertible notes (4 ) 1,156 Deferred revenue 165 401 Other accruals and reserves 730 440 Total deferred tax assets 103,187 93,411 Valuation Allowance (97,143 ) (89,139 ) Total deferred tax assets, net $ 6,044 $ 4,272 Deferred tax liabilities: Marketable securities (315 ) — Loans payable (5,729 ) (4,272 ) Total deferred tax liabilities (6,044 ) (4,272 ) Net deferred tax assets $ — $ — The effective tax rate differs from the statutory rate, primarily due to the Company’s history of incurring losses, which have not been utilized, the foreign rate differential related to subsidiary earnings, and other permanent differences. A summary reconciliation of the effective tax rate calculated at the combined Canadian federal and provincial statutory corporate tax rate is as follows: Years ended 2021 2020 Federal and provincial statutory tax rate 27 % 27 % Foreign losses taxed at different rates 0 % 1 % Research and development credits 0 % (3 )% Permanent differences (2 )% 18 % Other 1 % 7 % Change in valuation allowance (26 )% (50 )% Effective tax rate 0 % 0 % Realization of deferred tax assets is dependent upon future earnings, if any, the timing and the amount of which are uncertain. As of December 31, 2021, the Company maintained a valuation allowance with respect to its subsidiaries’ net operating losses that it believes is more likely than not that the deferred tax asset will not be realized. The Company will continue to reassess the valuation allowance annually and if future evidence allows for a partial or full release of the valuation allowance, a tax benefit will be recorded accordingly. As of December 31, 2021, the Company had Canadian tax losses carried forward of approximately $155.7 million that will expire between 2027 and 2041 as well as Scientific Research and Experimental Development expenditures of approximately $100.3 million that can be carried forward indefinitely, which are available to be applied against future taxable income. In addition, the Company has investment tax credits of approximately $13.5 million that will expire between 2023 and 2041 that are available to be applied against future Canadian federal income taxes payable. The Company also has US tax losses carried forward of approximately $43.9 million which may be applied against future taxable income, of which $18.4 million will expire between 2032 and 2037, while $25.5 million can be carried forward indefinitely. Future utilization of US tax losses carried forward is subject to certain limitations under the Internal Revenue Code (IRC), including limitations under IRC section 382. The Company has not performed a full analysis under IRC section 382.

Common stock and non-redeemable

Common stock and non-redeemable convertible preferred stock	12 Months Ended
	Dec. 31, 2021
D-Wave Systems Inc. [Member]
Common stock and nonredeemable convertible preferred stock [Line Items]
Common stock and non-redeemable convertible preferred stock	11. Common stock and non-redeemable convertible preferred stock The Company’s capital structure consists of common shares and non-redeemable convertible preferred stock. As of December 31, 2021 and 2020, the Company was authorized to issue an unlimited As respectively. The Company’s non-redeemable convertible preferred shares as of December 31, 2021 consisted of the following (in thousands, except share and per share data): Non-redeemable convertible preferred stock Shares Shares issued Original Carrying Class A Unlimited 27,065,219 $ 1.75 $ 47,336 Class B1 Unlimited 52,700,609 1.75 119,977 Class B2 Unlimited 29,000,000 1.75 23,000 Class B3 Unlimited 29,000,000 0.00001 0.29 Issuance costs (432 ) Total preferred stock Unlimited 137,765,828 $ 189,881 The Company’s non-redeemable convertible preferred stock as of December 31, 2020 consisted of the following (in thousands, except share and per share data): Non-redeemable convertible preferred stock Shares Shares issued Original Carrying Class A Unlimited 27,065,219 $ 1.75 $ 47,336 Class B1 Unlimited 52,700,609 1.75 119,977 Class B2 Unlimited 29,000,000 1.75 23,000 Class B3 Unlimited 29,000,000 0.00001 0.29 Issuance costs (432 ) Total preferred stock Unlimited 137,765,828 $ 189,881 The Company’s non-redeemable convertible preferred stock contains the following rights: Dividends The holders of Class A Preferred Shares (“Class A”) are entitled, subject to the rights of the Class B1 Preferred Share (“Class B1”) holders, the Class B2 Preferred Share (“Class B2”) holders and holders of any other class of shares entitled to receive dividends in priority or concurrently with the holders of the Common Shares, to receive dividends if, as and when declared by the Board of Directors (“BOD”). The holders of Class B1 are entitled, concurrently with holders of the Class B2 and holders of any other class of shares entitled to receive dividends in priority or concurrently with the holders of the Common Shares and the Class A, to receive dividends if, as and when declared by the BOD. The holders of Class B3 Preferred Shares (“Class B3”) shall in no circumstances be entitled to receive any dividends from the Company, whether on a dissolution event or otherwise, and the BOD of the Company shall not declare any dividends on the Class B3. As of December 31, 2021 and 2020, no dividends have been declared by the Company. Liquidation rights Upon liquidation, dissolution, or winding up of the Company, or upon certain change of control or asset sale events where holders of not less than rds of the outstanding voting preferred shares of the Company have not elected otherwise, the holders of the outstanding Clas s B shall be entitled to receive, pari passu with the holders of the Class B and prior and in preference to any distribution to the holders of the Class A and Common Share, an amount per share equal to the greater of (i) times the original issue price plus any dividends accrued but unpaid thereon, or (ii) an amount that would have been paid had such shares been converted into Common Shares immediately prior to such liquidation or deemed liquidation. After distribution to the Class B2 and Class B1 holders, holders of the Class A shall be entitled to receive, prior and in preference to any distribution to the holders of Common Shares, an amount per share equal to the greater of (i) the original issue price plus any dividends declared but unpaid thereon, or (ii) an amount that would have been payable had such share been converted into Common Shares immediately prior to such liquidation or deemed liquidation. The remaining assets will be distributed to holders of the Company’s Common Share. In the event of any dissolution event, the holders of Class B3 Preferred Shares then outstanding shall not be entitled to participate and share in any distribution of the property or assets of the Company. Conversion Each Class A, Class B and Class B will be convertible, at the option of its holder, at any time and from time to time, and without the payment of additional consideration by its holder, into such number of fully paid and non-assessable Common Shares as is determined by dividing the Class A, Class B and Class B original issue price by the respective Class A, Class B and Class B conversion price in effect at the time of conversion. The Class A, Class B and Class B conversion price will initially be equal to $ and is subject to adjustment. Upon either (i) that date and time which is immediately prior to a public offering of Common Shares with a concurrent listing on The Toronto Stock Exchange, the New York Stock Exchange or quotation for trading on Nasdaq (National Market) or such other stock exchange having received the approval of the directors of the Company which raises aggregate gross proceeds (prior to deduction of any underwriting discounts and registration expenses) of not less than $40 million at a price per Common Share that values the Company at not less than $250 million (a “Qualified IPO”), or (ii) the date and time, or the occurrence of an event, specified by vote or written consent of the holders of Class A, Class B1 or Class B2 holding at least 2/3rds of the shares of such class, then (a) all outstanding shares of such class will automatically be converted into Common Shares, at the then effective conversion rate and (b) such shares may not be reissued by the Company. No shareholder will (i) convert any number of Class B2 unless such shareholder causes the same number of Class B3 (on a one-for-one one-for-one Redemption In the event of a deemed liquidation event or a Qualified IPO the holders of the Class B3 shall not be entitled to any payment, dividend, or distribution of securities, or to participate and share in any distribution of the property of assets of the Company, and immediately prior to a deemed liquidation event or the listing of the securities of the Company pursuant to a Qualified IPO, all of the Class B3 will be deemed null and void and cancelled, without any payment or other distribution whatsoever to the holders of the Class B3 (the “Cancellation Date”). For certainty, from and after the Cancellation Date, the Class B3 shall not be entitled to exercise any of the rights of shareholders in respect thereof. Voting Rights The holders of Class A, Class B1, Class B2 and Class B3 are entitled to receive notice of, and to attend, all meetings of the shareholders of the Company and to that number of votes equal to the number of whole Common Shares into which the Class A, Class B1, Class B2 and Class B3 held by such holder are convertible as of the record date for determining shareholders entitled to vote on such matter, at all meetings of shareholders, except for meetings at which only holders of another specified class or series of shares are entitled to vote separately as a class or series, and will vote together with the holders of Common Shares and the Voting Preferred Shares on an as-converted to Common Share basis as a single class class, all provided that (i) the holders of Class B2 shall not be entitled to vote, at a meeting or otherwise, on any resolution pertaining to the election, appointment or removal of a director of the Company, and (ii) the holders of Class B3 are only entitled to vote to the extent that the vote pertains to the election, appointment or removal of a director of the Company.

Stock-based compensation

Stock-based compensation	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	10. Stock-based compensation Equity Plans 2020 Equity Incentive Plan In April 2020, the Board of Directors of D-Wave 2022 Equity Incentive Plan In connection with the Business Combination (Note 3), the shareholders approved the D-Wave Stock option valuation The Company estimates the fair value of stock options on the date of grant using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires estimates of highly subjective assumptions, which affect the fair value of each stock option. • Risk-Free Interest Rate non-inflation-indexed • Expected Term • Expected Volatility • Expected Dividend Yield • Fair Value of Underlying Common Stock D-Wave There were 1,500,081 stock options granted under the 2022 Plan and 4,341,966 stock options granted under the 2020 Plan during the nine months ended September 30, 2022 and 2021, respectively. The assumptions used to estimate the fair value of stock options granted during the nine months ended September 30, 2022 and 2021 are as follows: Nine months ended September 30, 2022 2021 Expected dividend yield — — Expected volatility 70.6 % 56.3 % Expected term (years) 6.1 6.1 Risk-free interest rate 3.0 % 0.9 % Common stock option activity The following table summarizes the Company’s stock option activity during the periods presented (in thousands except share and per share data): Number of Weighted average exercise price ($) Weighted Aggregate ($) Balance as of December 31, 2021 16,336,134 $ 0.81 8.55 $ 80,179 Granted 1,500,081 10.07 Exercised (174,378 ) 0.81 Forfeited (944,087 ) 0.81 Expired (28,981 ) 0.81 Balance as of September 30, 2022 16,688,769 $ 1.64 6.96 $ 74,546 Exercisable as of September 30, 2022 12,128,516 $ 0.84 6.20 $ 59,344 The aggregate intrinsic value of stock options was calculated as the difference between the exercise price of the stock options and the estimated fair value of the Company’s common stock for those stock options that had exercise prices lower than the fair value of the Company’s common stock. The weighted average grant date fair values per share of stock options granted during the nine months ended September 30, 2022 was $3.1. The weighted average grant date fair values per share of stock options granted during the nine months ended September 30, 2021 was $0.36. The total fair values of the stock options vested during the nine months ended September 30, 2022 and 2021 was $6,564,103 and $812,329 respectively. Common stock warrants On April 14, 2022, 617,972 common stock warrants of D-Wave Preferred stock warrants The Company did not record any movements during the nine months ended September 30, 2022. As of September 30, 2022, the following preferred stock warrants of D-Wave Number of Weighted Expiry Date Number 3,247,637 $ 1.92 29-Nov-26 1,299,055 Total, September 30, 2022 3,247,637 $ 1.92 1,299,055 As a result of the Business Combination and as per the Transaction Agreement, the preferred stock warrants of D-Wave Stock-based compensation The following table summarizes the stock-based compensation expense classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands): Three months ended 2022 2021 Research and development $ 329 $ 63 General and administrative 1,640 105 Sales and marketing 58 57 Total stock-based compensation $ 2,027 $ 225 Nine months ended 2022 2021 Research and development $ 539 $ 150 General and administrative 2,909 278 Sales and marketing 247 127 Total stock-based compensation $ 3,695 $ 555
D-Wave Systems Inc. [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation		12. Stock-based compensation In connection with a transaction between entities under common control by which the Company became the reporting entity in April 2020, the Board of Directors approved the 2020 Equity Incentive Plan (the “New Plan”) by which options granted under the New Plan were presenting similar commercial terms of the options granted under the D-Wave Options granted under the Plan generally vest over four years with a one-year Stock option valuation The Company estimates the fair value of stock options on the date of grant using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires estimates of highly subjective assumptions, which affect the fair value of each stock option. • Risk-Free Interest Rate non-inflation-indexed • Expected Term • Expected Volatility • Expected dividend Yield • Fair Value of Underlying Common Stock numerous objective and subjective factors to determine the fair value of the Company’s common stock at each meeting in which awards are approved. The factors considered include, but are not limited to: (i) the results of contemporaneous independent third-party valuations of the Company’s common stock; (ii) the prices, rights, preferences, and privileges of the Company’s Convertible Redeemable Preferred Stock relative to those of its common stock; (iii) the lack of marketability of the Company’s common stock; (iv) actual operating and financial results; (v) current business conditions and projections; (vi) the likelihood of achieving a liquidity event, such as an initial public offering or sale of the Company, given prevailing market conditions; and (vii) precedent transactions involving the Company’s shares. The assumptions used to estimate the fair value of stock options granted during the years ended December 31, 2021 and 2020 are as follows: Years ended 2021 2020 Expected dividend yield 0% 0% Expected volatility 56% 45% Expected term (years) 8.53 9.41 Risk-free interest rate 0.87% 0.43% Common stock option activity The following table summarizes the Company’s stock option activity during the periods presented (in thousands except share and per share data): Number of Weighted Weighted Aggregate Balance as of December 31, 2020 12,654,807 0.81 9.38 — D-Wave 4,369,866 0.82 — — D-Wave (105,203 ) 0.81 — — D-Wave (171,204 ) 0.81 — — D-Wave (412,132 ) 0.81 — — Balance as of December 31, 2021 16,336,134 0.81 8.55 80,179 Options unvested as of December 31, 2021 6,943,273 0.81 8.53 77,423 Options exercisable as of December 31, 2021 9,392,861 0.81 8.20 46,116 The aggregate intrinsic value of stock options was calculated as the difference between the exercise price of the stock options and the estimated fair value of the Company’s common stock for those stock options that had exercise prices lower than the fair value of the Company’s common stock. The weighted average grant date fair values per share of stock options granted during the years ended December 31, 2021 and 2020 were $1.99 and $0.35, respectively. The total fair values of the stock options vested during the years ended December 31, 2021 and 2020 were $1,733,745 and $1,035,000, respectively. Common stock warrants A continuity of the Company’s United States dollar common stock warrants issued and outstanding is as follows: Number Weighted Number of Weighted Balance as of December 31, 2020 617,972 1.75 3,247,637 1.92 Granted during the period — — — — Expired during the period — — — — Exercised during the period — — — — Balance as of December 31, 2021 617,972 1.75 3,247,637 1.92 The Company did not record any movements during the year ended December 31, 2021. As of December 31, 2021, the following United States dollar common stock warrants were outstanding and exercisable: Number of Weighted Expiry Date Number 617,972 $ 1.75 14-April-22 617,972 Total, December 31, 2021 617,972 $ 1.75 617,972 As of December 31, 2021, the following United States dollar preferred stock warrants were outstanding and exercisable: Number of Weighted Expiry Date Number 3,247,637 $ 1.92 29-Nov-26 1,299,055 Total, December 31, 2021 3,247,637 $ 1.92 1,299,055 Stock-based compensation The following table summarizes the stock-based compensation expense classified in the consolidated statements of operations and comprehensive loss as follows (in thousands): Years ended 2021 2020 Research and development $ 338 $ 1,513 General and administrative 1,164 1,346 Sales and marketing 237 130 Total stock-based compensation $ 1,739 $ 2,989

Geographic areas

Geographic areas	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Geographic areas	13. Geographic areas The following table presents a summary of revenue by geography for the three and nine month periods ended September 30, 2022 and 2021: Three months ended September 30, 2022 2021 United States $ 951 $ 784 Japan 293 304 Germany 237 70 Other 214 149 Total revenue $ 1,695 $ 1,307 Nine months ended September 30, 2022 2021 United States $ 2,461 $ 2,100 Japan 1,008 1,197 Germany 757 197 Other 552 359 Total revenue $ 4,778 $ 3,853 Other includes Europe, the Middle East, Africa (EMEA) and Asia, Canada and Australia. The Company has not had any sales in China, Russia or Ukraine. The following table sets forth the long-lived assets, consisting of property and plant, net, and operating lease right-of-use September 30, December 31, 2022 2021 Canada $ 10,106 $ 11,251 United States 497 576 Total long-lived assets $ 10,603 $ 11,827 As of September 30, 2022 and December 31, 2021, substantially all of the Company’s long-lived assets are located in Canada and in the United States. Significant customers The Company had significant customers during the three and nine month periods ended September 30, 2022 and 2021. A significant customer is defined as one that comprises up to ten percent or more of total revenues in a particular year or ten percent of outstanding accounts receivable balance as of the year end. The tables below present the significant customers on a percentage of total revenue basis for the three and nine month periods ended September 30, 2022 and 2021. Three months ended September 30, 2022 2021 Customer A 15 % 15 % Customer B 11 % 11 % Customer C 10 % — % Nine months ended September 30, 2022 2021 Customer A 13 % 13 % Customer B 13 % 12 % As of September 30, 2022 and 2021, there were no significant customers that comprised ten percent or more of outstanding accounts receivable balances. All revenues derived from major customers above are included in the United States and Germany during the three and nine month periods ended September 30, 2022 and the United States and Japan during the three and nine month periods ended September 30, 2021.
D-Wave Systems Inc. [Member]
Geographic areas		16. Geographic areas The following table presents a summary of revenue by geography for the years ended December 31, 2021 and 2020: For the years ended 2021 2020 United States $ 3,425 $ 3,119 Japan 1,614 1,630 Germany 741 155 Other 499 256 Total revenue $ 6,279 $ 5,160 Other includes EMEA, Canada and Australia. The following table sets forth the long-lived assets, consisting of property and plant, net, and operating lease right-of-use December 31, 2021 2020 Canada $ 11,251 $ 4,984 United States 576 858 Total long-lived assets $ 11,827 $ 5,842 As of December 31, 2021 and 2020, substantially all of the Company’s long-lived assets are located in Canada and in the United States. Significant customers The Company had significant customers during the year ended December 31, 2021 and 2020. A significant customer is defined as one that makes up ten percent or more of total revenues in a particular year or ten percent of outstanding accounts receivable balance as of the year end. December 31, 2021 2020 Customer A 15 % 22 % Customer B 13 % 17 % Customer C 12 % 10 % As of December 31, 2021 and 2020 there were no significant customers with ten percent or more of outstanding accounts receivable balances. All revenues derived from major customers above are included in the United States and Germany during the year ended December 31, 2021 and the United States and Japan during the year ended December 31, 2020

Commitment and contingencies

Commitment and contingencies	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Commitment and contingencies	11. Commitments and contingencies D-Wave In November 2020, contemporaneously with a revenue arrangement, D-Wave D-Wave As of September 30, 2022, these revenue-based milestones have yet to be met. The fair value of the Warrant Preferred Shares at the date of issuance was determined to be $1.1 million. During the nine months ended September 30, 2022, no Warrant Preferred Shares were vested or probable of vesting. As a result of the Business Combination and as per the Transaction Agreement, the Warrant Preferred Shares noted above, are exercisable for up to 2,889,282 Common Shares, which amount is equal to the number of warrants multiplied by the Conversion Ratio. The D-Wave D-Wave The Company estimated the fair value of D-Wave Share Based Compensation Lease obligation In November 2021, the Company amended a building lease to extend the term by ten years and six months through December 31, 2033. The lease amendment constituted a modification as it extended the original lease term and required evaluation of the remeasurement of the lease liability and corresponding right-of-use right-of-use In September 2022, the Company amended a building lease to extend the term by twelve months through June 30, 2024. The lease amendment constituted a modification as it extended the original lease term and required evaluation of the remeasurement of the lease liability and corresponding right-of-use right-of-use Financing of Directors and Officers Insurance In conjunction with the Business Combination, the Company entered into a Directors and Officers insurance policy on August 5, 2022 with a total premium, taxes and fees totaling $2.8 million. The insurance may cover certain liabilities arising from the Company’s obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances. Under the terms of the insurance financing, payments of $289,777, which include interest at the rate of 4.24% per annum, are due each month for nine months commencing on September 5, 2022. The total outstanding due to Woodruff Sawyer as of September 30, 2022 was $2.0 million. Litigation From time to time, the Company may become involved in various legal proceedings in the ordinary course of its business and may be subject to third-party infringement claims. In the normal course of business, the Company may agree to indemnify third parties with whom it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company, with respect to certain matters. The Company has agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, other third-party claims that the Company’s products when used for their intended purposes infringe the intellectual property rights of such other third parties, or other claims made against certain parties. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the Company’s limited history of prior indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim. As of September 30, 2022 and 2021, the Company has not been subject to any material litigation or pending litigation claims.
DWave System [Member]
Commitment and contingencies		14. Commitment and contingencies Warrant Transaction Agreements In November 2020, contemporaneously with a revenue arrangement, DWSI entered into a contract, pursuant to which DWSI agreed to issue to a customer a warrant to acquire up to 3,247,637 shares of Class A Preferred Share (the “Warrant Preferred Shares”), subject to certain vesting events. As the warrant was issued in connection with an existing commercial agreement with a customer, the value of the warrant was determined to be consideration payable to the customer and consequently will be treated as a reduction to revenue recognized under the corresponding revenue arrangement. Approximately 40% of the Warrant Preferred Shares vested and became immediately exercisable on August 13, 2020. The remaining Warrant Preferred Shares will vest and become exercisable upon satisfaction of certain milestones based on revenue generated under the commercial agreement with the customer, to the extent certain prepayments are made by the customer. The exercise price for the Warrant Preferred Shares is $1.92 per share and the warrant is exercisable through November 29, 2026. The fair value of the Warrant Preferred Shares at the date of issuance was determined to be $1.1 million. During the year ended December 31, 2021, no Warrant Preferred Shares were vested or probable of vesting. As of December 31, 2020, Warrant Preferred Shares with a fair value of $451,000 were vested. During the year ended December 31, 2020, $451,000 of the warrant was recorded into cost of revenue. In April 2020, DWSI entered into a contract pursuant to which DWSI agreed to issue to a customer a warrant to acquire a fixed number of 617,972 shares in the capital stock of DWSI (“Warrant Common Share” and collectively with the Warrant Preferred Shares, the “Warrant Shares”), at a fixed price of $1.75 per Warrant Common Share. As of December 31, 2021, and 2020, no Warrant Common Shares were vested or probable of vesting. The Company estimated the fair value of Warrant Shares on the date of grant using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires estimates of highly subjective assumptions, which affect the fair value of each warrant. The estimated fair value of Class A Preferred Shares and common stock was based on the Class A Preferred Shares and common stock offering price due to its proximity to the grant date of the Warrant Shares. The estimated term is based on the contractual life of the Warrant Shares. The remaining assumptions were developed consistent with the methodologies described further in Note 12 - Share Based Compensation The Warrant Preferred Shares are presented in the permanent equity on the balance sheets as the underlying shares are not redeemable, as discussed further in Note 11 - Common stock and non-redeemable convertible preferred stock. Lease obligation In November 2021, the Company amended a building lease to extend the term by 10 years and six months through December 31, 2033. The lease amendment constituted a modification as it extended the original lease term and required evaluation of the remeasurement of the lease liability and corresponding right-of-use right-of-use Litigation From time to time, the Company may become involved in various legal proceedings in the ordinary course of its business and may be subject to third-party infringement claims. In the normal course of business, the Company may agree to indemnify third parties with whom it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company, with respect to certain matters. The Company has agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, other third-party claims that the Company’s products when used for their intended purposes infringe the intellectual property rights of such other third parties, or other claims made against certain parties. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the Company’s limited history of prior indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim. As of December 31, 2021, and 2020, the Company has not been subject to any pending litigation claims.

Net loss per share

Net loss per share	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Net loss per share	12. Net loss per share As a result of the Business Combination (see Note 3), the Company has retroactively adjusted the weighted average shares outstanding prior to August 5, 2022 to give effect to the Conversion Ratio used to determine the number of Common Shares into which they were converted. The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders for the three and nine months ended September 30, 2022 and 2021 (in thousands, except share and per share data): For the three months ended 2022 2021 Numerator: Net loss attributable to common stockholders - basic and diluted $ (13,053 ) $ (4,209 ) Denominator: Weighted-average common stock outstanding 116,256,805 125,362,390 Net loss per share attributable to common stockholders - basic and diluted $ (0.11 ) $ (0.03 ) For the nine months ended 2022 2021 Numerator: Net loss attributable to common stockholders - basic and diluted $ (37,868 ) $ (17,705 ) Denominator: Weighted-average common stock outstanding 122,337,727 125,331,065 Net loss per share attributable to common stockholders - basic and diluted $ (0.31 ) $ (0.14 ) As of September 30, 2022 and 2021, the Company’s potentially dilutive securities were stock options, the Warrant Shares, and the Public Warrants and Private Warrants. Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities (upon conversion) that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: As of September 30, 2022 2021 Public Warrants as converted to Common Shares (Note 8) 14,426,301 — Private Warrants as converted to Common Shares (Note 8) 11,633,060 — D-Wave 2,889,282 2,889,282 Options to purchase common stock as converted to Common Shares 14,847,108 14,608,809 Total 43,795,751 17,498,091
D-Wave Systems Inc. [Member]
Net loss per share		15. Earnings per share The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data): For the years ended December 31, 2021 2020 Numerator: Net Income $ (31,545 ) $ (10,019 ) Denominator: Weighted-average shares outstanding, basic and diluted 111,911,127 121,358,989 Net loss per share, basic and diluted $ (0.28 ) $ (0.08 ) As of December 31, 2021 and 2020, the Company’s potentially dilutive securities were the stock options and warrants to purchase common stock and preferred stock. Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential common shares outstanding would have been anti-dilutive.

Subsequent events

Subsequent events	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Subsequent events	14. Subsequent events The Company has evaluated all events occurring through November 10, 2022, the date on which the condensed consolidated financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, except for the ones described below. Subsequent to the period ended September 30, 2022, the Company issued 764,796 common shares related to the exercise of stock options for proceeds of $696,000. On October 13, 2022 and October 27, 2022, the Company granted 4,496,833 and 3,578,590 Restricted Stock Units to certain of its employees, respectively. On October 27, 2022, the Company granted 167,605 Restricted Stock Units to certain members of the Company’s board of directors (the “Board”). On October 26, 2022, a registration statement in respect to the resale of up to $150.0 million Common Shares under the ELOC (see Note 2) became effective, enabling the Company to commence making sales pursuant to the ELOC.
DWave System [Member]
Subsequent events		17. Subsequent events The Company has evaluated all events occurring through March 15, 2022, the date on which the consolidated financial statements were issued, and during which time, nothing has occurred outside the normal course of business operations that would require disclosure except the following: Venture loan and security agreement. On March 3, 2022 (the “Effective Date”), the Company entered into the Venture Loan and Security Agreement (the “Venture Loan Agreement”), by and between D-Wave, D-Wave D-Wave D-Wave D-Wave The first tranche in an aggregate principal amount of $15.0 million was advanced on the Effective Date. Subject to certain terms and conditions being satisfied, the second tranche in an aggregate principal amount of $5.0 million will be advanced prior to June 30, 2022 and the third tranche in an aggregate principal amount of $5.0 million will be advanced prior to November 15, 2022. All advances outstanding under the Venture Loan Agreement will bear interest at a rate equal to the greater of either (i) the Prime Rate (as reported in The Wall Street Journal) plus 7.25%, and (ii) 10.5%. Interest on the outstanding advances is payable monthly, on the first business day of each calendar month through the earliest of December 31, 2022 and the closing of the Merger (the “Maturity Date”). The Company will pay an end of term charge of 5.0% of the aggregate amount of the advances made under the Venture Loan Agreement on the earliest date of (i) the Maturity Date; (ii) the date that the Company prepays all of the outstanding principal in full, or (iii) the date the loan payments are accelerated due to an event of default (as defined in the Venture Loan Agreement). The Venture Loan Agreement is secured by a first-priority security interest in substantially all of the Company’s assets and contains certain operational covenants. As of the date of the proxy statement/prospectus, the Company was in compliance with all covenants under our Venture Loan Agreement.

Basis of presentation and Sum_2

Basis of presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Basis of Presentation	Basis of Presentation The Company has prepared the accompanying condensed consolidated financial statements in accordance with the accounting principles generally accepted in the United States of America (“U.S. GAAP”). Any reference in these notes to applicable guidance is meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Updates (“ASUs”) of the Financial Accounting Standards Board (“FASB”) and pursuant to the regulations of the U.S. Securities and Exchange Commission (“SEC”). The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, DPCM, as a direct wholly-owned subsidiary of D-Wave, D-Wave (i) D-Wave D-Wave (iii) D-Wave (iv) D-Wave D-Wave D-Wave As a result, the condensed consolidated financial statements included herein reflect (i) the historical operating results of D-Wave D-Wave D-Wave In accordance with ASC 805 guidance applicable to these circumstances, the equity structure has been restated in all comparative periods up to the closing date of the Business Combination, to reflect the number of the Company’s shares of common stock, par value $0.0001 (“Common Shares”) issued to D-Wave D-Wave
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in the condensed consolidated financial statements upon consolidation. Liquidity and going concern The Company has prepared its condensed consolidated financial statements assuming that it will continue as a going concern. Since its inception, the Company has incurred net losses and negative cash flows from operations. As of September 30, 2022, the Company had an accumulated deficit of $363.1 million and a working capital deficiency of $11.7 million. For the three months ended September 30, 2022 and 2021, the Company incurred a net loss of $13.1 million and $4.2 million respectively. For the nine months ended September 30, 2022 and 2021, the Company incurred a net loss of $37.9 million and $17.7 million respectively. The Company had net cash outflows from operations of $34.3 million and $27.6 million, respectively. As of September 30, 2022, the Company had $13.8 million of cash. The Company expects to incur additional operating losses and negative cash flows from operations as it continues to expand its commercial operations and research and development programs. On August 5, 2022, the Company completed a Business Combination with DPCM. The Company received gross proceeds of $49.0 million from the PIPE Investment (as defined below) and the DPCM trust account. In conjunction with the Business Combination, the Company and D-Wave D-Wave D-Wave D-Wave D-wave D-Wave To the extent that sufficient capital is not obtained through the cash received in connection with the sale D-Wave D-Wave’s D-Wave D-Wave These condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. Such adjustments could be material.
Use of Estimate	Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s condensed consolidated financial statements and accompanying notes as of the date of the condensed consolidated financial statements. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience. The Company’s accounting estimates and assumptions may change over time in response to COVID-19
Public Warrants and Private Warrants	Public Warrants and Private Warrants The Company evaluated its outstanding warrants which were issued in exchange for (i) the warrants initially included in the DPCM units (the “Units”) issued in DPCM’s initial public offering (the “Public Warrants”), and (ii) the warrants of DPCM held by CDPM Sponsor Group, LLC (the “Sponsor”) that were issued to the Sponsor at the closing of DPCM’s initial public offering (the “Private Warrants,” and together with the Public Warrants, the “Warrants”), which are discussed in Note 8— Warrants 815-40, “Derivatives and Hedging—Contracts in Entity’s Own Equity The Private Warrants do not meet the derivative scope exception and are accounted for as derivative liabilities. Specifically, the Private Warrants contain provisions that cause the settlement amounts to be dependent upon the characteristics of the holder of the warrant which is not an input into the pricing of a fixed-for-fixed The Public Warrants also do not meet the indexation guidance in ASC 815-40
Operating segment	Operating segment Operating segments are defined as components of an enterprise for which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s Chief Executive Officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating and evaluating financial performance. As such, the Company views its operations and manages its business in one Geographic areas
Foreign currency translation and transactions	Foreign currency translation and transactions The Company’s reporting currency is the U.S. dollar. Generally, the functional and reporting currency of its international subsidiaries is the currency of their primary economic environment. Accordingly, all foreign balance sheet accounts have been translated into the U.S. dollars using the rate of exchange at the respective balance sheet date. Components of the condensed consolidated statements of operation and comprehensive loss have been translated at the average exchange rate for the year or the corresponding period. Translation gains and losses are recorded in accumulated other comprehensive loss as a component of stockholders’ equity. Gains or losses arising from currency exchange rate fluctuations on transactions denominated in a currency other than the local functional currency are included in the condensed consolidated statements of operations and comprehensive loss. For the three months ended September 30, 2022, the Company recorded $956,000 of foreign currency transaction gain in other income in its condensed consolidated statement of operations. For the three months ended September 30, 2021, the Company recorded $29,000 of foreign currency transaction loss in other income in its condensed consolidated statement of operations and comprehensive loss. For the nine months ended September 30, 2022 and 2021, the Company recorded $1,322,000 and $538,000 in foreign currency transaction gain, respectively, in other income in its condensed consolidated statements of operations and comprehensive loss.
Cash and cash equivalents	Cash and cash equivalents The Company’s cash and cash equivalents consists of money held in demand depository accounts. The carrying amount of cash was $13.8 million and $9.5 million as of September 30, 2022 and December 31, 2021, respectively, which approximates fair value and was determined based upon Level 1 inputs. The Company did not hold short-term investments as of September 30, 2022 and December 31, 2021.
Net income (loss) per share	Net income (loss) per share Basic net loss per common share is computed by dividing the net loss available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Diluted net loss per common share is computed by dividing the net loss available to common stockholders adjusted by any preferred stock dividends declared during the period by the weighted average number of common shares and potential common shares outstanding when the impact is not antidilutive. Contingently issuable shares are included in basic EPS only when there is no circumstance under which those shares would not be issued. Shares issuable for little or no cash consideration shall be considered outstanding common shares and included in the computation of basic EPS.
Fair Value of Financial Instruments	Fair value of financial instruments Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: • Level 1—Quoted prices in active markets for identical assets or liabilities. • Level 2—Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. • Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company recognizes transfers between levels of the fair value hierarchy on the date of the event or change in circumstances that caused the transfer. The carrying amounts reflected in the condensed consolidated balance sheets for cash , trade accounts receivable, net, trade accounts payable and accrued expenses approximate their fair values (Level 1). The Company carries its marketable investments at cost, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments by the same issuer, as they represent investments in privately held companies for which there are no quoted market prices. As of September 30, 2022 and December 31, 2021, the Company estimated the fair value of its securities denominated in Canadian dollars to be C$10.2 million for both periods presented, and its securities denominated in United States dollars to be $1.2 million and $279,000, respectively. The carrying value of its securities as of September 30, 2022 and December 31, 2021 was $1.2 million and $5,000, respectively and is included in other assets on the consolidated balance sheet. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis as of September 30, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value (in thousands): Description Level September 30, Liabilities: Warrant Liabilities – Public Warrants 1 $ 3,018 Warrant Liabilities – Private Placement Warrants 2 $ 2,480 The Warrants are accounted for as liabilities in accordance with ASC 815-40 The Warrants were initially valued using a binomial lattice model, which is considered to be a Level 3 fair value measurement. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the Warrants is the expected volatility of the Common Shares. The expected volatility as of the initial public offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own Public Warrant pricing. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrants was used as the fair value of the Warrants as of each relevant date. The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units are classified as Level 1 fair value measurements due to the use of an observable market quote in an active market. The subsequent measurements of the Private Warrants after the detachment of the Public Warrants from the Units are classified as Level 2 fair value measurements due to the use of an observable market quote for the Public Warrants, which are considered to be a similar asset in an active market. As of September 30, 2022, the liabilities for the Warrants were calculated by multiplying the quoted market price per DPCM Public Warrant of $0.31 by the 17,920,898 Warrants outstanding (see Note 8). Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs.
Concentration risk	Concentration risk Agreements which potentially subject the Company to concentration risk consist principally of two to three customer agreements. During the three month period ended September 30, 2022, the Company earned 15%, 11% and 10% of its total revenue from three customers. During the three month period ended September 30, 2021, the Company earned 15% and 11% of its total revenue earned from two customers. During the nine month period ended September 30, 2022, the Company earned 13% of its total revenue from two separate customers. During the nine months ended September 30, 2021, the Company earned 13% and 12% of its total revenue from two customers.
Government assistance	Government assistance The Company receives various forms of government assistance including (i) government grants (ii) investment credits, and (iii) government loans, for research and development initiatives from Canadian government agencies. The Company recognizes grants and investment tax credits relating to qualifying scientific research and development expenditures as a reduction of the related eligible expenses (research and development expenses) in its condensed consolidated statement of operations and comprehensive loss. Grants and investment tax credits are recognized in the period during which the related qualifying expenses are incurred, provided that the conditions under which the grants and investment tax credits have been met. The Company recognizes grants and investment tax credits in an amount equal to the estimated qualifying expenses incurred in each period multiplied by the applicable reimbursement percentage. Grants and investment tax credits that are recognized upon incurring qualifying expenses in advance of receipt of grant funding or proceeds from research and development incentives are recorded in the condensed consolidated balance sheets as research incentives receivable. In circumstances where the grants received relate to prior period eligible expenses, the Company recognizes them as government assistance in its condensed consolidated statement of operations and comprehensive loss in the current period. During the three months ended September 30, 2022 and 2021, the Company recorded a Scientific Research and Experimental Development (“SR&ED”) investment tax credit of $0.1 million and $$0.5 million in 2022 and 2021, respectively, as an offset to its research and development expenses in its condensed consolidated statements of operations and comprehensive loss. During the nine months ended September 30, 2022 and 2021, the Company recorded a SR&ED investment tax credit of $1.0 million and $1.2 million, respectively, as an offset to its research and development expenses in its condensed consolidated statements of operations and comprehensive loss. The Company has received government loans under funding agreements that bear interest at rates that are below market rates of interest or are interest-free. The Company accounts for the imputed benefit arising from the difference between a market rate of interest and the rate of interest charged as additional grant funding, and records interest expense for the loans at a market rate of interest. On the date that loan proceeds are earned, the Company recognizes the portion of the loan proceeds allocated to grant funding as a discount to the carrying value of the loan and as other liability, which is subsequently recognized as additional government assistance upon draw down of the qualified loan amounts.
Revenue recognition	Revenue recognition The Company recognizes revenue in accordance with Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) 340-40, The standard was adopted on a full retrospective method on January 1, 2018. The adoption of ASC 606 had no impact on the Company and as such there was no recorded transition adjustment. The core principle of ASC 606 is that an entity shall recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To support this core principle, the Company applies the following five step approach: • Identify the contract with the customer • Identify the performance obligations • Determine the transaction price • Allocate the transaction price to the performance obligations • Recognize revenue when (or as) the entity satisfies a performance obligation The Company generates revenue through subscription sales to access its Quantum Computing as a Service (“QCaaS”) cloud platform and from professional services related to the practical applications of quantum computing technology to solve its customers’ business challenges, to develop quantum proofs-of-concepts, re-sellers re-seller re-sellers’ re-seller mark-up Revenue from QCaaS is recognized evenly over the contractual period, on a straight-line basis over the subscription term, beginning on the date that the service is made available to the customer. Professional services are recognized as they are earned based on the terms of the contract or based on the cost-to-cost cost-to-cost
Recently adopted accounting standards and amendments	Recently adopted accounting standards and amendments D-Wave D-Wave
Recent accounting pronouncements not yet adopted	Recent accounting pronouncements not yet adopted In November 2021, the FASB issued ASU No.2021-10, Disclosures by Business Entities about Government Assistance 2021-10 2021-10 2021-10 2021-10 initial application or (2) retrospectively to those transactions. The Company plans to adopt the ASU 2021-10
DWave System [Member]
Principles of Consolidation		Principles of consolidation The consolidated financial statements include the accounts of the Company. All intercompany accounts and transactions have been eliminated on consolidation.
Use of Estimate		Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s consolidated financial statements and accompanying notes as of the date of the consolidated financial statements. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience. The Company’s accounting estimates and assumptions may change over time in response to COVID-19
Deferred Offering Costs		Deferred Offering Costs Deferred offering costs consist of legal, accounting and consulting fees incurred through the balance sheet date that are directly related to the Merger mentioned in Note 1 – Description of the business
Operating segment		Operating segment Operating segments are defined as components of an enterprise for which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s Chief Executive Officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating and evaluating financial performance. As such, the Company views its operations and manages its business in one operating and reportable segment (See Note 16 - Geographic areas
Foreign currency translation and transactions		Foreign currency translation and transactions The Company’s reporting currency is the US dollar. Generally, the functional and reporting currency of its international subsidiaries is the currency of their primary economic environment. Accordingly, all foreign balance sheet accounts have been translated into the U.S. dollars using the rate of exchange at the respective balance sheet date. Components of the consolidated statements of operation and comprehensive loss have been translated at the average exchange rate for the year or the corresponding period. Translation gains and losses are recorded in accumulated other comprehensive loss as a component of stockholders’ equity. Gains or losses arising from currency exchange rate fluctuations on transactions denominated in a currency other than the local functional currency are included in the consolidated statements of operations and comprehensive loss. For the years ended December 31, 2021, and 2020, the Company recorded $608,000 and $623,000 in foreign currency transaction gains, respectively, in other income in its consolidated statements of operations and comprehensive loss.
Cash and cash equivalents		Cash and cash equivalents The Company’s cash and cash equivalents consists of money held in demand depositary accounts and highly liquid investments, including commercial papers with original maturities of three months or less at the date of the purchase. The carrying amount of cash and cash equivalents was $9.5 million and $21.3 million as of December 31, 2021, and 2020, respectively, which approximates fair value and was determined based upon
Income Taxes		Income taxes The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the estimated future tax consequences of events that have been included in the consolidated financial statements or in the Company’s tax returns. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax bases of assets and liabilities using the enacted tax rates and laws in effect for the years in when the differences are expected to reverse. Deferred income taxes are classified as current or non-current, To the extent that new information becomes available, which causes the Company to change its judgment regarding the adequacy of tax liabilities or valuation allowances, such changes will impact income tax expense in the period in which such determination is made. Interest and penalties, if any, related to accrued liabilities for potential tax assessments are included in income tax expense. The Company follows the authoritative guidance under ASC 740, which clarifies the accounting for uncertainty in tax positions recognized in the financial statements. ASC 740 provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits.
Net income (loss) per share		Net income (loss) per share The Company calculates earnings per share using the two-class Basic net income (loss) per share is computed by dividing the net income (loss) by the weighted average number of shares of common stock outstanding for the period. Diluted net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares outstanding for the period, including potential dilutive shares assuming the dilutive effect of outstanding stock options and of convertible preferred stock. For periods in which the Company has reported net losses, diluted net loss per common share is the same as basic net loss per share, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive .
Fair Value of Financial Instruments		Fair value of financial instruments Certain assets and liabilities are carried at fair value under US GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: • Level 1—Quoted prices in active markets for identical assets or liabilities. • Level 2—Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. • Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company recognizes transfers between levels of the fair value hierarchy on the date of the event or change in circumstances that caused the transfer. The carrying amounts reflected in the consolidated balance sheets for cash and cash equivalents, trade accounts receivable, net, trade accounts payable and accrued expenses approximate their fair values (Level 1). The Co
Concentration risk		Concentration of credit risk and other risks and uncertainties Credit risk Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company maintains cash and cash equivalents with major and reputable financial institutions. Deposits held with the financial institutions may exceed the amount of insurance provided by the Canadian Deposit Insurance Corporation on such deposits but may be redeemed upon demand. The Company performs periodic evaluations of the relative credit standing of the financial institutions. With respect to accounts receivable, the Company monitors the credit quality of its customers as well as maintain an allowance for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. Concentration risk Agreements which potentially subject the Company to concentration risk consist principally of three customer agreements. For the year ended December 31, 2021, 15% of the Company’s total revenue was earned from a single customer, 13% was earned from a second customer and 12% was earned from a third customer. For the year ended December 31, 2020, 22% of the Company’s total revenue was earned from a single customer, 17% was earned from a second customer and 10% was earned from a third customer. Foreign currency risk The Company’s customers are located in the United States, Japan, Europe, Canada and other locations; therefore, foreign exchange risk exposures arise from transactions denominated in currencies other than the functional and reporting currency (United States dollars). To date, a majority of the Company’s sales have been denominated in United States dollars and a significant portion of the Company’s operating expenses are denominated in Canadian dollars. The Company also purchases certain of its key manufacturing inputs in Euros. As the Company expands its presence in international markets, the Company’s results of operations and cash flows may increasingly be subject to fluctuations due to changes in foreign currency exchange rates and may be adversely affected in the future due to changes in foreign exchange rates. To date, the Company has not entered into any hedging arrangements to minimize the impact of these fluctuations in the exchange rates. The Company will reassess its approach to manage our risk relating to fluctuations in currency rates. The Company does not believe that foreign currency risk had a material effect on its business, financial condition, or result of operations during the periods presented. Inflation Risk We do not believe that inflation had a significant impact on our results of operations for any periods presented in our consolidated financial statements. Nonetheless, if our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs, and our inability or failure to do so could harm our business, financial condition, and results of operations.
Government assistance		Government assistance US GAAP for profit-oriented entities does not define government assistance; nor is there specific guidance applicable to government assistance. During the years ended 2021 and 2020, the Company received various forms of government assistance including (i) government grants (ii) investment credits, and (iii) government loans, for research and development initiatives from Canadian government agencies. The Company recognizes grants and investment tax credits relating to qualifying scientific research and development expenditures as a reduction of the related eligible expenses (research and development expenses) in its consolidated statement of operations and comprehensive loss. Grants and investment tax credits are recognized in the period during which the related qualifying expenses are incurred, provided that the conditions under which the grants and investment tax credits have been met. The Company recognizes grants and investment tax credits in an amount equal to the estimated qualifying expenses incurred in each period multiplied by the applicable reimbursement percentage. Grants and investment tax credits that are recognized upon incurring qualifying expenses in advance of receipt of grant funding or proceeds from research and development incentives are recorded in the consolidated balance sheets as research incentives receivable. In circumstances where the grants received relates to prior period eligible expenses, the Company recognizes them as government assistance in its consolidated statement of operations and comprehensive loss in the current period. During the year ended December 31, 2020, the Company recorded Sustainable Development Technology Canada and BC Innovative Clean Energy (“SDTC”) grants of $7.6 million, as an offset to its research and development expenses in its consolidated statements of operations and comprehensive loss. The Company did not record any SDTC grants during the year ended December 31, 2021. During the years ended December 31, 2021, and 2020, the Company recorded a Scientific Research and Experimental Development (“SR&ED”) investment tax credit of $1.5 million and $2.1 million, respectively, as an offset to its research and development expenses in its consolidated statements of operations and comprehensive loss. The Company has received government loans under funding agreements that bear interest at rates that are below market rates of interest or interest-free. The Company accounts for the imputed benefit arising from the difference between a market rate of interest and the rate of interest charged as additional grant funding, and records interest expense for the loans at a market rate of interest. On the date that loan proceeds are earned, the Company recognizes the portion of the loan proceeds allocated to grant funding as a discount to the carrying value of the loan and as other liability, which is subsequently recognized as additional government assistance upon draw down of the qualified loan amounts. During the year ended December 31, 2021, the Company recorded the interest benefit on Strategic Innovation Fund (“SIF”) government loans for $7.2 million, as government assistance in its consolidated statements of operations and comprehensive loss. During the year ended December 31, 2020, the Company recorded the interest benefit on SIF and Technology Partnership of Canada (“TPC”) government loans for $ million, as government assistance in its consolidated statements of operations and comprehensive loss. See Note 8 – Loans payable for further details on government loans.
Revenue recognition		Revenue recognition The Company recognizes revenue in accordance with Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) 340-40, The standard was adopted on a full retrospective method on January 1, 2018. The adoption of ASC 606 had no impact on the Company and as such there was no recorded transition adjustment. The core principle of ASC 606 is that an entity shall recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To support this core principle, the Company applies the following five step approach: • Identify the contract with the customer • Identify the performance obligations • Determine the transaction price • Allocate the transaction price to the performance obligations • Recognize revenue when (or as) the entity satisfies a performance obligation The Company generates revenue through subscription sales to access its Quantum Computing as a Service (“QCaaS”) cloud platform and from professional services related to the practical applications of quantum computing technology to solve its customers’ business challenges, to develop quantum proofs-of-concepts, re-sellers re-seller re-sellers’ re-seller mark-up When the Company determines that its contracts with customers contain multiple performance obligations, for these arrangements, the Company allocates the transaction price based on the relative standalone selling price (“SSP”) method by comparing the SSP of each distinct performance obligation to the total value of the contract. The Company uses a range of amounts to estimate SSP for products and services sold together in a contract to determine whether there is a discount to be allocated based on the relative SSP of the various products and services. In instances where SSP is not directly observable, such as when the Company does not sell the product or service separately, the Company determines the SSP using information that may include market conditions and other observable inputs. Standalone selling price is typically established as a range. In situations in which the stated contract price for a performance obligation is outside of the applicable standalone selling price range and has a different pattern of transfer to the customer than the other performance obligations in the contract, the Company will reallocate the total transaction price to each performance obligation based on the relative standalone selling price of each. At times, the Company may sell bundled services that include professional services, QCaaS and training. For these bundled arrangements, the Company’s selling prices associated with QCaaS and training are observable, predictable and consistent. Accordingly, the Company uses the residual method under which the total transaction price and observable SSP of the QCaaS and training performance obligations are used to arrive at the estimated SSP of the professional services performance obligation. The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring goods and services to the customer. Revenue is recorded based on the transaction price. The Company’s contracts with customers may include renewals or other options at fixed prices. Determining whether such options are considered distinct performance obligations that provide the customer with a material right and therefore should be accounted for separately requires significant judgment. Judgment is required to determine the standalone selling price for each renewal option to determine whether the renewal pricing is reflective of the standalone selling price or is reflective of a discount that would provide the customer with a material right. Based on the Company’s assessment of standalone selling prices, the Company determined that there were no significant material rights provided to its customers requiring separate recognition. The timing of revenue recognition may not align with the right to invoice the customer. The Company records accounts receivable when it has the unconditional right to issue an invoice and receive payment, regardless of whether revenue has been recognized. Deferred revenue is primarily composed of fees related to QCaaS, which are generally billed in advance and recognized as revenue over the related subscription term. Unbilled receivables relate to revenue recognized for milestones completed under professional services contracts for which the related milestone billing has not yet occurred. In instances where the timing of revenue recognition differs from the timing of the right to invoice, the Company has determined that a significant financing component generally does not exist. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable way of purchasing the products and services and not to receive financing from or provide financing to the customer. Additionally, the Company has elected the practical expedient terms that permit an entity not to recognize a significant financing component if the time between the transfer of a good or service and payment is one year or less. Payment terms on invoiced amounts are typically net 30 days. The Company does not offer rights of return for its services in the normal course of business and contracts generally do not include service-type warranties that provide any incremental service to the customer beyond providing assurance that the services conform to applicable specifications or customer-specific or subjective acceptance provisions. The Company also excludes from revenue government-assessed and imposed taxes on revenue-generating activities that are invoiced to customers. The Company has identified up to two performance obligations regularly included in arrangements involving the Leap Quantum Cloud (QCaaS) subscriptions and the D-Wave Launch professional services. The Company’s professional services are typically not coterminous with the QCaaS subscriptions. Revenue from QCaaS is recognized evenly over the contractual period, on a straight-line basis over the subscription term, beginning on the date that the service is made available to the customer. Professional services are recognized as they are earned based on the cost-to-cost cost-to-cost Contract assets and contract liabilities The timing of revenue recognition, billings and cash collections may result in accounts receivable, contract assets, and contract liabilities (deferred revenue) on the Company’s consolidated balance sheets. A receivable is recorded in the period in which we provide services when we have an unconditional right to payment. Contract assets primarily relate to the value of services transferred to the customer for which the right to payment is not just dependent on the passage of time. Contract assets are transferred to accounts receivable when rights to payment become unconditional. A contract liability is recognized when the Company receives payment or has an unconditional right to payment in advance of the satisfaction of performance. The contract liabilities represent deferred service revenue, Cost to obtain and fulfilling contracts The Company has elected to apply the practical expedient to expense contract acquisition costs as incurred when the expected amortization period is one year or less. The Company capitalizes incremental costs incurred to fulfill its contracts that (i) relate directly to the contract, (ii) are expected to generate resources that will be used to satisfy the Company’s performance obligation(s) under the contract, and (iii) are expected to be recovered through revenue generated under the contract. The Company has not identified any costs that are incremental to the acquisition of customer contracts that would be capitalized as deferred costs on the balance sheet in accordance with ASC 340-40. 340-40
Recently adopted accounting standards and amendments		Recently adopted accounting standards and amendments The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company is provided the option to adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as private companies, including early adoption when permissible. With the exception of standards, the Company elected to early adopt, when permissible, the Company has elected to adopt new or revised accounting guidance within the same time period as private companies, as indicated below. In June 2016, the FASB issued ASU 2016-13, available-for-sale 2016-13 In August 2018, the FASB issued ASU 2018-13, 2018-13 2019-08, 2019-08
Transaction between entities under common control		Transaction between entities under common control In April 2020, DWSI was formed with the primary objective of facilitating additional financing from existing shareholders and additional investors. Old D-Wave, D-Wave D-Wave The Class B Preferred Stock for $ million of proceeds. The DWSI newly non-redeemable convertible preferred stock issue price was $ per share for Class B1 and Class B2 Preferred Stock and $ for Class B Preferred Stock. The Transaction was recorded as a transaction between entities under common control that led to a change in the reporting entity. In the accompanying consolidated financial statements, the assets and the liabilities and relating operations of the transferring entity (Old D-Wave) D-Wave paid-in Amalgamation of Old D-Wave In order to simplify the corporate structure of DWSI Holdings Inc. and to reduce administrative costs, effective January 1, 2021, the Company completed a vertical short-form amalgamation pursuant to the British Columbia Business Corporations Act D-Wave. D-Wave D-Wave D-Wave The amalgamation did not have a significant effect on the business and operations of D-Wave.
Comprehensive loss		Comprehensive loss Comprehensive loss consists of two components, net loss and other comprehensive loss. The Company’s other comprehensive loss consists of foreign currency translation adjustments that result from consolidation of its foreign entities.
Trade accounts receivable, net		Trade accounts receivable, net Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company periodically reviews the need for an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and the Company’s customers’ respective financial conditions, the amounts of receivables in dispute and the current receivables aging and current payment patterns. To the extent identified, account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. To date, the Company’s customers have proven to be credit worthy. As of December 31, 2021, and 2020, the Company did not recognize any material write-offs and has not
Inventories		Inventories Inventories are stated at the lower of cost, using the weighted average cost method, or net realizable value. Inventory that is obsolete or in excess of forecasted usage is written down to its estimated net realizable value based on the assumptions about future demand and market conditions. Inventory write-downs are charged to cost of revenue and establish a new cost basis for the inventory. Inventories include raw materials, which consist of parts and supplies used in the Company’s manufacturing process and research and development activities as well as service parts for the Company’s quantum computer systems, work-in-process goods.
Property and equipment, net		Estimated Useful Lives Quantum computer systems 5 years Lab equipment 5 years Computer equipment 3 years Furniture and fixtures 5 years Leasehold improvements Shorter of expected lease term or estimated useful life Upon sale or retirement of the assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the statement of operations and comprehensive loss. Expenditures for general maintenance and repairs are expensed as incurred.
Internally developed software		Internally developed software Costs related to the formulation and design of internally developed software are expensed as incurred to research and development.
Impairment of Long-Lived Assets		Impairment of Long-Lived Assets Long-lived assets, such as property and equipment and other long-term assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group to be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent the carrying amount of the underlying asset exceeds its fair value. The Company did not record any impairment loss on long-lived assets during the years ended December 31, 2021 and 2020.
Leases		Leases The Company adopted ASC 842, Leases (“ASC 842”) as of January 1, 2018. ASC 842 was adopted using the modified retrospective transition approach, with no restatement of prior periods or cumulative adjustments to the use-of-hindsight to and non-lease components The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from a lease. ROU assets and operating lease liabilities are recognized at the commencement date based on the present value of the future minimum lease payments over the lease term. Operating lease ROU assets also include the impact of any lease incentives. Amendments to a lease are assessed to determine if it represents a lease modification or a separate contract. Lease modifications are reassessed as of the effective date of the modification using an incremental borrowing rate based on the information available at the commencement date. For modified leases, the Company also reassesses the lease classification as of the effective date of the modification. The interest rate used to determine the present value of the future lease payments is the Company’s incremental borrowing rate, because the interest rate implicit in the Company’s leases is not readily determinable. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in economic environments where the leased asset is located. The Company’s lease terms include periods under options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option in the measurement of its ROU assets and liabilities. The Company considers contractual-based factors such as the nature and terms of the renewal or termination, asset-based factors such as physical location of the asset and entity-based factors such as the importance of the leased asset to the Company’s operations to determine the lease term. The Company generally uses the base, non-cancelable, lease right-of-use
Cost of revenue		Cost of revenue Cost of revenue primarily consists of expenses related to delivering the Company’s services, including direct labor costs, direct services costs and depreciation and amortization related to the Company’s quantum computing systems and related software.
Research and development costs		Research and development costs Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred in performing research and development activities, including personnel costs, stock-based compensation, employee benefits, facility costs, depreciation, manufacturing expenses and all other costs for the Company’s hardware, software and engineering personnel who design and develop the Company’s quantum computing systems and research new quantum computing technologies. Unlike a standard computer, design and development efforts continue throughout the useful life of the Company’s quantum computing systems to ensure proper calibration and optimal functionality. Research and development expenses also include purchased hardware and software costs related to quantum computing systems constructed for research purposes that are not probable of providing future economic benefit and have no alternate future use.
Advertising Costs		Advertising Costs Advertising costs are expensed as incurred and are primarily included in sales and marketing expenses in the consolidated statements of operations and comprehensive loss. During the years ended December 31, 2021, and 2020, these costs were $887,000 and $1.0 million, respectively.
Stock-based compensation		Stock-based compensation The Company measures its stock-based awards made to employees based on the estimated fair value of the awards as of the grant date using the Black-Scholes option-pricing model. Stock-based compensation expense is recognized over the requisite service period using the straight-line method and is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. As such, the Company’s stock-based compensation is reduced for the estimated forfeitures at the grant date and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Stock-based compensation expenses to non-employees instruments issued, using the Bl a non-employees is remeasured each period as the underlying options vest. The Black-Scholes option-pricing model requires the use of subjective assumptions, which determine the fair value of share-based awards, including the fair value of the Company’s common stock, the option’s expected term, the price volatility of the underlying common stock, risk-free interest rates, and the expected dividend yield of the common stock. The assumptions used to determine the fair value of the stock awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.
Common stock valuations		Common stock valuations The Company obtained third-party valuations to estimate the fair value of its common stock for purposes of measuring stock-based compensation expense. The third-party valuations were prepared using methodologies, approaches, and assumptions consistent with the American Institute of Certified Public Accountants (“AICPA”) Accounting & Valuation Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation (“Practice Guide”). In accordance with the Practice Guide, the Company considered the following methods for allocating the enterprise value across its classes of capital stock to determine the fair value of its common stock at each valuation date. • Option Pricing Method (“OPM”). The OPM estimates the value of the common equity of D-Wave D-Wave non-marketable • Probability-Weighted Expected Return Method (“PWERM”). The PWERM employs additional information not used in the OPM, including various market approach calculations depending upon the likelihood of various discrete future liquidity scenarios, such as the sale of D-Wave D-Wave For financial reporting purposes, the Company also retrospectively assessed the deemed fair value of its common stock used for calculating and recording stock-based compensation charges after considering the fair value reflected on subsequent valuation reports and other facts and circumstances on the date of grant. The Company used a linear interpolation method to estimate the fair value between valuation dates. The Company believes that the linear interpolation methodology provides the most reasonable basis for the valuation of its common stock because the Company did not identify any significant events that occurred during the intervening periods that would have caused a material In addition to considering the results of these third-party valuation reports, our board of directors used assumptions based on various objective and subjective factors, combined with management judgment, to determine the fair value of our common stock as of each grant date, including: • the prices at which the Company sold shares of non-redeemable convertible preferred stock and the superior rights and preferences of the non-redeemable convertible preferred stock relative to its common stock at the time of each grant: • external market conditions affecting the research and development industry and trends within the industry. • the Company’s stage of development and business strategy • the Company’s financial condition and operating results, including its levels of available capital resources, and forecasted results. • developments in the Company’s business. • the progress of the Company’s research and development efforts. • equity market conditions affecting comparable public companies; and • general market conditions and the lack of marketability of its common stock. Application of these approaches involves the use of estimates, judgment and assumptions that are subjective, such as those regarding the Company’s expected future revenue, expenses and future cash flows, discount rates, market multiples, the selection of comparable companies and the probability of possible future events. Changes in any or all of these estimates and assumptions or the relationships between those assumptions impact the Company’s valuations as of each valuation date and may have a material impact on the valuation of its common stock.
Recent accounting pronouncements not yet adopted		Recent accounting pronouncements not yet adopted In December 2019, the FASB issued ASU 2019-12, Income 2019-12 is effective Company in the first quarter of 2021 and early adoption is permitted. The Company does not expect the adoption of this standard to have a material impact on the consolidated financial statements. In August 2020, the FASB issued ASU 2020-06, Debt, Debt (Subtopic 470-20) and (Subtopic 815-40) Accounting 2020-06

Basis of presentation and Sum_3

Basis of presentation and Summary of Significant Accounting Policies (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Summary of fair value liabilities measured on recurring basis	The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis as of September 30, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value (in thousands): Description Level September 30, Liabilities: Warrant Liabilities – Public Warrants 1 $ 3,018 Warrant Liabilities – Private Placement Warrants 2 $ 2,480
D-Wave Systems Inc. [Member]
Summary of cash and cash equivalents		The following table provides a reconciliation of cash and cash equivalents on the consolidated balance sheets to the totals presented on the consolidated statement of cash flows (in thousands): December 31, 2021 2020 Cash $ 9,483 $ 10,272 Cash equivalents - commercial papers — 11,063 Total cash and cash equivalents on the consolidated statements of cash flows $ 9,483 $ 21,335
Schedule of estimated useful lives of its property and equipment		The Company’s estimated useful lives of its property and equipment are as follows: Estimated Useful Lives Quantum computer systems 5 years Lab equipment 5 years Computer equipment 3 years Furniture and fixtures 5 years Leasehold improvements Shorter of expected lease term or estimated useful life

Business Combination (Tables)

Business Combination (Tables)	9 Months Ended
	Sep. 30, 2022
Reverse Recapitalization [Abstract]
Business combination	In accounting for the Business Combination and after redemptions, net proceeds received by the Company totaled $21.4 million. The following table presents the net proceeds from the Business Combination and PIPE Investment for the nine months ended September 30, 2022 (in thousands): Recapitalization Cash - DPCM trust and cash, net of redemptions $ 9,130 Cash - PIPE Investment 40,000 Less: Non-cash (13,728 ) Less: Transaction costs (14,017 ) Net Business Combination and PIPE Investment 21,385 Add back: Non-cash 13,728 Add back: Accrued transaction costs 2,459 Net cash contribution from Business Combination and PIPE Investment $ 37,572 The following table presents the number of shares of Common Shares issued immediately following the consummation of the Business Combination, PIPE Investment, and closing of the ELOC: Number of Exchange of DPCM Class A common stock for D-Wave 1,311,937 Exchange of DPCM Class B common stock for D-Wave 3,015,575 D-Wave 5,816,528 Business Combination and PIPE shares 10,144,040 Exchange of D-Wave D-Wave 99,736,752 D-Wave 127,180 Total D-Wave 110,007,972

Revenue from contracts with c_2

Revenue from contracts with customers (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Disaggregation of revenue	The following table depicts the disaggregation of revenue by type of products or services and timing of transfer of products or services (in thousands): Three months ended 2022 2021 Type of products or services QCaaS $ 1,346 $ 980 Professional services 347 306 Other revenue 2 21 Total revenue, net $ 1,695 $ 1,307 Timing of revenue recognition Revenue recognized over the time $ 1,660 $ 1,247 Revenue recognized at a point in time 35 60 Total revenue, net $ 1,695 $ 1,307 Nine months ended 2022 2021 Type of products or services QCaaS $ 3,905 $ 3,063 Professional services 812 736 Other revenue 61 54 Total revenue, net $ 4,778 $ 3,853 Timing of revenue recognition Revenue recognized over the time $ 4,618 $ 3,773 Revenue recognized at a point in time 160 80 Total revenue, net $ 4,778 $ 3,853
Accounts receivable, contract assets and liabilities, and changes in deferred revenue	The following table provides information about account receivable, contract assets and liabilities as of September 30, 2022 and December 31, 2021 (in thousands): September 30, December 31, 2022 2021 Contract assets: Trade account receivable $ 740 $ 421 Unbilled receivables, which are included in ‘Prepaid expenses and other current assets’ 252 17 Total contract assets 992 438 Contract liabilities: Deferred revenue, current 1,989 2,665 Deferred revenue, noncurrent — 54 Customer deposit, which are included in ‘Accrued expenses and other current liabilities’ 21 21 Total contract liabilities $ 2,010 $ 2,740 Changes in deferred revenue from contracts with customers were as follows (in thousands): September 30, December 31, 2022 2021 Balance at beginning of period $ 2,719 $ 4,713 Deferral of revenue 3,554 4,092 Recognition of deferred revenue (4,284 ) (6,086 ) Balance at end of period $ 1,989 $ 2,719
DWave System [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of revenue		The following table depicts the disaggregation of revenue by type of products or services and timing of transfer of products or services (in thousands): Years ended 2021 2020 Type of products or services QCaaS $ 4,424 $ 4,313 Professional services 1,786 426 Other revenue 69 421 Total revenue, net $ 6,279 $ 5,160 Timing of revenue recognition Revenue recognized over time $ 6,090 $ 4,688 Revenue recognized at a point in time 189 472 Total revenue, net $ 6,279 $ 5,160
Accounts receivable, contract assets and liabilities, and changes in deferred revenue		The following table provides information about account receivable, contract assets and liabilities as of December 31, 2021, and 2020 (in thousands): December 31, 2021 2020 Contract assets: Trade account receivable, net $ 421 $ 590 Unbilled receivables, which are included in ‘Prepaid expenses and other current assets’ 17 10 Total contract assets 438 600 Contract liabilities: Deferred revenue, current 2,665 4,713 Deferred revenue, noncurrent 54 — Customer deposit, which are included in ‘Accrued expenses and other current liabilities’ 21 — Total contract liabilities 2,740 4,713 Changes in deferred revenue from contracts with customers were as follows (in thousands): Years ended 2021 2020 Balance at beginning of period $ 4,713 $ 4,921 Deferral of revenue 4,092 4,513 Recognition of deferred revenue (6,086 ) (4,721 ) Balance at the end of period $ 2,719 $ 4,713

Fair value of financial instr_2

Fair value of financial instruments (Tables)	12 Months Ended
	Dec. 31, 2021
DWave System [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Schedule of the Company's financial assets measured at fair value on a recurring basis and indicating the level of the fair value hierarchy utilized to determine such fair values	The following tables present information about the Company’s financial assets measured at fair value on a recurring basis and indicating the level of the fair value hierarchy utilized to determine such fair values as of December 31, 2020 (in thousands): Fair value measurement as of Level 1 Level 2 Level 3 Assets Cash equivalents: Commercial paper $ — $ 11,063 $ — Total assets $ — $ 11,063 $ — Liabilities Other liabilities: Warrant liabilities — — — Total liabilities $ — $ — $ — During the years ended December 31, 2020, there were no transfers between Level 1, Level 2, and Level 3.

Balance sheet details (Tables)

Balance sheet details (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Schedule of Prepaid expenses and other current assets	Prepaid expenses and other current assets consisted of the following (in thousands): September 30, December 31, 2022 2021 Prepaid expenses: Prepaid Lincoln Park commitment fee $ 3,279 $ — Prepaid services 1,319 125 Prepaid software 1,027 531 Prepaid rent 121 151 Prepaid commissions 117 84 Other 11 156 Other current assets: Directors and Officers insurance $ 2,028 $ — Unbilled receivables 252 17 Security deposits 36 52 Total prepaid expenses and other current assets $ 8,190 $ 1,116
Accrued expenses and other liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): September 30, December 31, 2022 2021 Accrued expenses: Accrued transaction costs $ 2,459 $ — Accrued professional services 1,010 1,953 Accrued compensation and related benefits 1,438 1,108 Other accruals 113 318 Other current liabilities: Other payroll expenses $ 247 $ 175 Customer deposit 21 21 Current portion of long term debt, net 30 39 Total accrued expenses and other current liabilities $ 5,318 $ 3,614
DWave System [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Schedule Of Inventory Current		Inventories Inventories consisted of the following (in thousands): December 31, 2021 2020 Raw materials $ 2,103 $ 2,516 Work-in-process 11 5 Total inventories $ 2,114 $ 2,521
Schedule of Prepaid expenses and other current assets		Prepaid expenses and other current assets Prepaid expenses and other current assets consisted of the following (in thousands): December 31, 2021 2020 Prepaid expenses: Prepaid software $ 531 $ 469 Prepaid rent 151 187 Prepaid commissions 84 102 Prepaid services 125 179 Other 156 133 Other current assets: Security deposits 52 173 Unbilled receivables 17 10 Total prepaid expenses and other current assets $ 1,116 $ 1,253
Schedule Of Other Assets Non current		Other noncurrent assets consisted of the following (in thousands): December 31, 2021 2020 Investment in securities $ 1,169 $ 5 Long-term deposits 184 182 Total other noncurrent assets $ 1,353 $ 187
Accrued expenses and other liabilities		Accrued expenses and other current liabilities consisted of the following (in thousands): December 31, 2021 2020 Accrued expenses: Accrued professional services $ 1,953 $ 1,534 Accrued compensation and related benefits 1,108 1,211 Other accruals 318 147 Other current liabilities: Other payroll expenses 175 291 Customer deposits 21 — Current portion of long-term debt, net 39 — Total accrued expenses and other current liabilities $ 3,614 $ 3,183

Property and equipment, net (Ta

Property and equipment, net (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment, net	Property and equipment, net consisted of the following (in thousands): September 30, December 31, 2022 2021 Quantum computer systems $ 13,425 $ 13,425 Lab equipment 6,664 6,645 Computer equipment 3,439 3,305 Leasehold improvements 1,074 1,074 Furniture and fixtures 318 316 Construction-in-progress 379 285 Total property and equipment 25,299 25,050 Less: Accumulated depreciation (22,762 ) (21,801 ) Property and equipment, net $ 2,537 $ 3,249
DWave System [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, net		Property and equipment, net consisted of the following (in thousands): December 31, 2021 2020 Quantum computer systems $ 13,425 $ 12,103 Lab equipment 6,645 6,315 Computer equipment 3,305 2,954 Leasehold improvements 1,074 1,072 Furniture and fixtures 316 316 Construction-in-progress 285 502 Total property and equipment 25,050 23,262 Less: Accumulated depreciation (21,801 ) (20,368 ) Property and equipment, net $ 3,249 $ 2,894

Intangible assets, net (Tables)

Intangible assets, net (Tables)	12 Months Ended
	Dec. 31, 2021
D-Wave Systems Inc. [Member]
Finite-Lived Intangible Assets [Line Items]
Summary of Finite-Lived Intangible Assets	Intangible assets, net consisted of the following (in thousands): December 31, 2021 2020 Capitalized software $ 1,087 $ 862 Other intangible assets 35 35 Total intangible assets 1,122 897 Less: Accumulated amortization (850 ) (749 ) Intangible assets, net $ 272 $ 148

Loans payable (Tables)

Loans payable (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Short-term Debt [Line Items]
Components of loans payable	The following table shows the component of loans payable (in thousands): September 30, December 31, 2022 2021 Loan payable, beginning of period $ 29,844 $ 13,624 SIF contribution — 16,786 Financing of Directors and Officers Insurance 2,893 — Venture Loan 20,000 — Payments (1,262 ) (399 ) Interest and final fee on Venture Loan 1,808 — Repayment of the Venture Loan (21,808 ) — Foreign exchange (gain) loss (1,948 ) (167 ) Loan payable, end of period $ 29,527 $ 29,844 Discount, beginning of period $ (17,391 ) $ (11,948 ) SIF discount on additional contribution — (7,167 ) TPC discount on additional contribution — — Venture Loan discount (130 ) — Interest expense 1,902 1,728 Foreign exchange (gain) loss 1,236 (4 ) Total discount, end of period $ (14,383 ) $ (17,391 ) Total loans payable, end of period $ 15,144 $ 12,453 Short-term portion 2,232 220 Long-term portion 12,912 12,233 Total loans payable $ 15,144 $ 12,453
DWave System [Member]
Short-term Debt [Line Items]
Components of loans payable		The following table shows the component of loans payable, net (in thousands): December 31, 2021 2020 Loans payable, beginning of year $ 13,624 $ 5,555 SIF contribution 16,786 11,661 Payments (399 ) — TPC debt forgiveness — (3,873 ) Foreign exchange (gain) loss (167 ) 281 Loans payable, end of year $ 29,844 $ 13,624 Discount, beginning of year $ (11,948 ) $ — SIF discount on additional contribution (7,167 ) (11,199 ) TPC discount on additional contribution — (748 ) Government interest expense 1,728 232 Foreign exchange (gain) loss (4 ) (233 ) Discount, end of year $ (17,391 ) $ (11,948 ) Total Loans payable, net $ 12,453 $ 1,676 Short-term portion 220 355 Long-term portion 12,233 1,321 Total loans payable, net 12,453 1,676

Leases (Tables)

Leases (Tables) - D-Wave Systems Inc. [Member]	12 Months Ended
	Dec. 31, 2021
Leases [Line Items]
Summary of lease costs	The lease costs are reflected in the statement of operations and comprehensive loss as follow (in thousands): December 31, 2021 2020 Research and development $ 268 $ 268 General and administrative 1,057 1,158 Total lease costs $ 1,324 $ 1,426 The weighted-average remaining lease terms and discount rates for operating leases were as follows: December 31, 2021 2020 Weighted average remaining lease term in years 2.89 2.39 Weighted average discount rate (1) 18 % 20 % (1) For the lease contracts denominated in Canadian dollars, the discount rate was determined on a currency-equivalent basis.
Summary of future minimum operating lease payment under non-cancelable leases	Future minimum operating lease payment under non-cancelable Year ending December 31, Operating 2022 $ 1,687 2023 1,384 2024 1,179 2025 1,212 2026 1,245 Thereafter 9,648 Total future minimum lease payments $ 16,355

Income Tax (Tables)

Income Tax (Tables) - D-Wave Systems Inc. [Member]	12 Months Ended
	Dec. 31, 2021
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	Significant components of the Company’s deferred income tax assets and liabilities as of December 31, 2021, and 2020 are as follows: Years ended 2021 2020 Deferred tax assets: Net operating loss carryforwards $ 59,916 $ 54,018 Research and development credit carryforwards 13,675 12,003 Scientific research and experimental development deductions 23,071 20,137 Depreciation and amortization 5,634 5,256 Convertible notes (4 ) 1,156 Deferred revenue 165 401 Other accruals and reserves 730 440 Total deferred tax assets 103,187 93,411 Valuation Allowance (97,143 ) (89,139 ) Total deferred tax assets, net $ 6,044 $ 4,272 Deferred tax liabilities: Marketable securities (315 ) — Loans payable (5,729 ) (4,272 ) Total deferred tax liabilities (6,044 ) (4,272 ) Net deferred tax assets $ — $ —
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Years ended 2021 2020 Federal and provincial statutory tax rate 27 % 27 % Foreign losses taxed at different rates 0 % 1 % Research and development credits 0 % (3 )% Permanent differences (2 )% 18 % Other 1 % 7 % Change in valuation allowance (26 )% (50 )% Effective tax rate 0 % 0 %
Summary of domestic and foreign components of loss before income taxes	The following table presents domestic and foreign components of loss before income taxes for the years ended December 31, 2021, and 2020 (in thousands): Years ended 2021 2020 Domestic $ (27,205 ) $ (7,784 ) International (4,340 ) (2,235 ) Net loss before income taxes $ (31,545 ) $ (10,019 )

Stock-based compensation (Table

Stock-based compensation (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Assumptions used to estimate fair value of stock options granted	The assumptions used to estimate the fair value of stock options granted during the nine months ended September 30, 2022 and 2021 are as follows: Nine months ended September 30, 2022 2021 Expected dividend yield — — Expected volatility 70.6 % 56.3 % Expected term (years) 6.1 6.1 Risk-free interest rate 3.0 % 0.9 %
Stock option activity	The following table summarizes the Company’s stock option activity during the periods presented (in thousands except share and per share data): Number of Weighted average exercise price ($) Weighted Aggregate ($) Balance as of December 31, 2021 16,336,134 $ 0.81 8.55 $ 80,179 Granted 1,500,081 10.07 Exercised (174,378 ) 0.81 Forfeited (944,087 ) 0.81 Expired (28,981 ) 0.81 Balance as of September 30, 2022 16,688,769 $ 1.64 6.96 $ 74,546 Exercisable as of September 30, 2022 12,128,516 $ 0.84 6.20 $ 59,344
Preferred stock warrants outstanding and exercisable	As of September 30, 2022, the following preferred stock warrants of D-Wave Number of Weighted Expiry Date Number 3,247,637 $ 1.92 29-Nov-26 1,299,055 Total, September 30, 2022 3,247,637 $ 1.92 1,299,055
Stock-based compensation expense	The following table summarizes the stock-based compensation expense classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands): Three months ended 2022 2021 Research and development $ 329 $ 63 General and administrative 1,640 105 Sales and marketing 58 57 Total stock-based compensation $ 2,027 $ 225 Nine months ended 2022 2021 Research and development $ 539 $ 150 General and administrative 2,909 278 Sales and marketing 247 127 Total stock-based compensation $ 3,695 $ 555
D-Wave Systems Inc. [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Assumptions used to estimate fair value of stock options granted		The assumptions used to estimate the fair value of stock options granted during the years ended December 31, 2021 and 2020 are as follows: Years ended 2021 2020 Expected dividend yield 0% 0% Expected volatility 56% 45% Expected term (years) 8.53 9.41 Risk-free interest rate 0.87% 0.43%
Stock option activity		The following table summarizes the Company’s stock option activity during the periods presented (in thousands except share and per share data): Number of Weighted Weighted Aggregate Balance as of December 31, 2020 12,654,807 0.81 9.38 — D-Wave 4,369,866 0.82 — — D-Wave (105,203 ) 0.81 — — D-Wave (171,204 ) 0.81 — — D-Wave (412,132 ) 0.81 — — Balance as of December 31, 2021 16,336,134 0.81 8.55 80,179 Options unvested as of December 31, 2021 6,943,273 0.81 8.53 77,423 Options exercisable as of December 31, 2021 9,392,861 0.81 8.20 46,116
Preferred stock warrants outstanding and exercisable		As of December 31, 2021, the following United States dollar common stock warrants were outstanding and exercisable: Number of Weighted Expiry Date Number 617,972 $ 1.75 14-April-22 617,972 Total, December 31, 2021 617,972 $ 1.75 617,972 As of December 31, 2021, the following United States dollar preferred stock warrants were outstanding and exercisable: Number of Weighted Expiry Date Number 3,247,637 $ 1.92 29-Nov-26 1,299,055 Total, December 31, 2021 3,247,637 $ 1.92 1,299,055
Stock-based compensation expense		The following table summarizes the stock-based compensation expense classified in the consolidated statements of operations and comprehensive loss as follows (in thousands): Years ended 2021 2020 Research and development $ 338 $ 1,513 General and administrative 1,164 1,346 Sales and marketing 237 130 Total stock-based compensation $ 1,739 $ 2,989
D-Wave Systems Inc. [Member] | Common stock and preferred stock warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option activity		A continuity of the Company’s United States dollar common stock warrants issued and outstanding is as follows: Number Weighted Number of Weighted Balance as of December 31, 2020 617,972 1.75 3,247,637 1.92 Granted during the period — — — — Expired during the period — — — — Exercised during the period — — — — Balance as of December 31, 2021 617,972 1.75 3,247,637 1.92

Net loss per share (Tables)

Net loss per share (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Computation of basic and diluted net loss per share	The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders for the three and nine months ended September 30, 2022 and 2021 (in thousands, except share and per share data): For the three months ended 2022 2021 Numerator: Net loss attributable to common stockholders - basic and diluted $ (13,053 ) $ (4,209 ) Denominator: Weighted-average common stock outstanding 116,256,805 125,362,390 Net loss per share attributable to common stockholders - basic and diluted $ (0.11 ) $ (0.03 ) For the nine months ended 2022 2021 Numerator: Net loss attributable to common stockholders - basic and diluted $ (37,868 ) $ (17,705 ) Denominator: Weighted-average common stock outstanding 122,337,727 125,331,065 Net loss per share attributable to common stockholders - basic and diluted $ (0.31 ) $ (0.14 )
Potentially dilutive securities	Potentially dilutive securities (upon conversion) that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: As of September 30, 2022 2021 Public Warrants as converted to Common Shares (Note 8) 14,426,301 — Private Warrants as converted to Common Shares (Note 8) 11,633,060 — D-Wave 2,889,282 2,889,282 Options to purchase common stock as converted to Common Shares 14,847,108 14,608,809 Total 43,795,751 17,498,091
D-Wave Systems Inc. [Member]
Computation of basic and diluted net loss per share		The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data): For the years ended December 31, 2021 2020 Numerator: Net Income $ (31,545 ) $ (10,019 ) Denominator: Weighted-average shares outstanding, basic and diluted 111,911,127 121,358,989 Net loss per share, basic and diluted $ (0.28 ) $ (0.08 )
Potentially dilutive securities		Potentially dilutive securities (upon conversion) that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: For the years ended 2021 2020 Options to purchase common shares 16,336 12,655 Warrants to purchase common shares 618 618 Warrants for preferred shares 3,248 3,248

Geographic areas (Tables)

Geographic areas (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Schedule of Investments [Line Items]
Disaggregation of revenue	The following table presents a summary of revenue by geography for the three and nine month periods ended September 30, 2022 and 2021: Three months ended September 30, 2022 2021 United States $ 951 $ 784 Japan 293 304 Germany 237 70 Other 214 149 Total revenue $ 1,695 $ 1,307 Nine months ended September 30, 2022 2021 United States $ 2,461 $ 2,100 Japan 1,008 1,197 Germany 757 197 Other 552 359 Total revenue $ 4,778 $ 3,853
Long-lived assets by geographic area	The following table sets forth the long-lived assets, consisting of property and plant, net, and operating lease right-of-use September 30, December 31, 2022 2021 Canada $ 10,106 $ 11,251 United States 497 576 Total long-lived assets $ 10,603 $ 11,827
Significant customers	The tables below present the significant customers on a percentage of total revenue basis for the three and nine month periods ended September 30, 2022 and 2021. Three months ended September 30, 2022 2021 Customer A 15 % 15 % Customer B 11 % 11 % Customer C 10 % — % Nine months ended September 30, 2022 2021 Customer A 13 % 13 % Customer B 13 % 12 %
D-Wave Systems Inc. [Member]
Schedule of Investments [Line Items]
Disaggregation of revenue		The following table presents a summary of revenue by geography for the years ended December 31, 2021 and 2020: For the years ended 2021 2020 United States $ 3,425 $ 3,119 Japan 1,614 1,630 Germany 741 155 Other 499 256 Total revenue $ 6,279 $ 5,160
Long-lived assets by geographic area		December 31, 2021 2020 Canada $ 11,251 $ 4,984 United States 576 858 Total long-lived assets $ 11,827 $ 5,842
Significant customers		The Company had significant customers during the year ended December 31, 2021 and 2020. A significant customer is defined as one that makes up ten percent or more of total revenues in a particular year or ten percent of outstanding accounts receivable balance as of the year end. December 31, 2021 2020 Customer A 15 % 22 % Customer B 13 % 17 % Customer C 12 % 10 %

Common stock and non-redeemab_2

Common stock and non-redeemable convertible preferred stock (Tables)	12 Months Ended
	Dec. 31, 2021
D-Wave Systems Inc. [Member]
Common stock and nonredeemable convertible preferred stock [Line Items]
Schedule of non-redeemable convertible preferred shares	Non-redeemable convertible preferred stock Shares Shares issued Original Carrying Class A Unlimited 27,065,219 $ 1.75 $ 47,336 Class B1 Unlimited 52,700,609 1.75 119,977 Class B2 Unlimited 29,000,000 1.75 23,000 Class B3 Unlimited 29,000,000 0.00001 0.29 Issuance costs (432 ) Total preferred stock Unlimited 137,765,828 $ 189,881 The Company’s non-redeemable convertible preferred stock as of December 31, 2020 consisted of the following (in thousands, except share and per share data): Non-redeemable convertible preferred stock Shares Shares issued Original Carrying Class A Unlimited 27,065,219 $ 1.75 $ 47,336 Class B1 Unlimited 52,700,609 1.75 119,977 Class B2 Unlimited 29,000,000 1.75 23,000 Class B3 Unlimited 29,000,000 0.00001 0.29 Issuance costs (432 ) Total preferred stock Unlimited 137,765,828 $ 189,881

Business Combination - Narrativ

Business Combination - Narrative (Details) $ / shares in Units, $ in Thousands	Aug. 05, 2022 USD ($) $ / shares shares	Sep. 30, 2022 shares	Aug. 04, 2022 shares	Dec. 31, 2021 shares
Schedule Of Reverse Recapitalization [Line Items]
Exchange ratio	1.4541326
Sale of stock, price (in usd per share) | $ / shares	$ 10
Cash - PIPE Investment | $	$ 40,000
Net proceeds received | $	$ 21,385
Stock forfeited (in shares)			4,484,425
Conversion ratio	0.889657
Common stock, outstanding (in shares)	110,007,972	110,377,357		2,817,498
Private Placement [Member]
Schedule Of Reverse Recapitalization [Line Items]
Issuance of common stock (in shares)	5,816,528
D-Wave Systems Inc. Stockholders
Schedule Of Reverse Recapitalization [Line Items]
Exchange of common stock (in shares)	99,736,752
DCPM Class A common stock subject to redemption
Schedule Of Reverse Recapitalization [Line Items]
Common stock, outstanding (in shares)			30,000,000
Stock redeemed (in shares)			29,097,787
DCPM Class A common stock
Schedule Of Reverse Recapitalization [Line Items]
Stock exchanged (in shares)	902,213
DCPM Class A common stock | DPCM Capital, Inc. Stockholders
Schedule Of Reverse Recapitalization [Line Items]
Exchange of common stock (in shares)	1,311,937
DCPM Class B common stock
Schedule Of Reverse Recapitalization [Line Items]
Common stock, outstanding (in shares)	3,015,575		7,500,000
DCPM Class B common stock | DPCM Capital, Inc. Stockholders
Schedule Of Reverse Recapitalization [Line Items]
Exchange of common stock (in shares)	3,015,575
D-Wave Systems common stock
Schedule Of Reverse Recapitalization [Line Items]
Common stock, outstanding (in shares)			112,106,972
Exchangeable Shares [Member] | D-Wave Systems Inc. Stockholders
Schedule Of Reverse Recapitalization [Line Items]
Exchange of common stock (in shares)	48,409,601

Business Combination - Net Proc

Business Combination - Net Proceeds (Details) - USD ($) $ in Thousands		9 Months Ended
	Aug. 05, 2022	Sep. 30, 2022	Sep. 30, 2021
Reverse Recapitalization [Abstract]
Cash - DPCM trust and cash, net of redemptions	$ 9,130
Cash - PIPE Investment	40,000
Less: Non-cash net liabilities assumed from DPCM	(13,728)
Less: Transaction costs	(14,017)	$ (6,528)	$ 0
Net Business Combination and PIPE Investment	21,385
Add back: Non-cash net liabilities assumed from DPCM	13,728
Add back: Accrued transaction costs	2,459
Net cash contribution from Business Combination and PIPE Investment	$ 37,572

Business Combination - Common S

Business Combination - Common Stock (Details) - shares		9 Months Ended
	Aug. 05, 2022	Sep. 30, 2022	Aug. 04, 2022	Dec. 31, 2021
Schedule Of Reverse Recapitalization [Line Items]
Business Combination and PIPE shares (in shares)	10,144,040
Common stock, outstanding (in shares)	110,007,972	110,377,357		2,817,498
DCPM Class B common stock
Schedule Of Reverse Recapitalization [Line Items]
Common stock, outstanding (in shares)	3,015,575		7,500,000
DPCM Capital, Inc. Stockholders | DCPM Class A common stock
Schedule Of Reverse Recapitalization [Line Items]
Exchange of common stock (in shares)	1,311,937
DPCM Capital, Inc. Stockholders | DCPM Class B common stock
Schedule Of Reverse Recapitalization [Line Items]
Exchange of common stock (in shares)	3,015,575
D-Wave Systems Inc. Stockholders
Schedule Of Reverse Recapitalization [Line Items]
Exchange of common stock (in shares)	99,736,752
ELOC
Schedule Of Reverse Recapitalization [Line Items]
Issuance of common stock (in shares)	127,180	381,540
PIPE
Schedule Of Reverse Recapitalization [Line Items]
Issuance of common stock (in shares)	5,816,528

Basis of presentation and Sum_4

Basis of presentation and Summary of Significant Accounting Policies - Other Narrative (Details) $ / shares in Units, $ in Millions			3 Months Ended		9 Months Ended		12 Months Ended
	Aug. 05, 2022 USD ($) shares	Feb. 07, 2022 USD ($)	Sep. 30, 2022 USD ($) board_member $ / shares shares	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) SEGMENT board_member $ / shares shares	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($) SEGMENT $ / shares	Dec. 31, 2021 CAD ($) SEGMENT	Dec. 31, 2020 USD ($) $ / shares	Jun. 16, 2022 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2021 CAD ($)
Accumulated deficit			$ 363,136,000		$ 363,136,000		$ 325,268,000
Working capital deficit			(11,700,000)		(11,700,000)
Net income (loss)			$ (13,053,000)	$ (4,209,000)	(37,868,000)	$ (17,705,000)
Net cash outflows from operations					$ (34,270,000)	(27,615,000)
Common stock, par value (in usd per share) | $ / shares			$ 0.0001		$ 0.0001		$ 0.0001
Number of reportable segments | SEGMENT					1
Foreign currency transaction gain			$ 956,000,000	29,000,000	$ 1,322,000,000	538,000,000
Cash and cash equivalents			13,764,000		13,764,000		$ 9,483,000
Marketable investments, fair value			1,200,000		1,200,000		279,000,000,000					$ 10.2
Marketable investments			1,200,000		1,200,000		5,000,000
SR&ED investment tax credit			$ 100,000	$ 500,000	$ 1,000,000	$ 1,200,000
Number of board members | board_member			7		7
Cash			$ 13,800,000		$ 13,800,000		9,500,000
Cash Acquired Through Reverse Recapitalization And Proceeds From Issuance Of Private Placement	$ 49,000,000
ELOC, right to sell common stock										$ 150,000,000
Equity line of credit ownership restriction percentage										9.90%
Equity line of credit floor stock price										1%
Class of warrant or right cap on issuable number of shares ratio			0.361		0.361
Class Of Warrant Or Right Quoted Price | shares			0.31		0.31
Class of Warrant or Right, Outstanding | shares			17,920,898		17,920,898
Revenue from Contract with Customer Benchmark [Member] | Customer A [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage			15%	15%	13%	13%
Revenue from Contract with Customer Benchmark [Member] | Customer B [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage			11%	11%	13%	12%
Revenue from Contract with Customer Benchmark [Member] | Customer C [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage			10%	0%
Revenue from Contract with Customer Benchmark [Member] | Two Customers [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage					13%
D Wave Systems Existing Stockholders [Member]
Voting Interest			91%		91%
Board Member Designated By D P C M Capital Inc [Member]
Number of board members | board_member			1		1
Board Member Retained From D Wave Systems Board [Member]
Number of board members | board_member			3		3
Independent Board [Member]
Number of board members | board_member			3		3
Equity Line Of Credit [Member]
Issuance of common stock (in shares) | shares	127,180				381,540
DWave System [Member]
Accumulated deficit							325,268,000		$ 293,723,000
Working capital deficit							8,900,000
Net income (loss)							(31,545,000)		(10,019,000)
Net cash outflows from operations							(34,800,000)		$ (29,287,000)
Amount of financing		$ 40,000,000					$ 25,100,000	$ 40
Common stock, par value (in usd per share) | $ / shares							$ 0		$ 0
Deferred offering costs							$ 1,200,000		$ 0
Number of reportable segments | SEGMENT							1	1
Foreign currency transaction gain							$ 608,000		623,000
Cash and cash equivalents							9,483,000		21,335,000
Financing received							25,100,000	$ 32
Marketable investments, fair value							1,200,000		279,000,000			$ 10.2
Marketable investments							1,200,000		5,000,000
SR&ED investment tax credit							1,500,000		2,100,000
Allowance for doubtful accounts receivable current							0		0
Impairment of long-lived assets to be disposed of							0		0
capitalized contract fulfillment costs							0		0
Marketing and advertising expense							$ 887,000,000		$ 1,000,000
DWave System [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer A [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage							15%	15%	22%
DWave System [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer B [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage							13%	13%	17%
DWave System [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer C [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage							12%	12%	10%
DWave System [Member] | Old D-Wave [Member]
Equity method investment, ownership percentage							75%					75%
DWave System [Member] | Strategic Innovation Fund (SIF) Government loans [Member]
Interest expense, borrowings							$ 7,200,000
DWave System [Member] | Technology Partnership of Canada (TPC) Government Loans [Member]
Interest expense, borrowings									$ 12,000,000
DWave System [Member] | Venture Loan Agreement [Member]
Debt, face amount											$ 25,000,000

Basis of presentation and Sum_5

Basis of presentation and Summary of Significant Accounting Policies - Concentration Risk (Details) - Revenue - Customer concentration risk - DWave System [Member]	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
First Customer [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	15%	22%
Second Customer [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	13%	17%
Third Customer [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	12%	10%

Basis of presentation and Sum_6

Basis of presentation and Summary of Significant Accounting Policies - Transaction between entities under common control (Details) - D-Wave Systems Inc. [Member] - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Proceeds from issuance of preferred stock for cash	$ 43,600	$ 43,679
Preferred stock, par value (in Dollars per share)	$ 0	$ 0
Class B1 Preferred Stock [Member]
Stock issued, shares (in Shares)	11,787,320
Class B2 Preferred Stock [Member]
Stock issued, shares (in Shares)	13,142,857
Class B3 Preferred Stock [Member]
Stock issued, shares (in Shares)	29,000,000
Preferred stock, par value (in Dollars per share)	$ 0.00001
Class B1 and B2 Preferred Stock [Member]
Preferred stock, convertible, conversion price	$ 1.75

Basis of presentation and Sum_7

Basis of presentation and Summary of Significant Accounting Policies - Summary of cash and cash equivalents (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	$ 13,764	$ 9,483
D-Wave Systems Inc. [Member]
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents		9,483	$ 21,335
D-Wave Systems Inc. [Member] | Cash [Member]
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents		9,483	10,272
D-Wave Systems Inc. [Member] | Commercial Paper [Member]
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents		$ 0	$ 11,063

Basis of presentation and Sum_8

Basis of presentation and Summary of Significant Accounting Policies - Schedule of estimated useful lives of its property and equipment (Details) - DWave System [Member]	12 Months Ended
	Dec. 31, 2021
Schedule of Estimated Useful Lives of its Property and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Lab Equipment [Member]
Schedule of Estimated Useful Lives of its Property and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Computer Equipment [Member]
Schedule of Estimated Useful Lives of its Property and Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Furniture and Fixtures [Member]
Schedule of Estimated Useful Lives of its Property and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Leasehold Improvements [Member]
Schedule of Estimated Useful Lives of its Property and Equipment [Line Items]
Property plant and equipment shorter of expected lease term or estimated useful life	Shorter of expected lease term or estimated useful life

Basis of Presentation and Sum_9

Basis of Presentation and Summary of Significant Accounting Policies - Fair Value of Financial Instruments (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Fair Value, Inputs, Level 1 [Member] | Public Warrants [Member]
Warrants and Rights Outstanding	$ 3,018
Fair Value, Inputs, Level 2 [Member] | Private Warrants [Member]
Warrants and Rights Outstanding	$ 2,480

Revenue from contracts with c_3

Revenue from contracts with customers - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Total revenue, net	$ 1,695	$ 1,307	$ 4,778	$ 3,853
Revenue recognized over the time
Disaggregation of Revenue [Line Items]
Total revenue, net	1,660	1,247	4,618	3,773
Revenue recognized at a point in time
Disaggregation of Revenue [Line Items]
Total revenue, net	35	60	160	80
QCaaS
Disaggregation of Revenue [Line Items]
Total revenue, net	1,346	980	3,905	3,063
Professional services
Disaggregation of Revenue [Line Items]
Total revenue, net	347	306	812	736
Other revenue
Disaggregation of Revenue [Line Items]
Total revenue, net	$ 2	$ 21	$ 61	$ 54
DWave System [Member]
Disaggregation of Revenue [Line Items]
Total revenue, net					$ 6,279	$ 5,160
DWave System [Member] | Revenue recognized over the time
Disaggregation of Revenue [Line Items]
Total revenue, net					6,090	4,688
DWave System [Member] | Revenue recognized at a point in time
Disaggregation of Revenue [Line Items]
Total revenue, net					189	472
DWave System [Member] | QCaaS
Disaggregation of Revenue [Line Items]
Total revenue, net					4,424	4,313
DWave System [Member] | Professional services
Disaggregation of Revenue [Line Items]
Total revenue, net					1,786	426
DWave System [Member] | Other revenue
Disaggregation of Revenue [Line Items]
Total revenue, net					$ 69	$ 421

Revenue from contracts with c_4

Revenue from contracts with customers - Receivables, Contract Assets and Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Contract assets:
Trade account receivable	$ 740	$ 421
Unbilled receivables, which are included in 'Prepaid expenses and other current assets'	252	17
Total contract assets	992	438
Contract liabilities:
Deferred revenue, current	1,989	2,665
Deferred revenue, noncurrent	0	54
Customer deposit, which are included in 'Accrued expenses and other current liabilities'	21	21
Total contract liabilities	$ 2,010	2,740
DWave System [Member]
Contract assets:
Trade account receivable		421	$ 590
Unbilled receivables, which are included in 'Prepaid expenses and other current assets'		17	10
Total contract assets		438	600
Contract liabilities:
Deferred revenue, current		2,665	4,713
Deferred revenue, noncurrent		54	0
Customer deposit, which are included in 'Accrued expenses and other current liabilities'		21	0
Total contract liabilities		$ 2,740	$ 4,713

Revenue from contracts with c_5

Revenue from contracts with customers - Change in Deferred Revenue (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Contract With Customer, Liability [Roll Forward]
Balance at beginning of period	$ 2,719	$ 4,713
Deferral of revenue	3,554	4,092
Recognition of deferred revenue	(4,284)	(6,086)
Balance at end of period	1,989	2,719	$ 4,713
DWave System [Member]
Contract With Customer, Liability [Roll Forward]
Balance at beginning of period	$ 2,719	4,713	4,921
Deferral of revenue		4,092	4,513
Recognition of deferred revenue		(6,086)	(4,721)
Balance at end of period		$ 2,719	$ 4,713

Revenue from contracts with c_6

Revenue from contracts with customers - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 2	$ 2.7
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage		98%
Remaining performance obligation, period		12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	99%
Remaining performance obligation, period	12 months
DWave System [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation		$ 2.7	$ 4.7
DWave System [Member] | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-12-31
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage			100%
Remaining performance obligation, period			12 months
DWave System [Member] | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-12-31
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage		98%
Remaining performance obligation, period		12 months

Balance sheet details - Schedul

Balance sheet details - Schedule Of Inventory Current (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total inventories	$ 2,533	$ 2,114
DWave System [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Raw materials		2,103	$ 2,516
Work-in-process		11	5
Total inventories		$ 2,114	$ 2,521

Balance sheet details - Sched_2

Balance sheet details - Schedule of Prepaid expenses and other current assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Prepaid expenses:
Prepaid Lincoln Park commitment fee	$ 3,279	$ 0
Prepaid services	1,319	125
Prepaid software	1,027	531
Prepaid rent	121	151
Prepaid commissions	117	84
Other	11	156
Other current assets:
Directors and Officers insurance	2,028	0
Unbilled receivables	252	17
Security deposits	36	52
Total prepaid expenses and other current assets	$ 8,190	1,116
DWave System [Member]
Prepaid expenses:
Prepaid services		125	$ 179
Prepaid software		531	469
Prepaid rent		151	187
Prepaid commissions		84	102
Other		156	133
Other current assets:
Security deposits		52	173
Unbilled receivables		17	10
Total prepaid expenses and other current assets		$ 1,116	$ 1,253

Balance sheet details - Sched_3

Balance sheet details - Schedule Of Other Assets Non current (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total other noncurrent assets	$ 1,345	$ 1,353
DWave System [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Investment in securities		1,169	$ 5
Long-term deposits		184	182
Total other noncurrent assets		$ 1,353	$ 187

Balance sheet details - Accrued

Balance sheet details - Accrued expenses and other liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Accrued expenses:
Accrued transaction costs	$ 2,459	$ 0
Accrued professional services	1,010	1,953
Accrued compensation and related benefits	1,438	1,108
Other accruals	113	318
Other current liabilities:
Other payroll expenses	247	175
Customer deposit	21	21
Current portion of long term debt, net	30	39
Total accrued expenses and other current liabilities	$ 5,318	3,614
DWave System [Member]
Accrued expenses:
Accrued professional services		1,953	$ 1,534
Accrued compensation and related benefits		1,108	1,211
Other accruals		318	147
Other current liabilities:
Other payroll expenses		175	291
Customer deposit		21	0
Current portion of long-term debt, net		39	0
Total accrued expenses and other current liabilities		$ 3,614	$ 3,183

Fair value of financial instr_3

Fair value of financial instruments -Schedule of the Company's financial assets measured at fair value on a recurring basis and indicating the level of the fair value hierarchy utilized to determine such fair values (Details) - D-Wave Systems Inc. [Member] - Fair Value, Recurring [Member] $ in Thousands	Dec. 31, 2020 USD ($)
Fair Value, Inputs, Level 1 [Member]
Assets
Commercial paper	$ 0
Total assets	0
Liabilities
Warrant liabilities	0
Total liabilities	0
Fair Value, Inputs, Level 2 [Member]
Assets
Commercial paper	11,063
Total assets	11,063
Liabilities
Warrant liabilities	0
Total liabilities	0
Fair Value, Inputs, Level 3 [Member]
Assets
Commercial paper	0
Total assets	0
Liabilities
Warrant liabilities	0
Total liabilities	0
Commercial Paper [Member] | Fair Value, Inputs, Level 1 [Member]
Assets
Commercial paper	0
Total assets	0
Commercial Paper [Member] | Fair Value, Inputs, Level 2 [Member]
Assets
Commercial paper	11,063
Total assets	11,063
Commercial Paper [Member] | Fair Value, Inputs, Level 3 [Member]
Assets
Commercial paper	0
Total assets	0
Warrant [Member] | Fair Value, Inputs, Level 1 [Member]
Liabilities
Warrant liabilities	0
Total liabilities	0
Warrant [Member] | Fair Value, Inputs, Level 2 [Member]
Liabilities
Warrant liabilities	0
Total liabilities	0
Warrant [Member] | Fair Value, Inputs, Level 3 [Member]
Liabilities
Warrant liabilities	0
Total liabilities	$ 0

Fair value of financial instr_4

Fair value of financial instruments - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020 USD ($)
DWave System [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	$ 0

Property and equipment, net (De

Property and equipment, net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 25,299		$ 25,299		$ 25,050
Less: Accumulated depreciation	(22,762)		(22,762)		(21,801)
Property and equipment, net	2,537		2,537		3,249
Depreciation expense	338,000	$ 393,000	1,000	$ 1,100
DWave System [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment					25,050	$ 23,262
Less: Accumulated depreciation					(21,801)	(20,368)
Property and equipment, net					3,249	2,894
Depreciation expense					1,400	1,900
Quantum computer systems
Property, Plant and Equipment [Line Items]
Total property and equipment	13,425		13,425		13,425
Quantum computer systems | DWave System [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment					13,425	12,103
Lab equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	6,664		6,664		6,645
Lab equipment | DWave System [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment					6,645	6,315
Computer equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	3,439		3,439		3,305
Computer equipment | DWave System [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment					3,305	2,954
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	1,074		1,074		1,074
Leasehold improvements | DWave System [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment					1,074	1,072
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	318		318		316
Furniture and fixtures | DWave System [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment					316	316
Construction-in-progress
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 379		$ 379		285
Construction-in-progress | DWave System [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment					$ 285	$ 502

Intangible assets, net - Summar

Intangible assets, net - Summary of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Intangible assets, net	$ 262	$ 272
DWave System [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		1,122	$ 897
Less: Accumulated amortization		(850)	(749)
Intangible assets, net		272	148
DWave System [Member] | Capitalized software
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		1,087	862
DWave System [Member] | Other intangible assets
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		$ 35	$ 35

Intangible assets, net - Narrat

Intangible assets, net - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
D-Wave Systems Inc. [Member]
Amortization of intangible assets	$ 101,000	$ 64,000

Loans payable - Components (Det

Loans payable - Components (Details) - USD ($) $ in Thousands		9 Months Ended		12 Months Ended
	Aug. 05, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Loans payable
Loan payable, beginning of period		$ 29,844	$ 13,624	$ 13,624
Contributions				16,786
Payments		(20,000)	(23)
Interest and final fee on Venture Loan		1,808
Foreign exchange (gain) loss		(1,948)		(167)
Loan payable, end of period		29,527		29,844	$ 13,624
Discount
Discount, beginning of period		(17,391)	(11,948)	(11,948)
Additional contribution discount		(130)		(7,167)
Interest expense		1,902		1,728
Foreign exchange (gain) loss		1,236		(4)
Total discount, end of period		(14,383)		(17,391)	(11,948)
Short-term portion		2,232		220
Long-term portion		12,912		12,233
Total loans payable		15,144		12,453
Directors And Officers Insurance Financing [Member] | Notes Payable, Other Payables [Member]
Loans payable
Contributions		2,893
Discount
Total loans payable		2,000
Venture Loan [Member] | Notes Payable, Other Payables [Member]
Loans payable
Contributions		20,000
Payments	$ (21,800)	(21,808)
Other Loans [Member] | Notes Payable, Other Payables [Member]
Loans payable
Payments		(1,262)		(399)
DWave System [Member]
Loans payable
Loan payable, beginning of period		29,844	13,624	13,624	5,555
Contributions				16,786	11,661
Payments				(31)
Payments				(399)	0
TPC debt forgiveness				0	(3,873)
Foreign exchange (gain) loss				(167)	281
Loan payable, end of period				29,844	13,624
Discount
Discount, beginning of period		$ (17,391)	$ (11,948)	(11,948)	0
Additional contribution discount				(7,167)	(11,199)
Interest expense				1,728	232
Foreign exchange (gain) loss				(4)	(233)
Total discount, end of period				(17,391)	(11,948)
Short-term portion				220	355
Long-term portion				12,233	1,321
Total loans payable				12,453	1,676
DWave System [Member] | TPC Loan [Member]
Loans payable
TPC debt forgiveness					(3,900)
Discount
Additional contribution discount				$ 0	$ (748)

Loans payable - Narrative (Deta

Loans payable - Narrative (Details) $ in Thousands

9 Months Ended

12 Months Ended

48 Months Ended

Aug. 05, 2022 USD ($)

Jun. 30, 2022 USD ($)

Mar. 03, 2022 USD ($)

Nov. 23, 2020 CAD ($)

Nov. 20, 2020 USD ($)

Sep. 30, 2022 USD ($)

Sep. 30, 2021 USD ($)

Dec. 31, 2021 USD ($)

Dec. 31, 2021 CAD ($)

Dec. 31, 2020 USD ($)

Apr. 30, 2025

Nov. 20, 2020 CAD ($)

Debt Instrument [Line Items]

Payment for directors and officers insurance

$ 19,870

$ 0

Contributions

$ 16,786

Repayments of Long-Term Debt

20,000

$ 23

SIF Loan

Debt Instrument [Line Items]

Discount percentage

26%

26%

Face amount

$ 40,000,000

Term

15 years

Repayment benchmark year, revenue

$ 70,000

Repayment benchmark year, period

14 years

Venture Loan | Notes Payable, Other Payables [Member]

Debt Instrument [Line Items]

Face amount

$ 25,000

Payment for directors and officers insurance

$ 5,000

$ 15,000

Contributions

20,000

Repayments of Long-Term Debt

$ 21,800

$ 21,808

Prime rate | Venture Loan | Notes Payable, Other Payables [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

7.25%

Variable rate basis, floor

3.25%

DWave System [Member]

Debt Instrument [Line Items]

Gain (loss) on extinguishment of debt

0

$ 3,873

Debt instrument, frequency of periodic payment

5

Payment for directors and officers insurance

111

Government assistance recognized

7,140

12,027

Repayments of Long-Term Debt

$ 31

DWave System [Member] | TPC Loan

Debt Instrument [Line Items]

Debt Instrument fund raised

$ 12,500,000

Debt Instrument, Payment Terms

May of each year

May of each year

Debt Instrument Forgiveness of unpaid accrued debt principal and interest

$ 5,000,000

Gain (loss) on extinguishment of debt

3,900

Debt instrument, waiver of interest on principal

2,500,000

Debt instrument, annual principal payment

$ 500,000

Discount percentage

25%

DWave System [Member] | SIF Loan

Debt Instrument [Line Items]

Discount percentage

26%

26%

Face amount

$ 40,000,000

Term

15 years

Repayment benchmark year, revenue

$ 70,000

Percentage of decrease in projected revenue

5%

5%

Debt Instrument, Increase (Decrease), Net

$ 157,000

Recognized research incentives receivable related to approved eligible expenditure claims

$ 3,100

11,700

Government assistance recognized

7,200

$ 12,000

Increase decrease in debt instrument carrying value

$ 3,800

Repayment benchmark year, period

14 years

Leases - Narrative (Details)

Leases - Narrative (Details) - DWave System [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Weighted average discount rate	18%	20%
Operating lease cost	$ 1,324	$ 1,426
Maximum [Member]
Lessee, operating lease, term of contract	10 years
Weighted average discount rate	20%
Minimum [Member]
Lessee, operating lease, term of contract	1 year
Weighted average discount rate	18%

Leases - Summary of Lease Costs

Leases - Summary of Lease Costs (Detail) - D-Wave Systems Inc. [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Total lease costs	$ 1,324	$ 1,426
Weighted average remaining lease term in years	2 years 10 months 20 days	2 years 4 months 20 days
Weighted average discount rate	18%	20%
Research and development
Total lease costs	$ 268	$ 268
General and administrative
Total lease costs	$ 1,057	$ 1,158

Leases - Summary of Future Min

Leases - Summary of Future Minimum Operating Lease Payment Under Non-Cancelable Leases (Detail) - D-Wave Systems Inc. [Member] $ in Thousands	Dec. 31, 2021 USD ($)
2022	$ 1,687
2023	1,384
2024	1,179
2025	1,212
2026	1,245
Thereafter	9,648
Total future minimum lease payments	$ 16,355

Warrant liabilities (Details)

Warrant liabilities (Details) $ / shares in Units, $ in Thousands		9 Months Ended
	Aug. 05, 2022 $ / shares shares	Sep. 30, 2022 USD ($) Day $ / shares shares	Sep. 30, 2021 USD ($)
Class of Warrant or Right [Line Items]
Warrants exercised (in shares) | shares		79,102
Proceeds from exercise of public warrants | $		$ 910	$ 0
Stock issued for exercise of warrants (in shares) | shares		115,025
Exchange ratio	1.4541326
Warrants outstanding (in shares) | shares		17,920,898
Warrants, exercise price, prior to exchange ratio (in usd per share) | $ / shares		$ 11.5
Warrants, exercise price (in usd per share) | $ / shares		7.91
Warrants, redemption price (in usd per share) | $ / shares		$ 0.1
Warrants, redemption notice period		30 days
Warrants, redemption share price threshold trading days | Day		20
Warrants, redemption share price threshold consecutive trading days		30 days
Sale of stock, price (in usd per share) | $ / shares	$ 10
Reference value (in usd per share) | $ / shares		$ 18
Public Warrants [Member]
Class of Warrant or Right [Line Items]
Business Combination, warrants assumed (in shares) | shares	10,000,000
Private Warrants [Member]
Class of Warrant or Right [Line Items]
Business Combination, warrants assumed (in shares) | shares	8,000,000

Income Tax (Details) - Summary

Income Tax (Details) - Summary of domestic and foreign components of loss before income taxes - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Valuation Allowance [Line Items]
Net loss before income taxes	$ (13,053)	$ (4,209)	$ (37,868)	$ (17,705)
D-Wave Systems Inc. [Member]
Valuation Allowance [Line Items]
Domestic					$ (27,205)	$ (7,784)
International					(4,340)	(2,235)
Net loss before income taxes					$ (31,545)	$ (10,019)

Income Tax (Details) - Schedule

Income Tax (Details) - Schedule of deferred tax assets (liability) - D-Wave Systems Inc. [Member] - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets:
Net operating loss carryforward	$ 59,916	$ 54,018
Research and development credit carryforwards	13,675	12,003
Scientific research and experimental development deductions	23,071	20,137
Depreciation and amortization	5,634	5,256
Convertible notes	(4)	1,156
Deferred revenue	165	401
Other accruals and reserves	730	440
Total deferred tax assets	103,187	93,411
Valuation Allowance	(97,143)	(89,139)
Total deferred tax assets, net	6,044	4,272
Deferred tax liabilities:
Marketable securities	(315)	0
Loans payable	(5,729)	(4,272)
Total deferred tax liabilities	(6,044)	(4,272)
Net deferred tax assets	$ 0	$ 0

Income Tax (Details) - Schedu_2

Income Tax (Details) - Schedule of reconciliation federal income tax rate - D-Wave Systems Inc. [Member]	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statutory federal income tax rate	27%	27%
Foreign losses taxed at different rates	0%	1%
Research and development credits	0%	(3.00%)
Permanent differences	(2.00%)	18%
Other	1%	7%
Valuation allowance/Effective tax rate	(26.00%)	(50.00%)
Income tax provision	0%	0%

Income Tax (Details)

Income Tax (Details) - D-Wave Systems Inc. [Member] $ in Millions	12 Months Ended
	Dec. 31, 2021 USD ($)
Tax credit carryforward, amount	$ 13.5
Tax credit carry forward expiration year	2023 and 2041
CANADA
Operating loss carryforwards expiration year	2027 and 2041
CANADA | Scientific Research and Experimental Development Expenditures [Member]
Operating loss carryforwards	$ 100.3
CANADA | Foreign Tax Authority [Member]
Operating loss carryforwards	$ 155.7
UNITED STATES
Operating loss carryforwards expiration year	2032 and 2037
UNITED STATES | Foreign Tax Authority [Member]
Operating loss carryforwards	$ 18.4
Net operating loss carryforwards	43.9
Operating loss carryforwards indefinitely	$ 25.5

Common stock and non-redeemab_3

Common stock and non-redeemable convertible preferred stock -Schedule of non-redeemable convertible preferred shares (Detail) - USD ($)		Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule OfNonRedeemable Convertible Preferred Shares [Line Items]
Preferred stock, issued (in shares)		0	122,564,333
Preferred stock, outstanding (in shares)		0	122,564,333
Carrying value	[1]	$ 0	$ 189,881,000
DWave System [Member]
Schedule OfNonRedeemable Convertible Preferred Shares [Line Items]
Preferred stock, issued (in shares)			137,765,828	137,765,828
Preferred stock, outstanding (in shares)			137,765,828	137,765,828
Original issue price			$ 0	$ 0
Carrying value			$ 189,881,000	$ 189,881,000
DWave System [Member] | Class A non redeemable convertible preferred stock
Schedule OfNonRedeemable Convertible Preferred Shares [Line Items]
Preferred stock, issued (in shares)			27,065,219	27,065,219
Preferred stock, outstanding (in shares)			27,065,219	27,065,219
Original issue price			$ 1.75	$ 1.75
Carrying value			$ 47,336,000	$ 47,336,000
DWave System [Member] | Class B1 Non redeemable Convertible Preferred Stock [Member]
Schedule OfNonRedeemable Convertible Preferred Shares [Line Items]
Preferred stock, issued (in shares)			52,700,609	52,700,609
Preferred stock, outstanding (in shares)			52,700,609	52,700,609
Original issue price			$ 1.75	$ 1.75
Carrying value			$ 119,977,000	$ 119,977,000
DWave System [Member] | Class B2 Non redeemable Convertible Preferred Stock [Member]
Schedule OfNonRedeemable Convertible Preferred Shares [Line Items]
Preferred stock, issued (in shares)			29,000,000	29,000,000
Preferred stock, outstanding (in shares)			29,000,000	29,000,000
Original issue price			$ 1.75	$ 1.75
Carrying value			$ 23,000,000	$ 23,000,000
DWave System [Member] | Class B3 Non redeemable Convertible Preferred Stock [Member]
Schedule OfNonRedeemable Convertible Preferred Shares [Line Items]
Preferred stock, issued (in shares)			29,000,000	29,000,000
Preferred stock, outstanding (in shares)			29,000,000	29,000,000
Original issue price			$ 0.00001	$ 0.00001
Carrying value			$ 290	$ 290
DWave System [Member] | Nonredeemable Convertible Preferred Stock [Member]
Schedule OfNonRedeemable Convertible Preferred Shares [Line Items]
Carrying value			189,881,000	189,881,000
Issuance Cost			$ (432,000)	$ (432,000)
[1]Shares of legacy non-redeemable convertible preferred stock and legacy common stock have been retroactively restated to give effect to the Business Combination.

Common stock and non-redeemab_4

Common stock and non-redeemable convertible preferred stock - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Aug. 05, 2022	Dec. 31, 2020
Common stock and nonredeemable convertible preferred stock [Line Items]
Common Stock, Par or Stated Value Per Share	$ 0.0001		$ 0.0001
Common Stock, Shares, Issued	110,377,357		2,817,498
Common Stock, Shares, Outstanding	110,377,357		2,817,498	110,007,972
Proceeds from issuance of common stock	$ 40,000	$ 0
D-Wave Systems Inc. [Member]
Common stock and nonredeemable convertible preferred stock [Line Items]
Dividends Declared			$ 0		$ 0
Common Stock, Par or Stated Value Per Share			$ 0		$ 0
Common Stock, Shares, Issued			3,166,949		3,061,746
Common Stock, Shares, Outstanding			3,166,949		3,061,746
Preferred Stock, Voting Rights			2/3
Common Stock Convertible Conversion Price			1.75%
ClassB2 Common share [Member] | D-Wave Systems Inc. [Member]
Common stock and nonredeemable convertible preferred stock [Line Items]
Common Stock, Shares, Issued			3,166,948		3,061,745
Common Stock, Shares, Outstanding			3,166,948		3,061,745
Common Stock, Conversion Basis			one-for-one basis
Qualified IPO [Member] | New York Stock Exchange [Member] | D-Wave Systems Inc. [Member]
Common stock and nonredeemable convertible preferred stock [Line Items]
Proceeds from issuance of common stock			$ 40,000
Qualified IPO [Member] | New York Stock Exchange [Member] | ClassB2 Common share [Member] | D-Wave Systems Inc. [Member]
Common stock and nonredeemable convertible preferred stock [Line Items]
Proceeds from issuance of common stock			$ 250,000

Stock-based compensation - Assu

Stock-based compensation - Assumptions Used to Estimate Fair Value of Stock Options Granted (Details)	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	0%	0%
Expected volatility	70.60%	56.30%
Expected term	6 years 1 month 6 days	6 years 1 month 6 days
Risk-free interest rate	3%	0.90%
DWave System [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield			0%	0%
Expected volatility			56%	45%
Expected term			8 years 6 months 10 days	9 years 4 months 28 days
Risk-free interest rate			0.87%	0.43%

Stock-based compensation - Stoc

Stock-based compensation - Stock Options Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Number of options outstanding
Balance (in shares)	16,336,134
Granted (in shares)	1,500,081
Exercised (in shares)	(174,378)
Forfeited (in shares)	(944,087)
Expired (in shares)	(28,981)
Balance (in shares)	16,688,769	16,336,134
Exercisable (in shares)	12,128,516
Weighted  average  exercise  price  ($)
Balance (in usd per share)	$ 0.81
Granted (in usd per share)	10.07
Exercised (in usd per share)	0.81
Forfeited (in usd per share)	0.81
Expired (in usd per share)	0.81
Balance (in usd per share)	1.64	$ 0.81
Exercisable (in usd per share)	$ 0.84
Weighted average remaining contractual term (years)
Balance	6 years 11 months 15 days	8 years 6 months 18 days
Exercisable	6 years 2 months 12 days
Aggregate intrinsic value ($)
Balance	$ 74,546	$ 80,179
Exercisable	$ 59,344
DWave System [Member]
Number of options outstanding
Balance (in shares)	16,336,134	12,654,807
Granted (in shares)		4,369,866
Exercised (in shares)		(105,203)
Forfeited (in shares)		(171,204)
Expired (in shares)		(412,132)
Balance (in shares)		16,336,134	12,654,807
Unvested (in shares)		6,943,273
Exercisable (in shares)		9,392,861
Weighted  average  exercise  price  ($)
Balance (in usd per share)	$ 0.81	$ 0.81
Granted (in usd per share)		0.82
Exercised (in usd per share)		0.81
Forfeited (in usd per share)		0.81
Expired (in usd per share)		0.81
Balance (in usd per share)		0.81	$ 0.81
Unvested (in usd per share)		0.81
Exercisable (in usd per share)		$ 0.81
Weighted average remaining contractual term (years)
Balance		8 years 6 months 18 days	9 years 4 months 17 days
Unvested		8 years 6 months 10 days
Exercisable		8 years 2 months 12 days
Aggregate intrinsic value ($)
Balance		$ 80,179
Unvested		77,423
Exercisable		$ 46,116

Stock-based compensation - Narr

Stock-based compensation - Narrative (Details) - USD ($)		9 Months Ended		12 Months Ended
	Apr. 14, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Nov. 30, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average grant date fair value, stock options granted (in usd per share)		$ 3.1	$ 0.36
Fair value of stock options vested		$ 6,564,103	$ 812,329
Warrants, exercise price (in usd per share)		$ 7.91
Warrants outstanding (in shares)		17,920,898
Common shares reserved for future issuance (in shares)		16,965,849
Period over which shares reserved for future issuance will increase		9 years
Additional shares reserved for issuance, percentage		5%
Expected dividend yield		0%	0%
Number of common stock warrants, Granted during the period		1,500,081
Share-based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected dividend yield		0%
Two Thousand Twenty Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Percentage of options vested				25%
The Two Thousand Twenty Two Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of common stock warrants, Granted during the period		1,500,081
The Two Thousand Twenty Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of common stock warrants, Granted during the period		4,341,966
DWave System [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average grant date fair value, stock options granted (in usd per share)				$ 1.99	$ 0.35
Fair value of stock options vested				$ 1,733,745	$ 1,035,000
Expected dividend yield				0%	0%
Number of common stock warrants, Granted during the period				4,369,866
DWave System [Member] | Two Thousand Twenty Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Options Grant Outstanding Number				$ 16,336,134,000	$ 12,654,807,000
Percentage of options vested				75%
DWave System [Member] | oneyearcliff [Member] | Two Thousand Twenty Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period				4 years
D Wave Systems Common Stock Warrants [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants expired (in shares)	617,972
Warrants, exercise price (in usd per share)	$ 1.75
Warrants outstanding (in shares)		0
Preferred Stock Warrants [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants, exercise price (in usd per share)						$ 2.16
Warrants outstanding (in shares)		3,247,637
Warrants, number of shares issuable (in shares)		2,889,282				3,247,637
Preferred Stock Warrants [Member] | DWave System [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants, exercise price (in usd per share)						$ 1.92
Warrants outstanding (in shares)				3,247,637	1,100,000	3,247,637

Stock-based compensation - Pref

Stock-based compensation - Preferred Stock Warrants (Details) - $ / shares	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020	Nov. 30, 2020	Apr. 30, 2020
Class of Warrant or Right [Line Items]
Number of warrants outstanding (in shares)	17,920,898
Weighted average exercise price (in usd per share)	$ 7.91
Preferred stock warrants
Class of Warrant or Right [Line Items]
Number of warrants outstanding (in shares)	3,247,637
Weighted average exercise price (in usd per share)				$ 2.16
Number exercisable (in shares)	1,299,055
Preferred stock warrants | DWave System [Member]
Class of Warrant or Right [Line Items]
Number of warrants outstanding (in shares)		3,247,637	1,100,000	3,247,637
Weighted average exercise price (in usd per share)				$ 1.92
Number exercisable (in shares)		1,299,055
Preferred stock warrants | Weighted average
Class of Warrant or Right [Line Items]
Weighted average exercise price (in usd per share)	$ 1.92
Preferred stock warrants | Weighted average | DWave System [Member]
Class of Warrant or Right [Line Items]
Weighted average exercise price (in usd per share)		$ 1.92
Common Stock Warrants [Member] | DWave System [Member]
Class of Warrant or Right [Line Items]
Number of warrants outstanding (in shares)		617,972			617,972
Weighted average exercise price (in usd per share)		$ 1.75			$ 1.75
Number exercisable (in shares)		617,972

Stock-based compensation - Expe

Stock-based compensation - Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	$ 2,027	$ 225	$ 3,695	$ 555
DWave System [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation					$ 1,739	$ 2,989
Research and development
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	329	63	539	150
Research and development | DWave System [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation					338	1,513
General and administrative
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	1,640	105	2,909	278
General and administrative | DWave System [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation					1,164	1,346
Sales and marketing
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	$ 58	$ 57	$ 247	$ 127
Sales and marketing | DWave System [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation					$ 237	$ 130

Stock-based compensation - Comm

Stock-based compensation - Common stock warrants (Details) - $ / shares	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance (in usd per share)	$ 0.81
Balance (in usd per share)	$ 1.64	$ 0.81
Balance (in shares)	16,336,134
Balance (in shares)	16,688,769	16,336,134
D-Wave Systems Inc. [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance (in usd per share)	$ 0.81	$ 0.81
Balance (in usd per share)		$ 0.81	$ 0.81
Balance (in shares)	16,336,134	12,654,807
Balance (in shares)		16,336,134	12,654,807
Common Stock Warrants [Member] | D-Wave Systems Inc. [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance (in usd per share)	$ 1.75		$ 1.75
Balance (in usd per share)		$ 1.75
Balance (in shares)	617,972	617,972
Balance (in shares)		617,972	617,972
Preferred Stock Warrants [Member] | D-Wave Systems Inc. [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance (in usd per share)	$ 1.92		$ 1.92
Balance (in usd per share)		$ 1.92
Balance (in shares)	3,247,637	3,247,637
Balance (in shares)		3,247,637	3,247,637

Promissory note - related par_2

Promissory note - related party (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2022	Apr. 13, 2022	Mar. 31, 2022	Feb. 28, 2022
Related Party Transaction [Line Items]
Promissory note - related party	$ 0		$ 420,000
PSPIB [Member] | Venture Loan Agreement [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount					$ 25,000,000
Affiliated Entity [Member] | Affiliate Note [Member]
Related Party Transaction [Line Items]
Notes Payable, Related Parties, Borrowing Capacity						$ 1,000,000
Promissory note - related party			200,000
Affiliated Entity [Member] | DCPM Note [Member]
Related Party Transaction [Line Items]
Notes Payable, Related Parties, Borrowing Capacity				$ 1,000,000
Promissory note - related party			$ 220,000
D-Wave Systems Inc. [Member]
Related Party Transaction [Line Items]
Due to Related Parties, Current	$ 0	$ 0
D-Wave Systems Inc. [Member] | Old D-Wave [Member]
Related Party Transaction [Line Items]
Equity Method Investment, Ownership Percentage	75%
D-Wave Systems Inc. [Member] | Thirdparty Consulting Firm [Member] | Advisory Services [Member]
Related Party Transaction [Line Items]
Related party transaction, amounts of transaction		$ 380,000
Related Party Transaction, Date	Dec. 31, 2020
D-Wave Systems Inc. [Member] | PSPIB [Member] | Venture Loan Agreement [Member] | Old D-Wave [Member]
Related Party Transaction [Line Items]
Equity Method Investment, Ownership Percentage					46.80%

Commitment and contingencies (D

Commitment and contingencies (Details) - USD ($)			1 Months Ended		12 Months Ended
	Aug. 05, 2022	Aug. 13, 2020	Sep. 30, 2022	Nov. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Nov. 30, 2020	Apr. 30, 2020
Other Commitments [Line Items]
Warrants outstanding (in shares)			17,920,898
Warrants, exercise price (in usd per share)			$ 7.91
Lease term			12 months	10 years 6 months
Operating lease right-of-use assets recognized in exchange for new operating lease obligations			$ 200,000	$ 6,800,000
Long-term Debt			15,144,000		$ 12,453,000
Notes Payable, Other Payables [Member] | Directors And Officers Insurance Financing [Member]
Other Commitments [Line Items]
Debt Instrument, Face Amount	$ 2,800,000
Debt Instrument, Periodic Payment	$ 289,777
Debt Instrument, Interest Rate, Stated Percentage	4.24%
Debt Instrument, Term	9 months
Long-term Debt			$ 2,000,000
Preferred stock warrants
Other Commitments [Line Items]
Warrants outstanding (in shares)			3,247,637
Warrants vested, percentage		40%
Warrants, exercise price (in usd per share)							$ 2.16
Warrants							$ 1,100,000
Warrants vested, fair value					0
Warrants, number of shares issuable (in shares)			2,889,282				3,247,637
D-Wave Systems Inc. [Member]
Other Commitments [Line Items]
Lease term				10 years 6 months
Operating lease right-of-use assets recognized in exchange for new operating lease obligations				$ 6,700,000	11,870,000	$ 4,932,000
Long-term Debt					$ 12,453,000	$ 1,676,000
D-Wave Systems Inc. [Member] | Preferred stock warrants
Other Commitments [Line Items]
Warrants outstanding (in shares)					3,247,637	1,100,000	3,247,637
Warrants vested, percentage		40%
Warrants, exercise price (in usd per share)							$ 1.92
Warrants vested, fair value					$ 0	$ 451,000
Warrants vested during period						$ 451,000
D-Wave Systems Inc. [Member] | Common stock warrants
Other Commitments [Line Items]
Warrants outstanding (in shares)					617,972			617,972
Warrants, exercise price (in usd per share)					$ 1.75			$ 1.75

Net loss per share - Computatio

Net loss per share - Computation (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended		12 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Numerator:
Net income (loss)		$ (13,053)	$ (4,209)	$ (37,868)	$ (17,705)
Net loss attributable to common stockholders, Diluted		(13,053)	(4,209)	$ (37,868)
Net loss attributable to common stockholders, Basic		$ (13,053)	$ (4,209)		$ (17,705)
Denominator:
Weighted-average common shares outstanding, basic (in shares)	[1]	116,256,805	125,362,390	122,337,727	125,331,065
Weighted-average common shares outstanding, diluted (in shares)	[1]	116,256,805	125,362,390	122,337,727	125,331,065
Net loss per share, basic (in usd per share)		$ (0.11)	$ (0.03)	$ (0.31)	$ (0.14)
Net loss per share, diluted (in usd per share)		$ (0.11)	$ (0.03)	$ (0.31)	$ (0.14)
D-Wave Systems Inc. [Member]
Numerator:
Net income (loss)						$ (31,545)	$ (10,019)
Denominator:
Weighted-average common shares outstanding, basic (in shares)						111,911,127	121,358,898
Weighted-average common shares outstanding, diluted (in shares)						111,911,127	121,358,989
Net loss per share, basic (in usd per share)						$ (0.28)	$ (0.08)
Net loss per share, diluted (in usd per share)						$ (0.28)	$ (0.08)
[1]Weighted-average shares have been retroactively restated to give effect to the Business Combination.

Net loss per share - Potentiall

Net loss per share - Potentially Dilutive Securities (Details) - shares	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	43,795,751	17,498,091
Options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	14,847,108	14,608,809
Options to purchase common stock | D-Wave Systems Inc. [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)			16,336	12,655
Warrants to purchase common stock | D-Wave Systems Inc. [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)			618	618
Warrants for Preferred shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	2,889,282	2,889,282
Warrants for Preferred shares | D-Wave Systems Inc. [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)			3,248	3,248
Warrant [Member] | Public Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	14,426,301	0
Warrant [Member] | Private Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	11,633,060	0

Geographic areas - Disaggregati

Geographic areas - Disaggregation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue, net	$ 1,695	$ 1,307	$ 4,778	$ 3,853
Total long-lived assets	10,603		10,603		$ 11,827
D-Wave Systems Inc. [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue, net					6,279	$ 5,160
Total long-lived assets					11,827	5,842
Canada
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	10,106		10,106		11,251
Canada | D-Wave Systems Inc. [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets					11,251	4,984
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue, net	951	784	2,461	2,100
Total long-lived assets	497		497		576
United States | D-Wave Systems Inc. [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue, net					3,425	3,119
Total long-lived assets					576	858
Japan
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue, net	293	304	1,008	1,197
Japan | D-Wave Systems Inc. [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue, net					1,614	1,630
Germany
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue, net	237	70	757	197
Germany | D-Wave Systems Inc. [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue, net					741	155
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue, net	$ 214	$ 149	$ 552	$ 359
Other | D-Wave Systems Inc. [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue, net					$ 499	$ 256

Geographic areas - Significant

Geographic areas - Significant Customers (Details) - Revenue - Customer concentration risk	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Customer A
Concentration Risk [Line Items]
Concentration risk, percentage	15%	15%	13%	13%
Customer A | D-Wave Systems Inc. [Member]
Concentration Risk [Line Items]
Concentration risk, percentage					15%	22%
Customer B
Concentration Risk [Line Items]
Concentration risk, percentage	11%	11%	13%	12%
Customer B | D-Wave Systems Inc. [Member]
Concentration Risk [Line Items]
Concentration risk, percentage					13%	17%
Customer C
Concentration Risk [Line Items]
Concentration risk, percentage	10%	0%
Customer C | D-Wave Systems Inc. [Member]
Concentration Risk [Line Items]
Concentration risk, percentage					12%	10%

Subsequent events (Details)

Subsequent events (Details) - USD ($)				1 Months Ended	9 Months Ended		12 Months Ended
	Oct. 27, 2022	Oct. 13, 2022	Mar. 03, 2022	Nov. 10, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Oct. 26, 2022	Jun. 16, 2022	Mar. 31, 2022
Subsequent Event [Line Items]
Exercise of stock options (in shares)					174,378
Proceeds from issuance of common stock upon exercise of stock options					$ 72,000	$ 66,000
ELOC, right to sell common stock										$ 150,000,000
DWave System [Member]
Subsequent Event [Line Items]
Exercise of stock options (in shares)							105,203
Proceeds from issuance of common stock upon exercise of stock options							$ 85,000	$ 5,000
DWave System [Member] | Venture Loan Agreement [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount											$ 25,000,000
Subsequent Event
Subsequent Event [Line Items]
Exercise of stock options (in shares)				764,796
Proceeds from issuance of common stock upon exercise of stock options				$ 696,000
ELOC, right to sell common stock									$ 150,000,000
Subsequent Event | Restricted Stock Units (RSUs) [Member] | Employees
Subsequent Event [Line Items]
Awards granted (in shares)	3,578,590	4,496,833
Subsequent Event | Restricted Stock Units (RSUs) [Member] | Members of board of directors
Subsequent Event [Line Items]
Awards granted (in shares)	167,605
Subsequent Event | DWave System [Member] | Venture Loan Agreement [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount			$ 25,000,000
Debt Instrument, Maturity Date			Dec. 31, 2022
Percentage of the aggregate amount of the advances made under the venture loan agreement			5%
Subsequent Event | DWave System [Member] | Venture Loan Agreement [Member] | Minimum [Member]
Subsequent Event [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			7.25%
Subsequent Event | DWave System [Member] | Venture Loan Agreement [Member] | Maximum [Member]
Subsequent Event [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			10.50%
Subsequent Event | DWave System [Member] | First Tranche Loan [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount			$ 15,000,000
Subsequent Event | DWave System [Member] | Second Tranche Loan [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount			5,000,000
Subsequent Event | DWave System [Member] | Third Tranche Loan [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount			$ 5,000,000